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Genome stability and genome caretaking mechanisms 
 
 
Harm de Waard1, Gijsbertus T.J. van der Horst1, Jan H.J. Hoeijmakers1 
 
1  MGC, Department of Cell Biology and Genetics, Erasmus Medical Center Rotterdam, 
P.O. Box 1738, 3000 DR Rotterdam, The Netherlands 
 
 
1.1 Genome instability 
 
DNA contains the genetic information for the proper functioning of all cell types that make 
up an organism. Although this information should be error-free passed from generation to 
generation, DNA is prone to deterioration and modifications, originating from 
environmental and endogenous produced physical and chemical agents. For example, the 
UV-component of sunlight causes formation of helix distorting cyclobutane pyrimidine 
dimers (CPDs) and pyrimidine-(6,4)-pyrimidone adducts (6-4PPs). Ionizing radiation can 
cause single and double strand breaks in the DNA, and in addition intracellular reactive 
oxygen species (ROS) that subsequently can induce oxidative DNA lesions. Similarly, 
chemotherapeutics (e.g. cis-platinum and mitomycin C) and other environmental chemical 
agents (as present in inhaled smoke or polluted air) underlie a plethora of different DNA 
lesions, including oxidative DNA base damages, intra- and inter-strand cross-links, as well 
as monoadducts. Importantly, also endogenous chemicals and physical agents cause a wide 
variety of DNA lesions. Metabolic processes will lead to reactive oxygen species in the cell, 
which will react with proteins, lipids, but also with DNA, and as such underlying a broad 
spectrum of oxidative DNA lesions, including 8-oxo-2’-deoxyguanosine (8-oxodG), 
thymine glycols, cyclopurines, etc, as well as single and double strand breaks (31). Finally, 
spontaneous hydrolysis or modifications of nucleotides is common in cells, which leave 
non-informative a-basic sites or altered, miscoding nucleotides (106). 
 
1.1.1 Consequences of genome instability 
 
An immediate effect of DNA lesions is interference with transcription and replication (100, 
118), causing cellular dysfunctioning and leading to a cell cycle arrest or programmed cell 
death (apoptosis). In addition, persistent DNA damage can be misinterpreted by the 
replication machinery, which results in the induction of mutations. These mutations, as well 
as other genetic changes resulting from chromosome instability and mis-segregation 
(rearrangements, deletions, insertions, and numerical aberrations), can on the long term 
result in cancer and inborn diseases. Moreover, cellular dysfunctioning, depletion of 
proliferative capacity of cells by senescence (a permanent cell cycle arrest) and apoptosis can 
cause aging (reviewed by (77)).  
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1.1.2 Cellular defense against genome instability 
 
To counteract the deleterious effects of DNA damage, the cell is equipped with a wide 
variety of genome caretaking mechanisms. Various DNA repair machineries, with partially 
overlapping substrate specificity, are capable of repairing DNA damage (Figure 1, reviewed 
by (67, 81)). Known repair processes are nucleotide excision repair (NER), base excision 
repair (BER), direct damage reversal, double strand break repair, cross-link repair and 
mismatch repair. The specificity and function of these repair processes is discussed below. 
To provide cells with an extended  time window for repair, cells are able to transiently block 
cell cycle progression (reviewed in (16)). When repair fails, cells may abort their proliferative 
capacity by executing a permanent cell cycle block (senescence) (32) or apoptosis (19). Cells 
lost via apoptosis might be replaced by progenitors. In time, this may lead to a situation 
where the regenerative capacity of that particular tissue may be exhausted. This 
phenomenon  probably  underlies  the  process  of aging (reviewed by (77, 131)). Therefore, 
 
Figure 1  
DNA lesions and repair mechanisms  
At the top of the figure, examples of common DNA damaging agents are depicted. As indicated by the arrows, it is 
important to realize that many DNA damage inducing agents rather than inducing one specific type of lesion, 
produce a spectrum of different (classes of) lesions. Oppositely, different DNA damaging agents can cause similar 
DNA lesions. The middle part of the figure shows the DNA helix, with several DNA lesions, as depicted under 
the figure. The lower part of the figure shows the various repair pathways that cells use to remove these lesions. 
Note that these pathways overlap in damage spectrum (adapted from (44)). 
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apoptosis might not always be desirable and cells with persisting DNA damage, instead of 
executing apoptosis, may bypass DNA damage during replication at the risk of mutation 
induction.  The various repair pathways, apoptosis, cell cycle regulation, damage bypass and 
their relationship will be discussed in more detail in the following paragraphs. 
 
1.2 Repair mechanisms 
 
1.2.1 Nucleotide excision repair 
 
Nucleotide excision repair is a versatile DNA repair mechanism, capable of removing 
numerous types of helix-distorting lesions, like UV induced photoproducts. Other 
substrates for NER include reactive oxygen species (ROS) induced 5’,8-purine 
cyclodeoxynucleotides (28, 93) and bulky lesions, which could for example be caused by 
polycylclic aromatic hydrocarbons (as present in tobacco smoke and air pollution). NER 
functions by a “cut and patch”-like mechanism, in which damage recognition, local opening 
of the DNA helix around the lesion, damage excision and gap-filling are the successive steps 
(Figure 2, reviewed by (1, 46, 81)).  NER is composed of two subpathways that differ in the 
way lesions are recognized: global genome NER (GG-NER) and transcription-coupled 
NER (TC-NER). 
 
1.2.2 Global genome repair 
 
The first step in GG-NER is damage recognition by the heterodimer XPC/hHR23B/Cen2 
(9, 170, 197), which binds with higher affinity to helix-distorting DNA lesions than to non-
damaged double stranded DNA (dsDNA) (151, 171). Since damage recognition is highly 
dependent on the degree of DNA helix distortion, DNA lesions that only mildly disturb the 
helical structure are poorly recognized by XPC/hHR23B and as a consequence are 
inefficiently repaired by GG-NER. One such lesion is the UV-induced CPD. GG-NER of 
this photolesion is greatly enhanced by the damaged DNA binding complex (DDB) (82, 
173, 175). The DDB complex is composed of the DDB1 (damaged DNA binding protein 1, 
p125) and DDB2 protein (damaged DNA binding protein 2, p48, XPE). In rodents, in 
contrast to other mammals, expression of the p48 subunit of DDB is not up regulated upon 
UV, probably due to lack of a p53 responsive element in the p48 promoter (173). Therefore, 
rodents poorly repair CPDs by GG-NER. Similarly, XPC is up regulated by UV in a p53-
dependent manner, as determined both on the RNA and the protein level (3, 7). Thus the 
damage recognition step is likely the rate-limiting factor in the GG-NER reaction.  
Subsequent to damage recognition, the multisubunit transcription factor TFIIH and the 
structure-specific endonuclease XPG are recruited to the lesion (197, 207). TFIIH contains 
the XPB and XPD proteins that act as 3’-5’ and 5’-3’ helicases, respectively, and function in 
local unwinding of the DNA around the lesion (55, 64, 156, 157, 203). Initial stability of the 
open structure is guaranteed by the presence of the XPG protein (64, 132). After 
verification of the damage by the XPA protein (197), this open structure is further stabilized
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Figure 2 
Mechanism of nucleotide excision repair 
This figure shows the principle of nucleotide excision repair (NER) and its two subpathways, global genome NER 
(GG-NER) and transcription-coupled NER (TC-NER). In GG-NER, the XPC/hHR23B protein complex 
recognizes the helix distorting lesion. In contrast, TC-NER is initiated when RNA polymerase II is stalled upon a 
lesion, a step that requires the function of the CSA and CSB protein. After damage recognition, GG-NER and TC-
NER both use the XPB and XPD helicases from the TFIIH complex to unwind the DNA around the lesion. The 
initial open complex is stabilized by XPG.  Next, XPA verifies the lesion and RPA stabilizes the open intermediate 
by binding single stranded DNA. The structure specific endonucleases ERCC1/XPF and XPG cleave 5’ and 3’ of 
the lesion, respectively. The resulting 24-32 nucleotide fragment, containing the lesion, is subsequently removed 
and the remaining single strand gap is filled in by the regular replication machinery (adapted from (81)). 
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by XPA and replication protein A (RPA) (45, 64, 105, 168). Next, the endonucleases XPG 
and ERCC1/XPF cleave 3’ and 5’ of the lesion, respectively, thereby excising a 24-32 nt 
single stranded DNA (ssDNA) fragment containing the DNA damage (132, 137, 163). 
Using the undamaged strand as a template, filling of the ssDNA gap is performed by the 
regular DNA replication machinery, consisting of RPA, proliferating cell nuclear antigen 
(PCNA), replication factor C (RFC) and DNA polymerase δ and ε (1, 30, 162). Finally, the 
resulting nick is sealed by DNA ligase I (10, 15). 
 
1.2.3 Transcription-coupled repair 
 
Damage in the transcribed strand of active genes can arrest the transcription machinery, 
which can cause a temporary block of RNA synthesis. This particularly holds for lesions 
that are slowly (or even not) repaired by GG-NER. To quickly remove damage from the 
transcribed strand of active genes and to resume transcription, the cell is equipped with the 
transcription-coupled NER system (22, 99, 126, 127). This mechanism is initiated by stalling 
of an elongating RNA polymerase II upon a lesion (181). TFIIH and XPG are recruited to 
the site of damage and as in GG-NER, XPA is needed for the damage verification. The 
remaining repair reaction is executed by the same mechanism, used by GG-NER. The 
cross-talk between a blocked RNA polymerase and the actual repair reaction, as well as the 
way in which the damage is made accessible, is still matter of debate. However, it is clear 
that somehow CSA- (78), CSB- (182) and XAB2-gene products (133) are involved in these 
steps. It has been shown that cell lines mutated for the CSA or the CSB gene or with an 
inactivated XAB2 protein are deficient in performing TC-NER. As a consequence, these 
cells fail to recover RNA synthesis after induction of UV damage, which indicates that the 
transcription block is not released (118, 133).  
Since damage recognition in TC-NER does not depend on helix distortion, but instead on 
blockage of RNA polymerase II, the spectrum of lesions recognized by TC-NER and GG-
NER differs. For example, whereas CPDs are poorly (and in rodents almost not at all) 
recognized and repaired by GG-NER, these lesions efficiently block transcription and 
accordingly are efficiently repaired by TC-NER (22). Moreover, also some lesions that were 
previously thought to be repaired by base excision repair only, might cause a (transient) 
block of the transcription machinery and might therefore be repaired in a transcription-
coupled manner. Evidence for transcription-coupled repair of BER lesions is given by the 
slight hypersensitivity of human CSA and CSB fibroblasts for ionizing radiation (98) and by 
deficient repair of 8-oxodG in the transcribed strand of a gene, introduced to the cell by 
transfection (97). Although TCR of oxidative DNA lesions has been suggested, these 
lesions do not very efficiently block RNA polymerase. It is possible that TCR is needed for 
the subset of oxidative DNA lesion, which efficiently block RNA polymerase, or that a 
transient pausing of the RNA polymerase on the lesion is already sufficient to recruit the 
repair machinery. Whether, damage recognition of oxidative lesions is followed by repair via 
NER or BER is unknown. We will refer to TC-NER when clearly the transcription-coupled 
repair pathway of NER is meant and to TCR in cases where it is not per sé known whether 
NER or BER is involved. 
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1.2.4 Other repair mechanism 
 
Base excision repair 
 
Base excision repair (BER) is capable of removing a wide variety of nucleotide 
modifications, which are mostly not helix-distorting (reviewed by (66, 91)). This repair 
mechanism is considered as the main guardian against DNA lesions caused by cellular 
metabolism, including base adducts resulting from ROS, methylation, deamination and 
hydroxylation. The BER reaction starts by recognition of the lesion by a battery of 
glycosylases with overlapping lesion specificity.  These glycosylases act by flipping out the 
damaged base of the helix and subsequent cleavage of this base from the DNA sugar 
backbone, leaving an abasic site (54). These abasic sites can also arise spontaneously in the 
DNA by hydrolysis (106). Next, these abasic sites are converted into a single strand break 
by the action of either endonuclease APE1 (48), or by the intrinsic apurinc/apyrimidinic 
(AP) lyase activity that certain glycosylases posses (154). These breaks might as well occur 
from other sources, like γ-ray irradiation, and funnel into the BER reaction. Probably 
poly(ADP-ribose) polymerase (PARP) and polynucleotide kinase (PNK) are needed to 
protect these single strand nicks and to trim the ends for repair synthesis (202). 
The nicked DNA is further processed by either short-patch or long-patch repair. During 
short-patch repair, the dominant repair mechanism in mammals, DNA polymerase β 
(DNApolβ) performs a one-nucleotide gap-filling reaction and removes the 5’-terminal 
baseless sugar via its lyase activity (116, 166). Finally, the XRCC1-ligase3 complex seals the 
remaining nick (33). Long patch DNA repair involves DNApolβ, polδ/ε, PCNA and 
replication factor-C (RFC) for repair synthesis of a 2-10 nt patch, thereby replacing a small 
DNA flap. This flap is cleaved of by the FEN1 endonuclease and finally the nick is sealed 
by DNA ligase I (89, 117, 140, 143).  
 
Mismatch repair 
 
Erroneous base incorporation, as well as slippage of DNA polymerases during replication 
and recombination can cause single base-base mismatches and small  insertion/deletion 
loops. Such lesions are dealt with by the mismatch repair (MMR) pathway, which is capable 
of repairing both classes of mismatches, hereby preventing the accumulation of these 
mutagenic lesions (reviewed by (113)).  
Damage recognition is performed by the hMutSα en hMutSβ complexes. hMutSα (hMSH2-
hMSH6 heterodimer) recognizes base-base mismatches, 1 nucleotide insertion/deletion 
loops and 2-8 nucleotide insertion/deletion loops. In contrast, the less abundant present 
hMutSβ (hMSH2-hMSH3 heterodimer) only recognizes 2-8 nt insertion/deletion loops (72). 
Subsequently, MLH1-PMS2 (or to a lesser extent the MLH1-PMS1, or MLH1-MLH3) 
binds to these MutS-DNA complexes. The misinserted base(s) is distinguished from the 
original template and removed by exonuclease I (71). The eliminated strand is resynthesized 
by polδ, using the original DNA template (110). 
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Direct damage reversal 
 
In contrast to genome care-taking systems  that remove damage via a “cut and patch”-like 
mechanism (i.e. NER, BER and MMR), cells can also possess repair enzymes that directly 
revert specific DNA lesions to the undamaged bases. For example, alkyltransferases repair 
methylated nucleotides (like the highly mutagenic and cytotoxic O6-methylguanine) by 
transferring the methyl group of a damaged base to an internal cysteine. As a consequence 
of this reaction, the protein irreversible inactivates itself, showing an example of the use of 
one entire protein to repair only one DNA lesion (reviewed by (141)). 
Another example of direct damage reversal is given by photoreactivation, an enzymatic 
reaction in which photolyases cleave the UV-induced bond between two adjacent 
pyrimidines, using visible light as an energy source. Since damage recognition and repair is 
highly substrate specific for these enzymes, both CPD- and 6-4PP-photolyases exists. 
Photoreactivation occurs  in prokaryotes as well as in eukaryotes, but has not been observed 
in placental mammals (206).  
  
Double strand break repair  
 
Double strand breaks (DSBs) arise from ionizing radiation, free radicals and chemicals. In 
addition they are formed during replication of single strand breaks. To repair these 
deleterious lesions, the cell is equipped with two different repair mechanisms: homologous 
recombination (HR) and non-homologous end joining (NHEJ) (reviewed by (187, 189)).  
Homologous recombination uses the homologous sequences of the sister chromatids or 
homologous chromosomes to precisely and error-free repair the DSB.  Contrarily, NHEJ 
simply links two DNA ends together with little or no use of homologous sequences present 
in these ends. Use of microhomology close to the DNA ends may result in loss of small 
pieces of DNA. These deletions, as well as processing of the DNA ends, cause NHEJ to be 
an error-prone repair pathway. NHEJ is probably employed when sister chromatids are not 
present or when homologous recombination between chromosomes is undesirable because 
of the risk of loss of heterozygosity.  
 
Cross-link repair 
 
Cross-link repair, is capable of removing inter-strand cross-links, but of all repair process 
studied, is the poorest understood. This is probably due to the fact that it likely depends on 
many factors involved in other repair processes and apparently is the result of a 
combination of interwoven repair pathways (reviewed by (57)).  
While in yeast NER enzymes generate most of the incisions during interstrand cross-link 
repair, their function is less clear in mammals. Thus far, only mutant cell lines with defects 
in the NER endonuclease ERCC1/XPF are known to display severe cross-link sensitivity 
(40). Whether this sensitivity can be attributed to an endonucleolitic incision adjacent to the 
cross-link, or by another function of the ERCC1/XPF complex later in the reaction is still 
not clear. Although it is not completely sure whether  one of the first repair intermediates in 
repair in removal of cross-links is a double strand break, homologous recombination 
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proteins play an important role in the repair reaction, as illustrated by the severe cross-link 
sensitivity of cells with defective Rad51, Rad54, BRCA1 or BRCA2 genes (20, 40, 63, 172, 
209). Some reports suggest that translesion repair might be an alternative pathway in cross-
link repair (129, 211). Defects in other factors with mainly unknown function, like SNM1 
and FA genes (mutated in Fanconi anemia) also cause sensitivity to cross-linking agents (29, 
56). Therefore, these factors at least perform a function in the cellular cross-link response, 
or even may be directly involved in the cross-link repair reaction.  
 
1.3 Repair-related disorders 
 
1.3.1 Diseases associated with deficiencies in genome caretaking processes 
 
The importance of DNA repair and other vital genome caretaking processes is best 
demonstrated by a variety of rare autosomal recessive disorders. Most of the DNA repair 
associated diseases show an elevated cancer risk, underscoring the prime function of DNA 
repair in preventing cancer.  
For instance, mutations in mismatch repair genes are known to cause hereditary non-
polyposis colorectal cancer (HNPCC) (142). In the case of Fanconi anemia, a severe 
hypersensitivity for cross-link producing agents is observed. Clinical symptoms of Fanconi 
anemia include progressive bone marrow failure, developmental abnormalities, growth 
retardation and a predisposition to cancer (11). Failure to respond to double strand breaks 
underlie ataxia telangiectasia (mutations in ATM, a key player in cellular response to DSBs; 
(152, 155)), ataxia telangiectasia-like disorder (mutations in Mre11; (167)) and Nijmegen 
breakage syndrome (mutations in NBS1; (53)). All three DSB-repair related disorders 
display cancer predisposition, hypersensitivity to ionizing radiation and chromosomal 
instability (179).  
 
Table 1: Main clinical symptoms of XP, CS and TTD 
Clinical Symptoms XP CS TTD 
Photosensitivity ++ + + 
Abnormal pigmentation ++ - - 
Skin cancer ++ - - 
Progressive mental degeneration    -/+ * + + 
Neuronal loss    -/+ * - - 
Neurodysmyelination - + + 
Bird-like face - + + 
Growth defect   +/- * + + 
Hypogonadism  -/+ + + 
Brittle hair and nails - - + 
Ichthyosis - - + 
* These neurological and growth defects are characteristic features of XP patients with the 
DeSanctis-Cacchione syndrome 
(Adapted from (24)) 
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Diseases specifically associated with mutations in BER enzymes have only recently been 
described. Patients with a form of autosomal recessive adenomatous polyposis were shown 
to carry biallelic mutations in MYH (a glycosylase) (6, 37).  
Mutations in genes involved in NER underlie three different disorders: xeroderma 
pigmentosum (XP), Cockayne syndrome (CS) and trichothiodystrophy (TTD) (reviewed by 
(24, 44)). Clinical characteristics of XP, CS and TTD are summarized in table 1. Specific 
features of these syndromes will be discussed in more detail in the following paragraphs. 
Interestingly, mutations in the XPV gene, coding for translesion polymerase η, underlie the 
cancer prone variant form of xeroderma pigmentosum (85, 114). Since XPV is caused by a 
defect in translesion synthesis rather than in NER, we further consider XPV as a separate 
disease. Therefore in the following paragraphs we refer to XP as the NER deficient type of 
XP.  
 
1.3.2 Xeroderma pigmentosum  
 
Xeroderma pigmentosum can be considered as the “classical” NER-disorder. Although 
symptoms are heterogeneous in occurrence as well as in severity amongst the different XP 
patients, the diagnostic features of XP are a dry scaly skin (xeroderma), abnormal 
pigmentation in sun-exposed skin-areas (pigmentosum), photosensitivity, and a 1000 fold 
increased risk of developing UV-induced skin cancer. Besides this skin cancer 
predisposition, a 10-20 fold increased risk of developing several types of internal cancers 
before the age of 20 has been described (24). 
Complementation studies have shown the involvement of 7 genes in XP (XPA through 
XPG). While XPC and XPE are specifically deficient in the global genome repair pathway 
(82, 175, 195, 196), the other five complementation groups display defects in both 
subpathways. The generally mild XP features (except for the cancer risk) in XPC and XPE 
patients can be explained by the fact that the TC-NER pathway in these complementation 
groups is still functional. Moreover, many mutations in XP genes do not cause a complete 
inactivation of proteins, thereby providing the cell with residual repair capacity. This 
probably causes the milder forms of XP (reviewed by (24)).  
Most XP patients develop almost normally but die of neoplasia, which reduces their average 
life span by approximately 30 years (90). A fraction of XP patients (18 %) display 
accelerated mental retardation, likely caused by enhanced neuronal degeneration due to loss 
of neurons throughout the brain, spinal cord and peripheral nervous system. Symptoms 
associated with XP neurological disease include peripheral neuropathy, sensorineural 
deafness, and loss of reflexes, followed by ataxia, EEG chances, and dementia.  
Neurological symptoms only occur in XP patients belonging to complementation groups A, 
C and D and are associated with a severe or total loss of repair capacity ((150), reviewed by 
(27)). The most severe form of XP is seen in patients displaying the clinical spectrum of 
DeSanctis-Cachione syndrome, with symptoms including immature sexual development, 
growth retardation, mental retardation, microcephaly and sensorineural deafness (reviewed 
by (24)). 
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1.3.3 Cockayne Syndrome  
 
Similar to XP, Cockayne syndrome (CS) is characterized by photosensitivity of the skin. 
Somewhat surprisingly for a DNA repair disorder, CS is not associated with an increased 
skin cancer risk. This low cancer predisposition is probably associated with functional GG-
NER in CS cells and an increased apoptosis rate, that likely removes premutagenic cells. In 
contrast to classical XP, Cockayne syndrome attributes pleiotropic features with physical 
and mental retardation (reviewed by (24, 134)). In general, CS patients display skeletal 
abnormalities like kyphosis, bird-like face, and in older patients osteoporosis. Other CS 
characteristics include impaired sexual development, caries, cachexia, progressive 
neurological degeneration, as evidenced by delayed psychomotor development, 
sensorineural hearing loss and mental retardation. These neurological symptoms might be 
associated with microcephaly, calcification of basal ganglia of the brain and progressive 
“patchy” neurodysmyelination. Other symptoms associated with Cockayne syndrome are 
pigmentary retinopathy, thin hair and cataracts. The mean age of death is 12.5 years, mainly 
caused by respiratory infections, resulting from an overall poor condition of patients. Many 
of these symptoms classify CS as a progeroid disease.  
CS, like XP, is a heterogeneous disease and several forms have been described: mild CS, 
classical CS (CS I) and severe CS (CS II). As a hallmark of CS, cellular studies must show 
impaired UV survival and lack of RNA synthesis recovery. Patients with mild CS have a late 
onset of symptoms, and in some cases show normal growth, intelligence and reproductive 
capacity. In addition to the cellular phenotype, classical CS is diagnosed by the presence of 
at least two of the following characteristics: growth failure, neurodevelopmental problems, 
photosensitivity of the skin, pigmentary retinopathy and cataracts, sensorineural hearing 
loss, dental caries and cachectic dwarfism. Finally, CS II patients are characterized by a more 
severe and early onset of symptoms, causing a mean age of death around 6-7 years (134).  
Complementation studies revealed the involvement of two genes in the onset of CS, CSA 
and CSB (174). A correlation between complementation group and severity of CS has not 
been observed. A subset of mutations in XPB, XPD and XPG can lead to the combined 
phenotype of XP and CS. In contrast to classical CS-patients these patients are cancer prone 
(24). 
 
1.3.4 Trichothiodystrophy 
 
The hallmark of TTD is the occurrence of brittle hair that is dry, sparse and easily broken, 
as a result of the absence of sulfur-rich proteins (145). Many, but not all TTD patients, also 
present a scaly skin, known as ichtyosis. In addition to these specific TTD characteristics, 
TTD shares many features with CS, and is thereby categorized as a premature aging 
syndrome. Although most TTD patients are photosensitive, few cases of non-
photosensitive TTD have been reported. TTD exhibits a pattern of mental retardation, 
including: low IQ, spasticity, hyperreflexia, tremor and ataxia. Microcephaly and 
hypomyelination of the cerebellar white matter have been shown, as well as growth 
retardation and cachexia. Also skeletal abnormalities, like a bird-like face, axial 
Genome stability and genome caretaking mechanisms 19 
osteosclerosis, peripheral osteoporosis and kyphosis have been described. Like CS, TTD is 
not associated with an increased cancer risk. 
Genetically, TTD has been associated with mutations in XPB, XPD or TTDA. Hereby 
TTD is the third disease associated with XPB and XPD, clearly showing that specific 
mutations in these proteins can cause different diseases.  
 
1.3.5 XP, CS and TTD; defective NER and what else? 
 
As described in the previous paragraphs, XP, CS and TTD are associated with a NER-
defect. Photosensitivity, as observed in all three syndromes, as well as the increased cancer 
risk and hyperpigmentation in XP, can easily be explained by a defect in repair of UV 
induced DNA damage. The absence of cancer in CS can be attributed to proficient global 
genome repair in CS. Also other symptoms of XP, CS and TTD could possibly be 
connected to a repair defect of endogenous occurring NER-lesions (like 5’,8-purine 
cyclodeoxynucleotides). For example, the severity of neurological symptoms in XP patients 
correlates with the UV-sensitivity of fibroblasts derived from these patients (8). However, 
for many CS and TTD symptoms it is difficult to imagine a connection to defective NER 
and therefore these symptoms should probably be attributed to defects in other processes. 
For example, (partial) reduction in GG-NER- or TC-NER-activity can not explain the 
occurrence of specific TTD-characteristics, since these symptoms are not found in 
completely NER-deficient XPA patients. Since, mutations causing TTD are all found in 
components of the TFIIH complex, a link between defective transcription and the clinical 
onset of some TTD symptoms has been made (18, 23, 25, 43, 58).  
Another example is the notion that CS patients attribute in general more severe symptoms 
than XP patients, while in contrast to mutations in XP genes, mutations in CSA or CSB are 
associated with a TC-NER defect only (191, 194). To explain the CS features, additional 
roles for the CS proteins - outside the context of NER - have been suggested. Some of 
these functions are discussed below. 
CSB possesses chromatin remodeling activity and has affinity for histone tails (39). This 
activity can have a function in repair, but may also be required during transcription. Other 
indications that CSB might be involved in transcription are given by the interaction of CSB 
with TFIIH, and the fact that CSB is present in an RNA polymerase II-containing 
elongation complex (84, 176, 177, 190). Furthermore, CSB has been shown to function as a 
non-essential transcription elongation factor, required for bypass of pause-sites and of 
transcription of genes encoding structured RNAs (12, 51, 160, 208). Surprisingly, although 
CSA might as well interact with TFIIH (78), it does not reside in the same complex as CSB 
(190). A connection with transcription has not been shown for CSA, suggesting that 
although CSB might be involved in transcription, a transcription deficiency alone can not be 
held responsible for the onset of CS features. 
In addition, as discussed above, indications have been obtained for involvement of CSA and 
CSB proteins in repair of non-NER lesions, which suggests a wider action spectrum of 
transcription-coupled repair than NER lesions only (47, 97, 98). Interestingly, also cell lines 
from XP/CS patients with mutations in the XPB, XPD and XPG genes show a 
transcription-coupled repair defect for oxidative lesions (42, 97). In addition, CSB cell lines 
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have been reported to display a reduction of global genome repair of oxidative DNA 
damage, which may also contribute to the higher ionizing radiation sensitivity of these cells 
(139, 201). Also in XPG-CS patients, the repair of oxidative lesions may be further 
compromised by an additional reduction in global genome base excision repair (BER) (52, 
88, 201), contributing to the observed Cockayne syndrome phenotype. In chapter 2, 3 and 4 
we further investigate the link between non-classical NER lesions and Cockayne syndrome 
in Csa-/- and Csb-/- mice and cells derived thereof. 
 
1.4 When repair is incomplete 
 
Besides these various repair machineries, the cell is equipped with other defense-
mechanisms. To extend the time-window for repair, cells are able to arrest their cell cycle 
and thereby prevent induction of mutations during replication. However, when even this 
extra time is not enough to remove all lesions, or when conditions are encountered where 
rapid division is desired, cells can tolerate persisting DNA damage and continue replication. 
Since DNA polymerases are stalled by a variety of DNA lesions, specific damage tolerance 
mechanisms are needed for replication progression. However, these pathways can be error-
prone and thereby cause mutations. Alternatively, heavily damaged cells can be removed by 
senescence or apoptosis, to prevent genome instability. These pathways might be used if 
extra time is not enough to attenuate the damage load or if the risk of inappropriate 
replication is undesirable. The drawback of this strategy could be that cells have to be 
replaced, which ultimately might lead to exhaustion of the regenerative capacity of that 
particular cell compartment. In scope of this thesis we will discuss damage tolerance during 
replication, and the relation between NER and cell cycle arrest or apoptosis. 
 
1.4.1 Damage tolerance  
 
In order to prevent replication blockage when repair is too slow or even fails, the cell is 
equipped with two main mechanisms to bypass the damage during replication: damage 
avoidance and translesion synthesis (TLS) (reviewed by (17, 68, 119)).  
Damage avoidance is achieved by daughter strand gap repair or by DNA template 
switching. Daughter strand gap repair of newly synthesized DNA involves homologous 
recombination for repair of the gap that is formed as a result of dissociation and restart of 
the polymerase in the vicinity of the DNA lesion. During DNA template switching, the 
DNA polymerase transiently uses the newly synthesized DNA of the daughter chromatid to 
detour the DNA lesion. Since both mechanisms do not use the damaged template, these 
processes can be considered as error-free.  
In marked contrast, translesion synthesis is a process in which a collection of specific low-
fidelity translesion polymerases with a less stringent template usage (polζ-κ), put a 
nucleotide opposite the damage. TLS is initiated when the regular DNA polymerase gets 
stalled at a DNA lesion. Few bases after the damage, the normal processive DNA 
polymerase again takes over from the TLS polymerase. Since the chance of incorporation of 
a wrong nucleotide opposite the damaged base is rather high, these translesion polymerases 
can cause replication errors, which ultimately might cause cancer. However, since for 
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example polymerase η has a tendency to incorporate adenine opposite the damaged 
nucleotide, bypass of TT-photoproducts is error-free. The increased UV-induced cancer 
risk in XPV patients (which have mutations in polymerase η) forms an example of the 
protective activity of a translesion polymerase.      
 
1.4.2 Cell cycle arrest 
 
The cell is equipped with a set of checkpoints acting at different phases during the cell cycle.  
These checkpoints are meant to (1) prevent mitosis when the DNA is not yet fully 
replicated (G2/M checkpoint), (2) delay replication when DNA perturbations are signaled 
(intra-S-phase-checkpoint) and (3) prevent a premature start of replication (G1-checkpoint) 
(for recent reviews on cell cycle control see (2, 34, 161)).   
The first step in the cell cycle control process is damage sensing, leading to activation of 
transducers. This, in turn, can activate effectors that evoke the cell cycle block. Central 
transducers in the DNA damage checkpoint response are the protein kinases ATM and 
ATR. Both proteins are members of the PI3-kinase related protein kinase family and are 
activated upon DNA damage induction. While ATM is mainly activated by ionizing 
radiation, ATR is activated by exposure of cells to UV and ionizing radiation. Upon 
activation, both proteins phosphorylate numerous other effectors as well as primary 
sensors. Integration of the different signals of this effector-network and modification of the 
ATM- and ATR-activity by feedback loops, drive the decisions whether a cell should arrest 
in a specific phase of the cell cycle. The substrate specificity for ATR and ATM differs, 
which underlies the different cell cycle response upon ATM or ATR activation (2, 161).  
Although the core machinery of cell cycle control is known, it is less well understood how 
the DNA damage sensing process that leads to a cell cycle block, functions. Recently, it has 
been shown that  ATR  binds  preferentially  to  UV  damaged  DNA  (186),  and that ATR 
-together with is partner ATRIP- is recruited to the site of damage by its interaction with 
RPA (214). RPA binds single stranded DNA, which in many repair pathways (e.g. NER) is 
an intermediate. Therefore, this mechanism could provide the cell with a single activity to 
sense different classes of DNA damage. Whether, NER activity is needed for checkpoint 
activation remains under debate. In S. cerevisiae, Zhang et al. showed that checkpoint 
signaling is independent of NER (210). However, others show that NER activity is 
indispensable for proper G1 and G2 checkpoint response upon UV (74). Also for 
mammalian cells, it is not clear whether NER activity acts as one of the pathways that cause 
a cell cycle block.  Alternatively, sensing of DNA damage (and in particular for NER-type 
lesions) can be due to blockage of the transcription- or replication-machinery. It has been 
shown that UV light and other NER-type lesions block RNA polymerase II transcription 
(118, 159), and that the stalled RNA polymerase can initiate a cell cycle arrest in a p53 
dependent or independent manner (21, 35, 73, 83, 204). When induced during the S-phase, 
UV lesions might block the replication machinery and cause a cell cycle arrest (192). In 
hamster cells, photoproducts have been shown the underlying cause of this S-phase delay 
(138). Since the cells in that study were p53-deficient, this response is probably p53 
independent. In conclusion, upon UV treatment (and other genotoxic assaults) the cell is 
able to stop the cell cycle at different moments during the cell cycle. 
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1.4.3 Apoptosis 
 
As mentioned in paragraph 1.4, it may happen that the damage load exceeds the repair 
capacity of a cell, even after a prolonged repair period provided by a cell cycle block. These 
cells form a risk factor for the organism since there is a chance that these cells no longer 
properly perform their function. Even more important, re-entering into the cell cycle when 
the damage is still present can cause mutations, which might lead to loss of growth control 
and, as a consequence, initiate carcinogenesis. Therefore, it is often beneficial for the 
organism to eliminate such heavily damaged cells, rather than maintaining them as a 
potential risk factor. Two distinct pathways of cell death exist: apoptosis and necrosis 
(reviewed by (96, 158)). Necrosis is a passive, traumatic fate of cell death in which ion 
pumps fail, the cell swells, and then undergoes lysis, which will lead to an inflammatory 
response.  In contrast, apoptosis is a controlled form of cell death, characterized by cell 
shrinkage, dehydration, fragmentation of the nucleus and phagocytosis of cell remnants. 
The benefit of apoptosis over necrosis is the prevention of inflammation. In some cases 
however, the cell can just not perform apoptosis and is therefore eliminated by necrosis 
(101). For example, this occurs when the cellular energy level is too low to fuel the 
apoptosis process.  
Apoptosis execution, like the mechanism of cell cycle arrest, depends on sensing of the 
DNA damage. UV irradiation causes elevated p53 levels (26, 204). Several reports show that 
indeed induction of apoptosis by UV irradiation is p53 dependent (102, 183, 213). In line 
with these observations, it has been shown that p53 deficient cells are less sensitive to UV-
exposure than their p53 proficient counterparts (14, 65, 86). Contrarily, other investigators 
show UV induced apoptosis to be p53 independent (146, 183, 185) and do not observe an 
effect of a p53 deficiency on UV sensitivity (83). In sharp contrast to its role as apoptosis 
promoting factor, p53 has been reported to protect cells from UV-induced apoptosis (61, 
94, 95, 120, 123, 200). A protective role of p53 against UV induced apoptosis is further 
illustrated by an increase in UV sensitivity in p53 deficient cell lines (61, 65, 94, 164, 200).   
Probably, most of the differences in p53 dependence of UV-induced apoptosis can be 
attributed to the fact that different cell types as well as different p53 mutant models have 
been studied. For example, Tron et al show apoptosis in differentiated keratinocytes to be 
p53-dependent, while in undifferentiated keratinocytes p53 appears not to be required for 
apoptosis induction (183). However, mouse dermal fibroblasts have been reported to posses 
p53-dependent apoptosis on the one hand (102), and p53 protection against apoptosis on 
the other hand (94, 95). Strikingly, in the first study UV-B light was used to induce damage, 
while the latter two studies were performed with a UV-C source. Given the reported 
difference in p53 response upon UV-B and UV-C exposure (115), it could well be that the 
effect of p53 on apoptosis partly depends on the wavelength used. Although UV-B and 
UV-C light do not induce different photoproducts, the wavelength might well be a major 
determinant on the UV-response of cells, which may (in part) originate from other factors 
than DNA damage. For example, the activation of mitogen-activated protein kinases is 
more efficient with UV-C, rather than UV-B light (4, 50, 125). This could be due to the fact 
that UV-B, to a far greater extent than UV-C, is able to alter the redox state of the cell 
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through production of reactive oxygen species (ROS) (184). ROS have also been shown to 
contribute to UVB induced apoptosis (92). Like the wavelength of UV used, the cell 
environment (such as the substrate on which cells are grown) may also have an impact on 
the p53 dependency of apoptosis (183). Using a human cell line expressing a murine 
temperature-sensitive p53 mutant protein (allowing tightly and reversibly regulation of p53 
function), it was shown that p53 induces distinct pro-apoptotic and anti-apoptotic signals, 
which could be separated both temporally and by the requirement for de novo protein 
synthesis (122). Taken together, UV induced apoptosis can be executed via p53-dependent 
and -independent pathways. Moreover p53 possesses activities that counteract its pro-
apoptotic function. 
The role of p53 in protection against apoptosis is probably linked to its role in repair and 
RNA synthesis recovery upon induction of UV damage (and other NER damages). For 
example, it has been shown that attenuation of p53 function causes only a modest increase 
in UV induced apoptosis in normal human fibroblasts. However in p53/XPC deficient 
human fibroblasts (120) a strong UV induced hyperapoptotic response is observed which 
strongly correlates with the strength of the RNA synthesis block. This suggests a protective 
role of p53 against apoptosis by promoting RNA synthesis recovery (120). A function of 
p53 in RNA synthesis recovery upon UV treatment has been suggested by several other 
reports (14, 122-124, 128). Moreover p53-dependent stimulation of NER has been 
suggested (14, 61, 65, 82, 104, 115, 124, 128, 153, 164, 165, 173, 178, 198-200, 212). 
Cells with a TC-NER- or with a total NER-deficiency are not able to repair damage in the 
transcribed strand and are unable to restore a transcription arrest after genotoxic treatment 
(118). Several reports show that TC-NER deficient cells are hyperapoptotic, both in vitro 
and in vivo (13, 26, 41, 70, 108, 124, 192). Although, RNA polymerase II, when stalled on 
DNA damage, is an efficient inducer of p53 (26, 41, 108, 109, 204) and p53 induction 
strongly correlates with execution of apoptosis, the latter process can be at least partially 
p53 independent in TC-NER deficient cell lines and mice (111, 120, 146, 147). Evidence is 
accumulating that the apoptotic response of TC-NER deficient cell lines vanishes at high 
UV doses (121, 149). Since, the attenuation of the apoptotic response in TC-NER deficient 
cells coincides with their inability to enter S-phase, it seems that replication is a prerequisite 
for apoptosis induction (121). In line with these findings, it has been shown that apoptosis 
in ERCC1 and ERCC3 (XPB) mutant Chinese hamster fibroblasts is predominantly 
occurring in the second cell cycle after UV treatment (59, 60). This coincides with 
replication-induced double strand breaks which probably induce the apoptotic response (60, 
86). Proietti De Santis et al. showed that in CSB-deficient Chinese hamster’s fibroblasts part 
of the apoptosis is related to entry into the S-phase, and part can occur during G1 phase. 
This suggests the existence of different mechanisms of apoptosis induction upon 
transcription stalling (147, 148). 
Beside induction of apoptosis by arrested RNA polymerases, other sensing mechanisms for 
NER type of lesions might exist. For example, prolonged S-phase arrest (138) and also 
damage in the non-transcribed areas of the genome can contribute to apoptosis (this study, 
chapter 5). 
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1.4.4 Link between repair, cell cycle and apoptosis 
 
Repair, cell cycle regulation, and apoptosis are not separate processes that function 
independently. As described earlier, some repair factors or repair intermediates are signaling 
to the cell cycle machinery. Moreover, many factors are functional in more than one process 
(for reviews see (5, 19)).  For example, whereas the p53 protein is already known for its 
function in regulation of the cell cycle, as well as in apoptosis-execution, it recently also has 
been shown to stimulate NER (65, 115, 124, 153, 164, 165, 178, 198, 199, 212). Use of a 
particular factor in multiple pathways provides the cell with the possibility to decide - 
depending on the situation - which pathway it is going to use. For instance, only low dose 
UV irradiation stimulates NER in a p53 dependent fashion, whereas at higher UV doses a 
p53 dependent apoptotic response is activated (102). Also, the balance between cell cycle 
arrest and apoptosis is partly influenced by the cellular level of p53 and partly requires 
separate p53 functions (38). 
In conclusion, it seems that repair, cell cycle arrest and apoptosis are inter-regulated and that 
a specific balance between these different genome caretaking processes exists.  
 
1.5 The importance of different genome caretaking processes in a variety of 
cell types 
 
Vertebrates are built up of a wide spectrum of different cell types, all with their specific 
functions and demands. All cells are somewhere in the spectrum between terminally 
differentiated, without any possibility to be replaced, till totally undifferentiated with a good 
chance to be replaced. Since all these cells have different needs and functions, it appears 
logical that they may need a different balance between the interwoven processes of repair, 
cell cycle control and apoptosis that together are responsible for genome caretaking. For 
example, persisting DNA damage can cause mutations, when replicated, which ultimately 
will cause cancer. To counteract the chance of cancer induction, cells can be eliminated by 
apoptosis. However, when apoptotic cells are not replenished in time, this can lead to organ 
dysfunctioning. Moreover, even when a high apoptotic rate is sufficiently compensated by 
new cells, the organism can still suffer from the effect of apoptosis, as elevated levels of 
apoptosis and tissue regeneration can lead to depletion of the specific stem cell 
compartment. This process has been suggested to contribute to aging and likely forms the 
connection between aging and impaired repair (reviewed in (131)). Therefore, not only the 
need of the specific cell, but also the balance between cancer and aging demands for a 
specific cell-type-dependent response upon DNA damage. In the following paragraphs, 
some examples of a specific DNA damage response in defined cell types will be discussed. 
 
1.5.1 Genome caretaking in neurons and other post-mitotic cell types 
 
Neurons are probably the epitome of terminally differentiated cells. A given number of 
neurons should perform their task during the entire life time of an organism.  Since neurons 
do not proliferate and are generally not replaced when lost, it is important that such cells 
stay in good condition over a long time. In the absence of replication, the chance of gaining 
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mutations and development of cancer is negligible. This suggestion is supported by the 
rarity of neuronal tumors. Because of their terminally differentiated status, there is probably 
little variation in the transcriptional program of neurons. Together with the notion that 
neurons do not divide, this suggests that removing DNA damage from non-transcribed 
DNA (representing the bulk of their genome) is dispensable in these cells. Indeed, a low 
level of global genome NER in neurons has been reported (87, 136, 169). Over time, this 
reduced GG-NER activity probably causes an elevated damage load in the entire genome. 
Under extraordinary conditions, as is the case when non-cycling neurons are forced to re-
enter the cell cycle, this increased damage load may cause a replication catastrophe. 
Interestingly, it has been shown that neuron death in Alzheimers disease happens after re-
entry into the cell cycle (205).  
In contrast to GG-NER, TC-NER is active in neurons, allowing efficient repair of the 
transcribed strand of active genes. Moreover, it has been shown that in certain cells also the 
non-transcribed strand of transcribed genes is repaired more efficiently than nontranscribed 
DNA (76, 135, 136). The latter mechanism, associated with repair of active regions (but not 
per sé with repair of the transcribed strand) is named differentiation associated repair 
(DAR). Repair of the non-transcribed strand of active genes is needed for maintaining an 
error-free template for repair of the transcribed strand of active genes by TC-NER.  
Nouspikel et al. suggest that DAR is active in a range of different cell types (135), although 
these cells differ from neurons in the sense that they can be replaced. For example, Ho and 
Hanawalt show that upon differentiation of L8 myoblasts to myocytes, global genome 
repair is largely lost while gene specific repair is improved. They do not show a strand bias 
in repair of active genes, suggesting the existence of DAR in myocytes (80). Recently, this 
finding was disputed since differences in global genome repair between cardiac myocytes 
and fibroblasts could not be detected. Moreover, TC-NER is similar in fibroblasts and 
myocytes (188). The existence of DAR, at least in some cell types, is a fine example of an 
adaptation of a repair mechanism to the demands of a specific cell type (for review see 
(135)). 
 
1.5.2 Genome caretaking in differentiating keratinocytes 
 
It is well known that keratinocytes do not form a homogenous cell population within the 
epidermis. New keratinocytes are continuously generated from cells in the basal layer of the 
epithelium, and subsequently differentiate progressively while migrating towards the surface 
where these cells ultimately shed off (69). The spectrum of differences in proliferative 
capacity and differentiation status in keratinocytes, together with the fact that these cells are 
severely challenged by UV light in sun-exposed areas of the human body, make these cells 
an interesting example to study how different genome caretaking processes interact.   
Keratinocytes are more resistant to UV irradiation than fibroblasts, present in the 
underlying dermis (49). Despite their reduced UV sensitivity, keratinocytes are more 
susceptible to UV induced apoptosis than fibroblasts. This seeming discrepancy is probably 
caused by the fact that sensitivity not only reflects the apoptotic response of a cell, but also 
other pathways of cell death and persistent cell cycle blocks. In contrast to keratinocytes, 
fibroblasts attribute a prominent G1-S phase arrest after UV irradiation. It has also been 
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shown that repair of CPDs in the global genome is more efficient in keratinocytes 
compared to fibroblasts (49). These findings are indicative for a clear divergence in the use 
of different genome caretaking processes in two distinct cell types. As mentioned, 
keratinocytes do not form a homogeneous cell population and therefore differences might 
exist between keratinocytes at various stages in differentiation. 
Several lines of evidence show that DNA repair in differentiated keratinocytes is less 
efficient than in their undifferentiated proliferating counterparts (103, 107, 130). Moreover, 
whereas in undifferentiated keratinocytes NER is p53 regulated, this regulation fades in 
differentiated keratinocytes (103). Tron et al. show that in contrast to NER, apoptosis is 
more prominent in differentiated mouse keratinocytes (183). This finding is in line with the 
observation that sunburn cells, which are in fact apoptotic cells, are predominately located 
in the suprabasal, differentiated keratinocyte compartment of the human skin (75). 
Mirroring the NER situation, apoptosis in undifferentiated keratinocytes is p53 independent 
and becomes p53 dependent upon differentiation (183). Interestingly, also formation of 
sunburn cell is p53 dependent in the mouse skin (213). These findings are in contrast with 
the reported decline in apoptosis upon differentiation in human keratinocytes (36). This 
discrepancy might be due to a difference between mouse or human keratinocytes, or to 
differences in culture conditions, which can drastically influence apoptosis (36). 
Notwithstanding this discrepancy, it is clear that differentiation status of the cell is a major 
determinant in genome caretaking decisions in keratinocytes. Evidently, this balance in the 
use of different genome caretaking processes in a certain cell is logically influenced by the 
need of that particular cell and the organ it is part of. For instance, loss of the epidermis 
would resemble a third-degree burn, probably resulting in death. Therefore DNA repair is 
the preferred method of managing damaged DNA in basal keratinocytes, including the cell 
population they originate from. In the differentiated compartment of the epidermis, 
apoptosis may be an acceptable manner for eliminating damaged cells, as differentiating 
keratinocytes have a limited life time anyway. 
 
1.5.3 Genome caretaking in undifferentiated cells 
 
Embryonic stem cells are the precursors of all different cell types present in the body.  
Therefore, mutations in these cells could have detrimental consequences to the whole 
organism. Early phases of embryonic development are associated with a dramatic rate of 
proliferation of undifferentiated cells. During this developmental stage, the cell cycle can 
even be as short as 3.5 to 7.5 hours (112). Since proliferation and differentiation are tightly 
time and space regulated, it is not difficult to envisage that a transient cell cycle block after 
DNA damage will dramatically interfere with the developmental program, and therefore is a 
non-favorable option. Instead, Heyer et al. show that upon in utero irradiation with ionizing 
radiation at a dose, that does not cause any effect in somatic cells, early embryonic cells 
show a hyper-apoptotic response (79). This apoptotic response is most prominent in 5.5 up 
to 8.5 days old embryos, appears clearly restricted to cells of the embryonic lineage, and is 
not observed in the extra embryonic regions. Moreover, within the embryonic region most 
apoptosis is observed in the ectoderm, indicative for a lineage specific DNA damage 
response, and resulting in a 50 % reduction in number of animals born. Notwithstanding 
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this high level of intra-uterine death after in-utero radiation, all animals born are healthy, 
fertile and do not develop any abnormalities, as determined up to 10 months after birth. 
This suggest that apoptosis apparently is an effective way to protect the embryo from 
developing large malformation, however at the cost of death of a subpopulation of 
embryos.  
Also ES cells, when challenged with DNA damaging compounds, are hyper-apoptotic (62, 
180, 193). This hyper-apoptotic response, as observed in (relative) undifferentiated 
embryonic cells, is probably reflected in other undifferentiated cells. For example, it has 
been shown that ionizing radiation exposure of the small intestine causes apoptosis in stem 
cells of the crypt, but not in the more differentiated cells in the villi (144).  
Although apoptosis plays a prominent role in protecting stem cells against genotoxic insults, 
also a role for DNA repair exist. This is evident from the sensitivity of ES cells that lack 
certain DNA repair pathways to DNA damaging agents (62, 180, 193). Also, a differential 
use of repair pathways with overlapping substrate specificity has been observed. Essers et al. 
showed that while double strand break repair in differentiated cells largely depends on the 
error prone non homologous end joining, in ES cells the error free repair of double strand 
breaks by homologous recombination is an alternative (62). Van Sloun et al. show that NER 
is functional in ES cells, however, repair capacity seems to be saturated a low dose (193). So 
far it is unknown how processes like TC-NER and GG-NER are regulated in ES cells, and 
whether, as shown for neurons, these processes are differentially regulated compared to 
other cell types. In this study we examined the role of TC-NER and GG-NER in protection 
of ES cells and more differentiated cells against various genotoxic agents. We also relate 
deficiencies in either TC-NER, GG-NER or in total NER to the apoptotic and cell cycle 
response of ES cells.  
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Abstract 
 
Mutations in the CSB gene cause Cockayne syndrome (CS), a rare inherited disorder, 
characterized by UV sensitivity, severe neurodevelopmental and progeroid symptoms. CSB 
functions in the transcription-coupled repair (TCR) subpathway of nucleotide excision 
repair (NER), responsible for the removal of UV-induced and other helix-distorting lesions 
from the transcribed strand of active genes. Several lines of evidence support the notion 
that the CSB TCR defect extends to other non-NER type transcription-blocking lesions, 
notably various kinds of oxidative damage, which may provide an explanation for part of 
the severe CS phenotype. We used genetically defined mouse models to examine the 
relationship between the CSB defect and sensitivity to oxidative damage in different cell 
types and at the level of the intact organism. The main conclusions are: (1) Csb-/- mouse 
embryo fibroblasts (MEFs) exhibit a clear hypersensitivity to ionizing radiation, extending 
the  findings  in genetically heterogeneous human CSB fibroblasts to another species. (2) 
Csb-/- MEFs are highly sensitive to paraquat, strongly indicating that the increased 
cytotoxicity is due to oxidative damage. (3) The hypersensitivity is independent of genetic 
background and directly related to the Csb defect and is not observed in totally NER-
deficient Xpa-/- MEFs. (4) Wild type embryonic stem (ES) cells display an increased 
sensitivity to ionizing radiation compared to fibroblasts. Surprisingly, the Csb deficiency has 
only a very minor additional effect on ES cell sensitivity to oxidative damage and is 
comparable to that of an Xpa defect, indicating cell-type-specific differences in the 
contribution of TCR and NER to cellular survival. (5) Similar to ES cells, Csb and Xpa mice  
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both display a minor sensitivity to whole body X-ray exposure. This suggests that the 
response of an intact organism to radiation is largely determined by the sensitivity of stem 
cells, rather than differentiated cells. These findings establish the role of transcription-
coupled repair in resistance to oxidative damage and reveal a cell- and organ-specific impact 
of this repair pathway to the clinical phenotype of CS and XP. 
 
2.1 Introduction 
 
Cockayne syndrome (CS) is a rare inherited DNA repair disorder, with a wide range of 
physical and mental manifestations, including: UV-sensitivity, severe postnatal growth 
failure, cachectic dwarfism, mental retardation, retinal degeneration, deafness, associated 
with neurodemyelination and skeletal abnormalities including osteoporosis and a bird-like 
face. Various symptoms point to premature aging, classifying Cockayne syndrome as a 
progeroid condition. The mean age of death is 12.5 years, mainly caused by respiratory 
infections, associated with neurological problems, and overall poor condition of patients. 
Complementation studies revealed the involvement of two genes in the onset of CS, CSA 
and CSB (for review see (3, 33)). 
In mammals, helix-distorting DNA lesions induced by UV-light and numerous chemicals 
are removed by the nucleotide excision repair (NER) pathway. NER functions by a ‘cut and 
patch’-like mechanism in which the damaged nucleotide is removed together with some 
flanking sequences. The resulting single-stranded gap is filled in by DNA polymerase and 
ligase (for review see (9, 16, 25)). Two NER sub-pathways exist: global genome NER (GG-
NER) repairs helix-distorting base damages in the entire genome, while transcription-
coupled NER (TC-NER) specifically repairs transcription-blocking lesions in the 
transcribed strand of active genes. Some transcription-blocking lesions such as UV-induced 
cyclobutanepyrimidines (CPDs) are repaired inefficiently by GG-NER: thus repair in the 
transcribed strand mainly depends  on TC-NER. CSA- and CSB-deficient cells are 
specifically impaired in this TC-NER pathway (49). 
The prototype NER disorder is xeroderma pigmentosum (XP), which shares with CS the 
pronounced UV sensitivity. Otherwise the diseases are remarkably dissimilar: XP features 
include pigmentation abnormalities in sun-exposed skin-areas and a more than 1000-fold 
increased risk of skin cancer, which is strikingly absent in CS. Many XP patients develop 
quite normally but die of neoplasia, reducing their life span by an average of 30 years (3). 
Accelerated mental retardation has been noted in a fraction of XP patients, likely caused by 
enhanced neuronal degeneration due to loss of neurons (35), contrasting with the much 
more severe progressive mental deterioration in CS due to neurodemyelination (35). 
Complementation studies have shown the involvement of 7 genes in XP (XPA through 
XPG) (3). Defects in both NER sub-pathways are observed in 5 out of 7 XP 
complementation groups: XPC and XPE are specifically deficient in the global genome 
repair pathway (17, 42, 50, 51). A subset of mutations in XPB, XPD and XPG can lead to a 
combined phenotype of XP and CS (3).  
The notion that mutations in CSA and CSB are associated with defects in only one pathway, 
TC-NER, is difficult to reconcile with the more severe symptoms observed in CS compared 
to XP patients, which frequently carry defects in both GG-NER and TC-NER. Additional 
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roles for the CS proteins outside the context of NER have been suggested. It has been 
shown that CSB can remodel chromatin and has affinity for histone tails (5). CS proteins 
may have an auxiliary function in transcription. Moreover CSA and CSB have been reported 
to physically interact with TFIIH, a protein complex involved in NER and transcription 
initiation (15, 38, 43) and a fraction of CSB resides in an RNA polymerase II-containing 
elongation complex (43, 48). Along the same lines, evidence has been collected for a role of 
CSB as a non-essential transcription elongation factor, required for bypass of pause-sites 
and of structured RNA (2, 11, 37, 56). In addition, indications have been obtained for 
involvement of CSA and CSB proteins in repair of non-NER lesions. TC-NER deficient 
human CSA and CSB fibroblasts display a slight hypersensitivity to ionizing radiation, 
which is not observed with completely NER-deficient XPA patient fibroblasts (23) and is 
attributed to defective transcription-coupled repair of oxidative lesions (23), suggesting a 
wider action spectrum of transcription-coupled repair than only NER lesions. In view of the 
ubiquitous occurrence of oxidative damage, the biological impact of this lesion may be 
significant. Interestingly, also cell lines from XP/CS patients with mutations in XPB, XPD 
and XPG show a transcription-coupled repair defect for oxidative lesions (7, 22). In XPG-
CS patients the repair of oxidative lesions may be further compromised by an additional 
reduction in global genome base excision repair (BER), contributing to the observed 
Cockayne syndrome phenotype (7, 12, 54).  
In recent years, mouse models for XPA and CSB have been generated (10, 32, 47). Xpa-
deficient mice resemble to a considerable extent the human phenotype. The Csb mutant 
mouse mimics the human phenotype in terms of the repair defect and manifestation of UV-
sensitivity of skin and eyes and retinal degeneration. In contrast to CSB patients, UV- or 
DMBA-induced cancer predisposition and only mild neurological problems have been 
observed in CSB mutant mice (47). 
These mouse models provide an excellent system to analyze genotype-phenotype relations 
in a defined and homogenous genetic context and not only allow studies in a variety of cell 
types and tissues, but, importantly, also in the intact organism. Here we present a systematic 
analysis of the spectrum of sensitivities caused by the Csb and Xpa defects. 
 
2.2 Materials and methods 
 
2.2.1 Cell lines 
 
Isolation of primary Csb-/- (FVB/129Ola) and Xpa-/- (C57Bl6J/129Ola) MEFs and 
corresponding wt cell lines has been described (10, 47). Cells were cultured in F10/DMEM 
(1:1) (Gibco) medium, supplemented with 10 % fetal calf serum and 50 µg/ml penicillin 
and streptomycin (Gibco). Spontaneously immortalized cell lines were obtained by 
continuous subculturing of primary MEFs.  
Wild type, Csb-/- and Xpa-/- embryonic stem (ES) cells were isolated from blastocysts (3.5 
days post coitum) obtained from wt, Csb-/- and Xpa-/- mice intercrosses respectively (all in a 
C57Bl6J genetic background). Day 3.5 embryos were isolated and individually placed into a 
gelatinized well of a 24-well plate. After incubation for 7 days, without medium 
replacement, the wells were washed with PBS and single inner cell mass outgrowths were 
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carefully dislodged. After incubation for 5 min at 37°C in 100 µl trypsin/EDTA, they were 
mechanically dissociated in small cell clumps (2-5 cells). Finally, they were transferred to a 
12-well plate with a feeder-layer. Feeder-layers were obtained by lethal irradiation from 
confluent primary MEF cultures irradiated with 20 Gy from a 137Cs-source. Medium was 
changed every other day and colonies were picked 5-14 days after plating the dissociated 
inner cell mass. Colonies were dissociated by trypsin/EDTA and plated on gelatinized 
plates. Alternatively, in stead of picking colonies the whole well was trypsinized and plated 
on gelatinized plates. ES cells were maintained on gelatin-coated dishes in 50% buffalo rat 
liver cell conditioned DMEM / 50 % fresh DMEM supplemented with 15 % fetal calf 
serum, 0.1 mM non-essential amino acids (Gibco), 50 µg/ml penicillin and streptomycin 
(Gibco), 1000 U/ml leukemia inhibitory factor (Chemicon) and 0.1 mM 2-mercaptoethanol 
(Sigma) .  
 
2.2.2 Cellular sensitivity studies 
 
For determination of the γ-ray-sensitivity of immortalized MEFs and ES cells, cells were 
plated in 6cm dishes, at various dilutions. After 12-16 h, cells were irradiated with a single 
dose in the range of 0-8 Gy using a 137Cs source. Cells were grown for 5 to 14 days, fixed, 
stained and counted to asses the colony-forming ability. All experiments were performed in 
triplicate.  
UV sensitivity was determined as described (39). Briefly, MEFs were exposed to different 
doses of UV (254 nm, Philips TUV lamp) and allowed to grow for another 3-5 days, before 
reaching confluency. The number of proliferating cells was estimated by scintillation 
counting of the radioactivity incorporated during a 3 hr pulse with [3H]Thymidine 
(5µCi/ml, s.a. 40-60 Ci/mmole; Amersham). Cell survival was expressed as the ratio of 3H- 
incorporation in treated and non-treated cells. This protocol was adapted for paraquat 
survival by growing MEF cultures for 3-5 days in medium containing different 
concentrations of paraquat, followed by determination of the amount of proliferating cells 
as described above. 
RNA synthesis recovery after UV treatment was measured according to Mayne et al. (1982) 
(29). Cells were exposed to 10 J/m2 of UV (254 nm, Philips TUV lamp) allowed to recover 
for 16 hr, labeled 1 hour with [5,6-3H]uridine (10 µCi/ml, s.a. 50 Ci/mmole; Amersham), 
and processed for autoradiography. The relative rate of RNA synthesis was expressed as the 
quotient of the number of autoradiographic grains over the UV-exposed nuclei and the 
number of grains over the nuclei of non-irradiated cells (average of 50 nuclei per cell line).  
  
2.2.3 X-ray irradiation of mice 
 
Wild type (n=45), Csb-/- (n=38) and Xpa-/- (n=37) mice in a C57Bl6 background received 
total body irradiations of 2.2 Gy for 5 consecutive days (cumulative dose 11 Gy) using a 
200kV X-ray machine operating at 20 mA. Animals (3-8 mice/cage) were irradiated in a 
filter-top containing polyethylene cage fitting in the 18x24cm field of the applicator. At a 
source to target distance of 74cm, a dose rate of 0.31 Gy/min was obtained. Dosimetry 
indicated a dose variation of less than 5% over the irradiation field. Except for the 
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irradiation procedure, animals were housed in sterile micro-isolators to minimize the risk of 
infections and followed for 30 days after the last irradiation. Animals were daily screened for 
discomfort. Differences in radiosensitivity of wt and mutant mice were assessed on the basis 
of the time interval between the last dose and death (latency period). Mice that died during 
the experiment as well as surviving animals (euthanized at day 30) were fixed in 1 % 
formalin for pathology. Animal experiments were approved by the local animal ethical 
committee of the Erasmus University Rotterdam. 
 
2.3 Results 
 
2.3.1 Csb-/- mouse embryonic fibroblasts are hypersensitive to γ-ray irradiation 
 
To critically investigate whether cells from Csb-/- mice are more sensitive to ionizing 
radiation than cells from wild type (wt) and Xpa-/- mice, we performed clonogenic γ-ray 
survival experiments on spontaneously immortalized Csb-/-, Xpa-/- and wt mouse embryonic 
fibroblasts (MEFs). Figure 1a shows that Csb-/- MEFs are approximately two times more 
sensitive to a single dose of γ-ray irradiation than MEFs derived from wt littermates. Xpa-/- 
MEFs, which are completely deficient in both NER sub-pathways show similar γ-ray 
survival as wt MEFs (Figure 1a). The observed difference in γ-ray survival rates of Csb-/- and 
Xpa/- MEFs is in contrast to UV-survival characteristics. As shown in figure 1b, Xpa-/- and 
Csb-/- MEFs are both hypersensitive for UV-irradiation, although Csb-/- MEFs appear 
slightly more resistant than Xpa-/- MEFs. The difference presumably reflects the relatively 
minor contribution of global genome NER to UV survival. Thus, we observe a specific 
Figure 1  
Survival of wild type, Csb-/- and Xpa-/- mouse embryonic fibroblasts after exposure to γ-ray or UV-light. 
Panel A: Survival of spontaneously immortalized Csb-/- (diamonds), Xpa-/- (open triangles) and wild type (squares) 
MEFs after exposure to increasing doses of γ-rays, as determined by the colony survival assay. Panel B: Survival of 
spontaneously immortalized Csb-/- (diamonds), Xpa-/- (open triangles) and wild type (squares) MEFs after exposure 
to increasing doses of UV-light (254 nm), as determined by the [3H]-thymidine incorporation assay. For each cell 
line, experiments were performed at least 3 times and for each genotype identical results were obtained with at least 
two independent cell-lines (data not shown). Representative examples are shown. Bars indicate the standard error 
of the mean. 
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Figure 2  
Sensitivity of Csb-/- mouse embryonic fibroblasts 
to paraquat. 
Paraquat survival of  spontaneously immortalized 
Csb-/- (diamonds) and wild type (two independent 
lines; closed and open squares) mouse embryonic 
fibroblasts. Experiments were performed at least 3 
times per cell line, as determined by the [3H]-
thymidine incorporation assay. Shown are 
representative curves. Bars indicate the standard 
error of the mean.
γ-ray sensitivity of Csb-/- MEFs, which 
differs from the UV sensitivity, indicating 
that this sensitivity is not caused by a 
classical NER-deficiency. 
To investigate the effect of variations in 
genetic background on the observed γ-ray 
sensitivities, we determined the γ-ray 
survival of wt MEFs from genetically 
different mouse strains (FVB/129OLA, 
C57Bl6/129OLA, C57Bl6). No difference 
in γ-ray-sensitivity was detected (data not 
shown); indicating that influence of genetic 
background is negligible.  
 
2.3.2 Sensitivity of Csb-/- MEFs to γ-ray-
irradiation is probably due to oxidative 
lesions. 
 
Treatment of cells with γ-rays causes 
different classes of DNA lesions, including 
single and double strand DNA breaks and 
various types of oxidative base damages. To 
determine whether γ-ray sensitivity in Csb-/- MEFs originated from oxidative DNA lesions, 
we treated these cells with paraquat. Enzymatic reduction of paraquat produces paraquat 
radicals, which react with molecular oxygen, thereby generating a superoxide anion that is 
converted into hydrogenperoxide. This inflicts oxidative stress to cells and thereby causes 
oxidative DNA injury (1). Figure 2 shows that Csb-/- MEFs are approximately two times 
more sensitive to paraquat treatment than wt MEFs, which is strikingly similar to the γ-ray-
sensitivity. In conclusion these data strongly suggest that the sensitivity of Csb-/- MEFs to 
both γ-ray and paraquat treatment is caused by oxidative DNA lesions. 
 
2.3.3 Hypersensitivity of Csb-/- MEFs for paraquat and γ-rays is due to a CSB defect 
 
To find out whether the observed paraquat sensitivity of Csb-/- MEFs is indeed due to the 
Csb defect, we transfected a human CSB cDNA into these cells and selected clones which 
stably express the exogenous CSB. In line with previous findings with CSB-deficient CHO 
mutants (45) introduction of the human CSB cDNA induces a detectable albeit incomplete 
rescue of UV sensitivity and RNA synthesis recovery after UV-treatment (Figure 3a and 
3b). Thus, expression of the human CSB cDNA partly corrects the UV-phenotype of Csb-/- 
MEFs. Concomitantly, transfected MEFs have acquired increased resistance to paraquat 
treatment (Figure 3c). Similar results are obtained with γ-ray irradiation (data not shown). 
Therefore, we conclude that the observed sensitivity of Csb-/- MEFs to paraquat treatment 
and γ-ray-irradiation is caused by the Csb defect and not by other genetic factors. The partial 
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Figure 3 
Correction of the Csb sensitivity by hCSB cDNA. 
Panel A: Survival of spontaneously immortalized Csb-/- (closed diamonds), hCSB cDNA corrected Csb-/- (open 
diamonds), an uncorrected Csb-/- subclone derived from the same transfection experiment (gray diamonds) and 
wild type (closed squares) MEFs after exposure to increasing doses of UV-light (254 nm), as determined by the 
[3H]-thymidine incorporation assay. Panel B: RNA synthesis recovery of wild type and Csb-/- MEFs as well as hCSB 
cDNA corrected and uncorrected Csb-/- MEFs, 16 hr after exposure to 10 J/m2 254 nm UV. Panel C: Paraquat 
survival of spontaneously immortalized Csb-/- (closed diamonds), hCSB cDNA corrected Csb-/- (open diamonds), an 
uncorrected Csb-/- subclone derived from the same transfection experiment (gray diamonds) and wild type (closed 
squares) MEFs, as determined by the [3H]-thymidine incorporation assay. For each cell line, experiments were 
performed at least 3 times and for each genotype identical results were obtained with at least two independent cell-
lines (data not shown). Representative examples are shown. Bars indicate the standard error of the mean. 
 
nature of the correction may be due to interspecies (human-rodent) type of 
complementation or to suboptimal expression properties of the transfected cDNA vector 
construct compared to the endogenous gene. 
 
2.3.4 Cell-type specific differences in γ-ray sensitivity associated with the Csb-/- 
defect 
 
To determine whether the sensitivity of Csb-/- MEFs to oxidative DNA lesions is a general 
feature, we extended our study to another cell type. To this end, an isogenic set of 
pluripotent, undifferentiated mouse embryonic stem cells (ES cells) was established from 
wt, Csb-/- and Xpa-/- blastocysts.  Figure 4 shows clonogenic γ-ray survival curves for Csb-/-, 
Xpa-/- and wt ES cells. In comparison to the MEF data, three important differences are 
observed. Firstly, wt ES cells are clearly more sensitive to γ-rays when compared with the 
survival of wt MEFs at the same γ-ray-dose. Secondly, Csb-/- ES cells display a slight 
increase in γ-ray sensitivity compared to wt ES cells, however this hypersensitivity is very 
mild in comparison with the hypersensitivity caused by Csb deficiency in MEFs. Thirdly, the 
Xpa mutation in ES cells -in striking contrast with MEFs- gives rise to similar γ-ray 
sensitivity as a Csb defect. We conclude that  a Csb  deficiency  causes cellular sensitivity to 
γ-ray irradiation in various cell types, but with significant variation in the magnitude of the 
response: fibroblasts being significantly more ionizing radiation sensitive than ES cells. The 
opposite is observed for a total NER defect: no hypersensitivity is registered in Xpa-/- 
fibroblasts whereas Xpa-/- ES cells exhibit a (albeit minor) γ-ray sensitivity. Thus, defects in 
TCR as well as total NER cause cell-type specific (differences in) responses to γ-rays. 
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2.3.5 Whole body X-ray irradiation of wt, 
Csb-/- and Xpa-/- mice 
 
The cellular findings above raise the 
clinically relevant question how Csb and Xpa 
defects translate into γ-ray response upon 
whole-body exposure to ionizing radiation 
and if oxidative damage sensitivity of MEFs 
and/or ES cells has a predictive value for 
ionizing radiation sensitivity of the animal. 
To compare the ionizing radiation sensitivity 
of wild type and Csb-/- mice, we considered 
to use a split-dose protocol (as frequently 
used in the clinic in radiotherapy treatment) 
to enlarge potential minor differences in 
survival of repair proficient and deficient 
cells. To explore this approach in vitro, we 
first irradiated wt and Csb-/- MEFs with two 
doses of γ-rays at a 6h interval and 
compared this with a single dose, equal to 
the cumulative dose used in the ‘split dose 
protocol’. Indeed, we observed a significant 
increase in resistance when using a split dose instead of a single dose. This increase is larger 
in wt MEFs compared to Csb-/- MEFs, indicating a poorer recovery from irradiation in Csb-/- 
MEFs during the 6 hours time interval between the exposures (Figure 5a).  
On this basis, we decided to use a split dose whole body irradiation protocol and exposed 
wt (n=45), Csb-/- (n=38) and Xpa-/- (n=37) mice on 5 consecutive days to 2.2 Gy X-rays per 
day. Animals were housed in micro-isolators to minimize the risk of infections during the 
experiment. Mice were scored as dead either when found dead, or when they had to be 
sacrificed, according to the local bio-ethical standards (criteria applied: severe weight loss 
(>20%), no food-intake, no movement, no response to external stimuli and hunchbacked 
appearance). Figure 5b shows the percentage of surviving mice up to 30 days after the last 
day of irradiation. There is a tendency for Csb-/- and Xpa-/- animals to have a shorter latency 
time and a lower chance to survive, resembling the ES cell response. However, statistical 
analysis revealed that the differences are below the level of confidence (Kaplan-Maier, 
p=0.3). Pathological examinations of non-surviving animals revealed bleedings and anemia 
in almost all wt and mutant animals (Table 1).  In accordance with these findings, 
histological examination of the bone marrow showed a virtual complete deprivation of 
blood-forming cells. However, in comparison to wt animals Csb-/- and Xpa-/- deficient mice 
seemed more prone to infections, resulting in sepsis as scored by the presence of bacterial
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Figure 4 
γ-ray sensitivity of Csb-/- and Xpa-/- embryonic 
stem cells. 
Survival of Csb-/- (diamonds), Xpa-/- (open triangles) 
and wild type (squares) mouse embryonic stem cells 
after exposure to increasing doses of γ-rays, as 
determined by the colony survival assay. Shown is 
the average of at least three experiments, with for 
each genotype at least two independent cell lines. 
Bars indicate the standard error of the mean. 
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Figure 5
X-ray sensitivity of Csb-/- mice. 
Panel A: ƣ-ray survival curves of spontaneously immortalized Csb-/- (diamonds) and wild type (squares) MEFs. 
Radiation has been performed on the basis of a split dose (2 exposures with a 6h interval, closed symbols) or a 
single dose protocol (open symbols). The gray bars indicate the difference in dose needed to kill 37 % of cells by a 
split dose or a single dose protocol. Panel B: Surviving fraction of CSB-/- (n=38; red line), Xpa-/- (n=37; green line) 
and wild type (n=45; black line) mice after a fractionated whole body exposure of 11 Gy (2.2 Gy/day for 5 
consecutive days). Panel C: Representative examples of HE stained livers of X-ray exposed wild type and Csb-/-
mice (taken at day 23). Note the presence of bacterial foci (stained purple) in the liver of the Csb-/- mouse. 
foci in various organs. Figure 5c shows representative examples of liver sections of non-
surviving CSB-/- and wt mice.  
A pilot experiment (20 wt, 12 Csb-/- mice, Xpa-/- not included), performed under conditions 
in which the animals were not housed in microisolators, showed a comparable result. In this 
experiment CSB-/- mice also tend to have a shorter latency period and increased sensitivity 
to X-rays. We conclude that Csb/- (and Xpa-/-) mice exhibit a tendency to increased X-ray 
sensitivity compared to wt mice. 
B
C
wild type                                                       Csb-/-
A
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2. 4 Discussion 
 
2.4.1 NER-independent sensitivity of Csb-/- cells to ionizing radiation and paraquat 
 
We have exploited the genetically defined mouse system for a detailed analysis of the effect 
of CSB transcription-coupled repair defect to oxidative DNA damage sensitivity at the 
cellular level and at the level of an intact organism. We have demonstrated that Csb-deficient 
MEFs are hypersensitive to both γ-ray irradiation and paraquat, indicating that ionizing 
radiation sensitivity of Csb-/- cells is caused by oxidative lesions. Importantly, this finding 
unequivocally proofs that the reported ionizing radiation sensitivity of human CSB 
fibroblasts (23) originates from the CSB gene defect rather than potential differences in 
genetic background, and extends to other mammalian species. Furthermore, we find that 
the CSB sensitivity extends to other cell types, including keratinocytes (unpublished results) 
and ES cells. However, the latter cells are only marginally sensitive compared to wt ES cells, 
pointing to cell type-specific differences in dependence on TCR.  
 
2.4.2 Oxidative DNA damage as cause of the γ-ray and paraquat sensitivity of Csb-/- 
cells 
 
γ-Rays cause a wide diversity of DNA damages, notably single and double strand DNA 
breaks and various kinds of oxidative base modifications. The latter type of lesion is 
induced by reactive free radicals originating from the radiolysis of water in the vicinity of 
DNA (53). Double strand breaks, the most cytotoxic type of damage induced by γ-rays, are 
dealt with by homologous recombination repair or non-homologous end-joining (34). 
Despite their cytotoxic effect, it is unlikely that these are responsible for the ionizing 
radiation hypersensitivity of human and mouse CSB-/- cell lines. This is consistent with the 
similar sensitivity of Csb-deficient cells for paraquat and γ-rays, indicating that the critical 
lesions causing increased cytotoxicity are oxidative damage. Therefore, oxidative lesions 
such as thymine glycols and 8-oxo-2’-deoxyguanosines appear the prime candidates causing 
ionizing radiation sensitivity in Csb-deficient cells. This is further underlined by the finding 
that ionizing radiation-exposed human CSB fibroblasts accumulate more 8-oxo-2’-
deoxyguanosine than wild type cells (46).  
Oxidative DNA damage is primarily repaired via base excision repair (24, 30), although a 
minor fraction (e.g. cyclo-purines) is eliminated by the NER machinery (4, 20). The finding 
that completely NER-deficient Xpa-/- MEFs are not sensitive to γ-ray irradiation suggests 
that the latter type of DNA lesions is not responsible for the hypersensitivity of Csb-/- MEFs 
and excludes cyclo-purines as the causative lesions of the Csb sensitivity. 
The link between UV-sensitivity and inability to handle transcription-blocking UV-induced 
lesions suggests that the γ-ray and paraquat sensitivities of Csb-/- cells originate from 
transcription-blocking oxidative DNA lesions. Yet, we failed to observe a strong RNA 
synthesis block in wt and Csb-/- cells after γ-ray-irradiation (data not shown). However, 
controversy exists with respect to the ability of oxidative damage to block transcription by 
viral and bacterial RNA polymerases (13, 44, 52), whereas relatively little is known about 
this aspect for mammalian RNA polymerase II. Thymine glycols appear not to affect 
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transcription by RNA polymerase II in vitro (44). On the other hand, 8-oxo-2’-
deoxyguanosine has been found to block RNA polymerase II mediated transcription of a 
shuttle vector in vivo in the absence of the CSB protein (22). Nevertheless, both lesions 
constitute targets for TCR, as evident from the inability of human CSB as well as XP/CS 
fibroblasts to remove them from the transcribed strand (7, 22).  
 
2.4.3 A universal transcription-coupled repair model 
 
It is unclear whether transcription-coupled repair of oxidative lesions works via a presumed 
transcription-coupled BER mechanism or via transcription-coupled NER, documented for 
UV damage. Figure 6 puts the TCR process in a broader context. Oxidative DNA lesions 
block RNA polymerase II, which in turn can trigger p53-dependent and -independent 
apoptotic responses, as shown for UV-lesions (6, 27, 28). To enable repair CSB protein is 
required to make the lesion accessible, either by back-tracking or dissociation of RNA 
polymerase II. In a recent study, Woudstra et al. reported that in Saccharomyces cerevisiae a 
stalled RNA polymerase II triggers a coordinated rescue mechanism, requiring the Rad26 
(the yeast counterpart of CSB) and DEF1 proteins (55). DEF1 was suggested to enable 
proteolysis of RNA polymerase II in case the lesion cannot be rapidly removed via RAD26 
(55). Although the considerable differences between yeast and mammalian TCR as well as 
CSB/Rad26 function hamper a proper extrapolation of data, this observation underlines the 
importance of damage clearance. CSB-
mediated clearance of the lesion can be 
directly coupled to a BER-type repair 
reaction involving DNA glycosylases. 
Recent findings that Ogg1-/- cells only lack 
repair of 8-oxo-2’-deoxyguanosine in the 
non-transcribed strand (21) indicate that 
transcription-coupled repair of this 
oxidative lesion does not depend on the 
OGG1 glycosylase. These results are 
consistent with either the removal of the 
lesion by classical TC-NER or by special 
DNA glycosylases, such as the recently 
identified NEI1/NEH1 glycosylase (14), as 
well as two novel glycosylases (TGG1 and 
TGG2) which might serve as specific 
transcription-coupled glycosylases or as 
backup repair proteins for oxidative lesions 
(41). Alternatively, or in addition, it is 
possible that transcription-coupled repair of 
oxidative damage is linked to a mechanism 
similar as the recently in E. coli discovered 
nucleotide incision repair. In this reaction 
the  nfo  protein  incises  the  DNA at the  
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Figure 6 
Hypothetic model of the fate of transcription 
blocking lesions. 
Oxidative DNA lesions block RNA polymerase II, 
which in turn can trigger p53-dependent and -
independent apoptotic responses. To enable repair of 
the lesion -and thus prevent apoptosis or cell cycle 
arrest- CSB protein is required to make the lesion 
accessible by either back-tracking or dissociating of 
RNA polymerase II. This action can be directly 
linked to transcription-coupled repair. Alternatively, 
when TCR is unable to cope with the damage, the 
lesion is made accessible for global genome repair. 
TCR can be mediated by the documented TC-NER 
reaction or by a presumed TC-BER pathway. 
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5’ side of oxidatively damaged bases, thus circumventing the generation of a toxic abasic site 
(18). The mammalian genome, in contrast to the yeast genome, lacks an nfo homologue but 
the incision activity might be provided by a yet unidentified enzyme. The dangling damaged 
base could subsequently be excised via FEN1 nuclease.  Lastly, unmasking of the lesion by 
the action of the CSB protein in principle also allows global genome repair (NER or BER) 
to function as a backup mechanism for removal of damage in the transcribed strand of 
active genes. In conclusion, the hypersensitivity of Csb-/- cells to ionizing radiation and 
paraquat may be caused by the inability to remove the stalled polymerase from the lesion in 
the absence of the CSB protein, hereby preventing transcription-coupled repair as well as 
the possibility of repair of the lesion by the global genome BER system. CSB (and also 
XPG) proteins have been proposed to stimulate global genome repair of oxidative DNA 
damage (7, 12, 40, 46, 54). Although this might contribute to the observed ionizing radiation 
sensitivity of CSB cells, it is unlikely the only underlying mechanism, since for example cell 
lines defective for mNTH  do not show any sensitivity to oxidative stress ((41) and our own 
unpublished results). 
The observed wt γ-ray resistance of Xpa-/- MEFs is not inconsistent with a possible 
involvement  of TC-NER in removal of oxidative lesions. In Xpa-/- MEFs, in contrast to 
Csb-/- cells, the RNA polymerase II can be removed from the lesion. This makes the lesion 
accessible for global genome BER, thereby preventing prolonged stalling of RNA 
polymerase II and subsequent triggering of the apoptotic response, resulting in wt cellular 
survival. 
 
2.4.4 Specific stem cell response 
 
Csb-deficient MEFs, keratinocytes (results not shown) and ES cells all displayed significant 
γ-ray hypersensitivity. Interestingly, however, we observed a marked difference between cell 
types in the intrinsic γ-ray sensitivity as well as in the consequence of a Csb defect. ES cells 
appear the most sensitive, but the influence of a Csb defect is relatively small. The same is 
found for other types of damages, such as UV injury (our own unpublished data). 
Interestingly, Xpa-/- ES cells (in contrast to Xpa-/- MEFs) display γ-ray sensitivity comparable 
to that of Csb-/- ES cells. The use of multiple independent cell lines of the same mutant (all 
in a C57Bl6 genetic background) excludes that this result is due to inter cell line variation. A 
possible explanation for the intrinsic sensitivity of ES cells and the similar behavior of Xpa-/- 
and Csb-/- ES cells to γ-ray irradiation can be inefficient back up repair and/or a lower 
threshold for the apoptotic response in undifferentiated cells, causing ES cells to die before 
back-up mechanisms can perform their repair activity. This may also explain why a number 
of XP lymphoblastoid cell lines are ionizing radiation sensitive while fibroblast cell lines 
derived from the same or similar patients are not sensitive to oxidative lesions (19, 26, 36).  
 
2.4.5 X-ray effects on Csb-/-, Xpa-/- and wt mice 
 
The differences in survival between X-ray exposed wt, Xpa-/- and Csb-/- mice were not 
statistically significant. Nevertheless, our data point to a tendency for Xpa-/- and Csb-/- mice 
to have a shorter latency time as well as a minor increase in sensitivity. A similar difference 
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between wt and Csb-/- mice  was also noted in a pilot experiment (involving 20 wt and 12 
Csb-/- animals), which constituted the basis for the more extensive study described above. 
Pathological examination of deceased animals points to hematopoietic failure as the cause 
of death: almost all animals demonstrated bleedings and a virtual complete deprivation of 
blood-forming cells resulting in anemia (data not shown).  
However, in comparison to wt animals, Csb- and Xpa-deficient mice appear more prone to 
infections, resulting in sepsis. This suggests that Xpa-/- and Csb-/- mice might be slightly more 
sensitive to X-ray irradiation than wt animals, due to a less effective immunological 
response. The response of Xpa-/- and Csb-/- mice after exposure to X-rays might be 
explained by a higher ionizing radiation sensitivity of progenitor stem cells of the immune 
system, which would reflect the ES cells response. This observation is in accordance with 
the reported ionizing radiation sensitivity of some XP lymphoblastoid cell lines as discussed 
in the previous section. These observations clearly show that the ionizing radiation 
sensitivity of cultured cells as a predictive value for sensitivity of the whole organism largely 
depends on the cell type used. Extrapolating to the human situation one might expect CS 
patients to be clinically more sensitive to X-rays but the magnitude may vary between cells 
and tissues. 
Recently, we have shown that inactivation of the Xpa gene (and thus abolishing NER) 
evokes acceleration of the premature aging phenotype in trichothiodystrophy (TTD) mice, 
which correlated with an increased cellular sensitivity to oxidative DNA damage, leading us 
to hypothesize that aging in the TTD mice is caused by unrepaired DNA damage that 
compromises transcription, leading to functional inactivation of critical genes and apoptosis 
(8). Interestingly, inactivation of the Xpa gene also has a profound effect on CSB mice: 
animals show early postnatal ataxia, abnormal cerebellar development and (like TTD/XPA 
mice) die around weaning (31). In view of the data presented in this paper, this aggravation 
of the TTD and CSB is likely to originate from a cell type-specific increase in oxidative 
damage sensitivity caused by the Xpa gene defect. 
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Abstract 
 
Mutations in the CSA and CSB gene cause Cockayne Syndrome (CS), a rare inherited 
disorder characterized by UV sensitivity, severe neurological abnormalities and progeroid 
symptoms. Both gene products function in the transcription-coupled repair (TCR) 
subpathway of nucleotide excision repair (NER), providing the cell with a mechanism to 
remove transcription-blocking lesions from the transcribed strand of actively transcribed 
genes. Besides a function in TCR of NER lesions, a role of CSB in (transcription-coupled) 
repair of oxidative DNA damage has been suggested.  
In this study we used mouse models to compare the effect of a Csa or a Csb defect on 
oxidative DNA damage sensitivity at the level of the cell and the intact organism. In 
contrast to Csb-/- mouse embryonic fibroblasts (MEFs), Csa-/- MEFs are not hypersensitive 
for γ-ray or paraquat treatment. Similar results were obtained in keratinocytes. In contrast, 
Csb-/- and Csa-/- ES cells both show slight γ-ray sensitivity. Finally, Csb-/-, but not Csa-/- mice 
fed with DEHP containing food (causing elevated levels of oxidative DNA damage in the 
liver) show weight reduction. These findings not only uncover a clear difference in oxidative 
DNA damage sensitivity between Csa- and Csb-deficient cell lines and mice, but also show 
that sensitivity to oxidative DNA damage is not a uniform characteristic of Cockayne 
syndrome. This difference in the DNA damage response between Csa- and Csb-deficient 
cells is unexpected, since until now no consistent differences between CSA and CSB 
patients have been reported. We suggest that CSA and CSB proteins in part perform a 
separate role in different DNA damage response pathways. 
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3.1 Introduction 
 
In order to cope with the continuous attack of endogenous and environmental genotoxic 
agents on the integrity of their genomes, cells are equipped with a battery of DNA repair 
systems with partly overlapping substrate specificity. In mammals, chemically and UV-
induced helix-distorting lesions are removed through the versatile nucleotide excision repair 
(NER) pathway. NER functions by excision of the lesion, as a ±30 nt oligonucleotide, after 
which the resulting single stranded gap is filled in by DNA polymerase and ligase. 
Recognition of the lesion occurs via two subpathways. In global genome NER (GG-NER), 
repair of helix-distorting base damage in the entire genome is initiated by recognition of 
these lesions by the XPC-HR23B-Cen2 complex, facilitated by the XPE dimer (UV-
DDB1/2). In transcription-coupled NER (TC-NER), repair of transcription blocking 
lesions is thought to be initiated by a RNA polymerase, unable to pass the lesion (for review 
see (11, 20, 31)). 
Mutations in NER genes can lead to several rare inherited recessive disorders. The 
prototype NER syndrome is xeroderma pigmentosum (XP), characterized by pronounced 
UV sensitivity, pigmentation abnormalities in sun-exposed areas of the skin, and a more 
than 1000-fold risk of developing skin cancer, causing a 30 year life span reduction. In a 
subpopulation of XP patients accelerated neurodegeneration occurs, due to early loss of 
neurons (4, 39). A distinct NER-associated disorder is Cockayne syndrome (CS), which 
shares with XP the pronounced UV sensitivity, but in addition has a wide range of severe 
physical and mental manifestations. These include: postnatal growth failure, chachectic 
dwarfism, retinal degeneration, deafness, mental retardation associated with 
neurodemyelination, and skeletal abnormalities such as osteoporosis and a bird-like face (4, 
37). Many of these symptoms, together with the average short lifespan of 12.5 years, point 
to premature aging.  
Complementation analysis by cell hybridization studies have shown the involvement of 
seven genes in the NER-deficient form of XP (XPA through XPG) (4). Mutations in XP 
genes cause a combined defect in both TC-NER and GG-NER pathways in five out of 
seven XP complementation groups. In contrast, mutations in XPC and XPE cause a 
deficiency in GG-NER only (21, 47, 55, 56). Cockayne syndrome is associated with a 
specific TC-NER defect, caused by mutations in two genes, CSA or CSB (54). Interestingly, 
mutations in XPB, XPD or XPG can cause a combination of XP and CS (4).  
The notion that mutations in CSA or CSB only affect the TC-NER pathway, while 
mutations causing XP frequently inflict both TC-NER and GG-NER, is difficult to 
reconcile with the more severe symptoms observed in CS compared to XP patients. To 
explain this phenomenon, a role of the CS proteins outside TC-NER has been suggested, 
such as an auxiliary function in transcription (3, 14, 42) and/or in (transcription-coupled) 
repair of oxidative DNA damage and other non-NER lesions (12, 13, 26, 28, 38, 46, 50). 
Similarly, cell lines from XP/CS patients with mutations in XPB, XPD or XPG show a 
defect in transcription-coupled repair (TCR) of oxidative DNA damage (9, 26), 
underscoring the possible involvement of unrepaired oxidative DNA lesions in the CS 
etiology.  
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Most studies on the role of CS proteins in other processes than classical TC-NER have 
been performed on CSB-deficient human cell lines. Since clinical differences have not been 
observed between patients belonging to CSA and CSB complementation groups, a similar 
response for CSA- and CSB-deficient cell lines is expected. Indeed, for NER-related assays 
there is no evidence for a CSB- or CSA-related difference. Therefore, findings obtained with 
non-NER-related assays in CSB-deficient systems have often been extrapolated to be 
general CS-characteristics. Yet, as clear biochemical differences between CSA and CSB exist 
(53), a minor variance in the cellular response to genotoxic stress may be present in CSA 
and CSB cells. In studying such potential subtle differences, isogenic NER deficient mouse 
models are highly valuable, as obtained results are not influenced by differences in genetic 
background. Previously, using a mouse model for CSB (52), we showed that Csb-deficient 
cells and animals are sensitive to oxidative DNA damage (12). Recently, we also have 
generated a mouse model for CSA (51) and have shown that both CS mouse models mimic 
the human phenotype in terms of the repair defect, retinal degeneration and manifestation 
of UV sensitivity of skin and eyes. To determine whether CSA and CSB are truly equivalent 
in their oxidative DNA damage response, we systematically compared the sensitivity to 
oxidative stress in a variety of cell types and in the intact organism in a Csa- and Csb-
deficient background.  
 
3.2 Material and Methods 
 
3.2.1 Cell-lines 
 
Isolation of primary Csb-/- (FVB/129Ola) and Csa-/- (C57BL6J/129Ola) MEFs and 
corresponding wild type cell lines has been described (51, 52). Cells were cultured in 
F10/DMEM (1:1) (Gibco) medium, supplemented with 10 % fetal calf serum and 50 µg/ml 
penicillin and streptomycin (Gibco). Spontaneously immortalized cell lines were obtained by 
continuous subculturing of primary MEFs.   
Primary wild type, Csa-/- and Csb-/- keratinocytes from 2-day old mice (in a pure C57BL6 
genetic background) were isolated as described (15, 19). Keratinocytes were cultured on 
collagen-fibronectin coated dishes in low calcium (0.05 mM) EMEM (BioWhittaker), 
supplemented with 8 % fetal calf serum (treated with chelex 100 (Biorad) to remove Ca2+ 
ions), 1 ng/ml keratinocyte growth factor (R&D systems) and 50 µg/ml penicillin and 
streptomycin (Gibco). Spontaneously immortalized cell lines were obtained by continuous 
subculturing of primary keratinocytes. 
Isolation of Csb-/- and wild type embryonic stem cell lines, in a C57BL6 background has 
been described (12). Csa-/- ES cell lines are isolated following the same procedure (12). ES 
cells were maintained on gelatin-coated dishes in 50% buffalo rat liver cell conditioned 
DMEM / 50 % fresh DMEM supplemented with 15 % fetal calf serum, 0.1 mM non-
essential amino acids (Gibco), 50 µg/ml penicillin and streptomycin (Gibco), 1000 U/ml 
leukemia inhibitory factor (Chemicon) and 0.1 mM 2-mercaptoethanol (Sigma).  
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3.2.2 Cellular sensitivity studies 
 
For determination of the γ-ray-sensitivity of immortalized MEFs, keratinocytes and ES cells, 
cells were plated in 6cm dishes, at various dilutions. After 12-16 h, cells were irradiated with 
a single dose in the range of 0-8 Gy using a 137Cs source. Cells were grown for 5 to 14 days, 
fixed, stained and counted to assess the colony-forming ability. All experiments were 
performed in triplicate. This protocol was adapted for determination of UV sensitivity of 
keratinocytes and ES cells by irradiating the cells with different doses of UV (254 nm, 
Philips TUV lamp) in stead of the γ-ray irradiation. UV sensitivity of MEFs was determined 
as described previously (43). Briefly, MEFs were exposed to different doses of UV (254 nm, 
Philips TUV lamp) and allowed to grow for another 3-5 days, before reaching confluency. 
The number of proliferating cells was estimated by scintillation counting of the radioactivity 
incorporated during a 3 hr pulse with [3H]Thymidine (5µCi/ml, s.a. 40-60 Ci/mmole; 
Amersham). Cell survival was expressed as the ratio of 3H incorporation in treated and non-
treated cells. This protocol was adapted for paraquat survival by growing MEF cultures for 
3-5 days in medium containing different concentrations of paraquat, followed by 
determination of the amount of proliferating cells as described above. 
 
3.2.3 DEHP treatment of mice 
 
Wild type, Csb-/- and Csa-/- female mice in a C57BL6 background were put on a DEHP 
(6000 ppm di(2-ethylhexyl)phthalate)(Sigma) containing diet or on a regular diet for four 
weeks (untreated: 5 wild type, 7 Csb-/- and 10 Csa-/- mice; treated 8 wild type, 7 Csb-/- and 13 
Csa-/- mice). Animals were daily screened for discomfort. At the start and during the 
experiment animals were weekly weighed. The relative weight is calculated as the ratio 
between the weights of the mouse during the experiment versus the weight at the start of 
the experiment. Plotted is the ratio of these relative weights of treated versus untreated 
animals of the same genotype. Animal experiments were approved by the local animal 
ethical committee of the National Institute of Public Health and the Environment, 
Bilthoven, the Netherlands. 
 
3.2.4 8-oxo-dG measurement in mouse liver 
 
The 8-oxo-dG analyses were performed as previously described (41). In short, the DNA 
from approximately 200 mg liver or 160 mg kidney (1 kidney) was extracted and 
precipitated by a NaI-based procedure originally described by Nakae et al. (36) and Asami et 
al. (2). The DNA was resuspended in 10 mM Tris/0.1 mM desferrioxamine prior to 
enzymatic hydrolysis with nuclease P1 and alkaline phosphatase (Boehringer Mannheim, 
Germany). The deoxyribonucleotides were then treated with DOWEX 1×8-400 ion-
exchange resin (The Dow Chemical Company, Midland, MI) to remove I- and finally 
filtered through a Micropure-EZ filter (Millipore, Bedford, MA). The levels of 8-oxo-dG 
and dGuo were measured using a HPLC system with electrochemical and UV detection. 
Peak areas were used for calculations. Calibrations curves were run together with each batch 
of samples. 
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3.3 Results 
 
3.3.1 Csa-/- mouse embryonic fibroblasts lack hypersensitivity to γ-ray irradiation 
 
Using [3H]-thymidine incorporation assays, primary Csa-/- and Csb -/- mouse embryonic 
fibroblasts (MEFs) have been shown UV-sensitive (51, 52). Since γ-ray sensitivity can not 
be determined in this manner, but rather requires a clonogenic assay, and since primary cells 
are not suitable for performing clonogenic experiments, we first subcultured MEFs until 
spontaneous transformation resulted in formation of established cell lines. Similar to 
primary MEFs, immortalized Csa-/- and Csb-/- MEFs are both UV sensitive (Figure 1A). 
To critically investigate whether Csa-/- MEFs, like Csb-/- MEFs, display hypersensitivity to 
ionizing radiation, we performed clonogenic γ-ray survival experiments with spontaneously 
transformed wild type, Csb-/- and Csa-/- MEFs (at least 2 independent cell lines/genotype). 
In accordance with previous experiments (12), we observed that Csb-/- MEFs are 
approximately 2-fold more sensitive to γ-ray-irradiation than wild type MEFs. Surprisingly 
however, Csa-/- MEFs show a similar γ-ray survival as wild type MEFs (Figure 1B). The 
observed difference in γ-ray sensitivity between Csa-/- and Csb-/- MEFs can not be attributed 
to differences in genetic backgrounds (FVB/129OLA and C57BL6/129OLA), since wild 
type MEFs from these different backgrounds attribute comparable γ-ray sensitivities (Figure 
1C). 
 
3.3.2 Csa-/- MEFs are not sensitive to paraquat 
 
To confirm that Csa-/- MEFs are insensitive to oxidative DNA damage, we next tested the 
survival of these cell lines following treatment with the herbicide paraquat. Enzymatic 
reduction converts paraquat into radicals that react with molecular oxygen and thereby 
produce  superoxide anions, giving rise to hydrogen peroxide (1). As shown  previously, 
Csb-/- MEFs are sensitive to paraquat exposure (12). In marked contrast, Csa-/- MEFs 
possess paraquat sensitivity in the wild type range (Figure 1D). On the basis of the observed 
insensitivity of Csa-/- MEFs to both γ-rays and paraquat exposure, we conclude, that Csa-/- 
MEFs are not sensitive to oxidative DNA damage. 
 
3.3.3 Cell type-specific differences in γ-ray sensitivity in Csa-/- and Csb-/- cells 
 
To determine whether the lack of hypersensitivity to oxidative damage of the Csa-/- MEFs is 
a general feature, we extended our study to other cell types. To this end we isolated 
keratinocytes from wild type, Csa-/- and Csb-/- newborn mice, all in a genetically identical 
C57BL6 background to avoid any influence of genetic background. Similar to MEFs, 
spontaneously transformed Csa-/- and Csb-/- keratinocytes are UV sensitive, as determined by 
clonogenic assays (Figure 2A). Next, we performed clonogenic γ-ray survival experiments 
on wild type, Csa-/- and Csb-/- keratinocytes. In line with our observation in MEFs, we show 
that a Csb deficiency causes hypersensitivity of keratinocytes for γ-ray irradiation, whereas a 
deficiency for Csa does not make these cells more sensitive to γ-rays (Figure 2B). 
Previously, we have demonstrated that Csb-/- embryonic stem cells (ES cells) attribute a 
slight γ-ray sensitivity (12). To extend this study to Csa-/- ES cells, we isolated pluripotent
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Figure 1 
Survival of wild type, Csb-/- and Csa-/- mouse embryonic fibroblasts (MEFs) after exposure to UV, γ-rays 
or paraquat.   
Panel A: UV survival of spontaneously immortalized Csb-/- (diamonds), Csa-/- (triangles) and wild type (squares) 
MEFs. Experiments were performed at least two times per cell-line, with at least 2 cell lines per genotype as 
determined by the [3H]-thymidine incorporation assay. Shown are representative curves. Bars indicate the standard 
error of the mean. Panel B: Survival of spontaneously immortalized Csb-/- (diamonds), Csa-/- (triangles) and wild 
type (squares) MEFs after exposure to increasing doses of γ-rays, as determined by the colony assay. Shown is the 
average over at least 2 cell lines per genotype, as measured by at least three independent experiments. Bars indicate 
the standard error of the mean. Panel C: Survival of spontaneously immortalized wild type MEFs in different 
C57BL6 (squares), FVB/129OLA (diamonds) or C57BL6/129OLA (triangle) background, after exposure to 
increasing doses of γ-rays, as determined by the colony assay. Shown is the average of at least three independent 
experiments. Bars indicate the standard error of the mean. Panel D: Paraquat survival of spontaneously 
immortalized Csb-/- (diamonds), Csa-/- (triangles) and wild type (squares) MEFs. Experiments were performed at 
least two times per cell-line, with at least 2 cell lines per genotype as determined by the [3H]-thymidine 
incorporation assay. Shown are representative curves. Bars indicate the standard error of the mean. 
 
ES cells from blastocysts derived from intercrosses between Csa-/- animals in a C57BL6 
background. We first analyzed the UV sensitivity of these ES lines, and observed that Csa-/- 
and to a somewhat lesser extent Csb-/- ES lines are UV sensitive (Figure 2C). Subsequently, 
we performed a clonogenic γ-ray assay on wild type, Csa-/- and Csb-/- ES cells. Unexpectedly, 
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Figure 2 
UV- and γ-ray-sensitivity of Csb-/-, Csa-/- and wild type keratinocytes and embryonic stem cells.  
Panel A and B: UV (A) and γ-ray (B) survival of spontaneously immortalized Csb-/- (diamonds), Csa-/- (triangles) and 
wild type (squares) keratinocytes, as determined by the colony assay. The wild type curve represents the average of 
a wild type, Csa+/- and Csb+/- cell line, as determined in at least 3 experiments. The Csb-/- curve is the average over 2 
cell lines, as measured by three independent experiments. The Csa-/- curve is the average of at least two 
independent experiments. Bars indicate the standard error of the mean. Panel C and D: UV (C) and γ-ray (D) 
survival of Csb-/- (diamonds), Csa-/- (triangles) and wild type (squares) ES cells, as determined by the colony assay. 
Shown is the average over at least 2 cell lines per genotype, as measured by at least three independent experiments. 
Bars indicate the standard error of the mean. 
 
since Csa-/- MEFs and keratinocytes display a wild type γ-ray sensitivity, we found a slight γ- 
ray sensitivity in three independent Csa-/- ES cell lines, comparable to the γ-ray sensitivity in 
Csb-/- ES cells (Figure 2D). A fourth Csa-/- ES cell line exhibited wild type sensitivity, which 
might be associated with loss of pluripotency.  
We conclude that a Csb-deficiency causes cellular sensitivity to γ-ray-irradiation in MEFs, 
keratinocytes and ES cells, however with a significant difference in magnitude. A deficiency 
for Csa has no effect on cellular sensitivity for γ-rays in MEFs and keratinocytes, whereas in 
ES cells a Csa deficiency causes a slight hypersensitive phenotype.  
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To investigate whether a combined Csa-Csb deficiency would act either synergistically or 
epistatic, we generated double mutant Csa-/-/Csb-/- mice. Double mutant animals appeared 
normal and do not display any overt phenotype up to an age of 18 months. A detailed 
comparative study of the phenotype of Csa-/-, Csb-/- and Csa-/-/Csb-/- mice is underway. Next, 
we generated established Csa-/-/Csb-/- MEFs and showed that they do not display an 
increased sensitivity to UV- or γ-ray-irradiation, when compared to the most sensitive single 
mutant. These findings indicate that both proteins function in the same pathway and are 
epistatic (data not shown). 
 
3.3.4 Different response of Csb-/- and Csa-/- mice to a DEHP-containing diet 
 
It is not known how the observed cell-type and genotype specific γ-ray response in cultured 
wild type, Csb-/- and Csa-/- cells can be extrapolated to cells in the context of the whole 
animal. Therefore, we aimed at investigating the sensitivity of the intact animal to oxidative 
DNA damage. As a potential oxidative damage inducing agent we used the plasticizer di(2-
ethylhexyl)phthalate (DEHP), which causes proliferation of peroxisomes in the liver by 
activation of peroxisome proliferator-activated receptor alpha (PPAR alpha) (58). This is 
believed to induce higher oxidative stress in the liver. To test whether indeed DEHP could 
be used as a proper method to induce oxidative stress in mice, we administrated wild type, 
Csa-/- and Csb-/- female mice (n ≥ 5) with food containing 6000 ppm DEHP for four weeks. 
The control group received unmodified food. Induction of oxidative DNA damage was 
assessed by (double-blind) measurement of the 8-oxo-2’-deoxyguanosine (8-oxo-dG) 
damage level in the DNA of treated versus untreated animals. We observed that DEHP-
treated mice showed a 2.5 times higher 8-oxo-dG content in the liver than untreated 
animals (Figure 3A), whereas no significant induction of 8-oxo-dG in kidneys is observed in 
any genotype tested (Figure 3B). This result confirms that DEHP is a liver specific toxic 
compound, inducing oxidative DNA damage. Moreover there seems to be no difference in 
accumulation of 8-oxo-dG between wild type, Csa-/- and Csb-/- mice.  
As read-out of the DEHP sensitivity of the mouse, we used the overall condition, as 
determined by body weight. The weight of every mouse was compared to its original weight 
before treatment. Plotted in Figure 3C is the relative weight of treated animals divided by 
that of untreated animals (x100), showing a clear weight loss in Csb-/- mice compared to wild 
type and Csa-/- mice (n ≥ 5) (Figure 3C). Surprisingly, wild type and Csa-/- (although to a 
somewhat lesser extent) animals fed with a DEHP containing diet gain more weight than 
untreated animals, from the same genotype. This phenomenon is probably due to an 
increased food intake in treated animals (Figure 3D). We suggest that Csb-/- mice at the 
organismal level are sensitive for oxidative DNA damage, reflecting the observed 
hypersensitivity for oxidative DNA damage in various cultured cell types. Csa-/- mice are far 
less sensitive for oxidative damage caused by DEHP treatment, which is in agreement with 
the observed lack of hypersensitivity of Csa-/- keratinocytes and MEFs for oxidative DNA 
damage. 
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Figure 3 
DEHP-sensitivity of Csb-/-, Csa-/- and wild type mice.  
Panel A and B: Average 8-oxo-dG/G ratio in livers (A) and kidneys (B) of animals after 4 weeks of DEHP-
containing (grey) or control diet (black) in Csb-/-, Csa-/- and wild type mice, as measured by using a HPLC system 
with electrochemical and UV detection. Shown is the average 8-oxo-dG/G ratio of at least 5 animals per group. 
Bars indicate the standard error of the mean. Panel C: Relative weight of Csb-/- (diamonds), Csa-/- (triangles) and 
wild type (squares) mice fed with food containing 6000 ppm DEHP versus animals on a regular diet. Shown is the 
average weight-ratio of at least 5 animals per group. Panel D: Relative food intake of Csb-/-, Csa-/- and wild type 
mice. Depicted is the ratio of average food intake per week over the whole treatment of mice fed with 6000 ppm 
DEHP-containing food versus regular diet.  
 
3.4 Discussion 
 
3.4.1 Sensitivity of Csb-/- cells and mice to oxidative stress 
 
Using genetically homogeneous mouse models, we investigated the effect of a Csb 
deficiency on oxidative DNA damage sensitivity in various cell types and at the level of the 
intact organism. As shown previously (12), cellular γ-ray sensitivity in general markedly 
depends on cell type. For instance, wild type ES cells are significantly more sensitive to γ-ray 
irradiation than either MEFs or keratinocytes. In line with previous findings (12, 28), we 
show oxidative DNA damage-sensitivity in Csb-deficient fibroblasts, keratinocytes and ES 
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cells, although to different relative extent. Moreover, also at the level of the intact animal, 
we could demonstrate a significant effect of a Csb deficiency on sensitivity for oxidative 
DNA damage, as illustrated by the DEHP experiment. This finding is in line with the 
previously observed tendency of Csb-/- mice to be more sensitive for the toxic/killing effects 
of γ-rays than wild type mice (12). In light of the recent discussion about the validity 
experiment showing TCR of oxidative DNA lesions (10, 16, 27), these data clearly show 
that Csb deficiency causes sensitivity for oxidative DNA damage in various cell types and on 
the organismal level.  
 
3.4.2 A cell-type-specific Csa effect on γ-ray response 
 
Previously, one primary human fibroblast cell line derived from a CSA patient was 
investigated, and reported to display a slight γ-ray sensitivity (28), suggesting that CSB and 
CSA are similar in this respect. However, because of the large genetic variation in the 
human population on the one hand, and the only minor difference in sensitivity on the 
other hand, it is difficult to draw firm conclusions on the potential link between a CSA 
deficiency and γ-ray sensitivity on the basis of the human fibroblast studies. Surprisingly, we 
fail to show an increased sensitivity for oxidative DNA damage in Csa-/- MEFs and 
keratinocytes. DEHP-treated CSA-/- mice, in contrast to Csb-/- mice fail to show a 
pronounced reduction in body weight compared to untreated mice, indicating that Csa-/- 
animals are barely sensitive to the 2-3 fold higher levels of 8-oxo-dG lesions in the liver. 
Despite the absence of oxidative damage sensitivity in Csa-/- MEFs, keratinocytes and 
animals, we could still demonstrate a slight γ-ray sensitivity in Csa-/- ES cells, which 
compares well to that observed in Csb-/- ES cells. 
These findings suggest that in a wide range of cell types, CSA is dispensable for the 
response to oxidative DNA damage. Yet, given the slight γ-ray sensitivity of Csa-/- ES cells 
and the tendency for somewhat less growth in DEHP treated Csa-/- mice compared to wild 
type mice, its function might be needed in specific cell types. To our knowledge, these data 
provide the first cell biological evidence that CSA and CSB proteins possess separable 
functions.   
 
3.4.3 Different functions of CSA and CSB? 
 
These observed biological differences between Csa- and Csb-deficient cells and mice, as 
uncovered by the divergence in oxidative damage sensitivity seem to be in contrast with the 
widely accepted notion that both CSA and CSB function in the same subpathway of 
transcription-coupled repair (26, 28, 54). However, biochemical analysis of the CSA and 
CSB protein has revealed marked differences that are suggestive for a potential difference in 
function. The CSA protein resides in a 420 kDa complex, whereas CSB is part of a >700 
kDa complex (53). While CSA was found to be a constituent of a complex containing 
DDB1, cullin 4A, Roc1 and the COP9 signalosome (17), CSB was found to interact with 
RNA polymerase II (48, 53), XPA, XPG, TFIIE and TFIIH (23, 42) and with several 
splicing factors. Moreover, a role of CSB, but most likely not of CSA in RNA Pol I 
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transcription has been suggested (5). Also, a CSB rather than a CSA deficiency might cause 
metaphase fragility for genes encoding specific highly structured transcripts (59).  
In contrast, arguments that CSA and CSB in some way might function together are 
provided by the reported in vitro interaction between CSA and CSB (18). Moreover, a recent 
study shows that genotoxic stress mediated  translocation of CSA to the nuclear matrix is 
hampered in CSB-deficient cell lines (24). Most importantly, there is no evidence for a 
difference in the clinical appearance of CSA and CSB patients (37, 44). Similarly, the 
phenotype of Csa -/- and Csb-/- mice fails to reveal obvious differences, since both mouse 
models are UV-sensitive, lack TCR (51, 52), show photoreceptor loss upon aging 
(51)(T.G.M.F. Gorgels, personal communication) and die before weaning when combined 
with a Xpa or Xpc deficiency (35, 51)(I. van der Pluijm, personal communication).  Finally, 
our Csa/Csb double mutant cells and mice provide genetic evidence for an epistatic 
relationship and involvement in the same pathway. 
In conclusion, arguments both in favor and against differences between CSA and CSB 
functions exist.  
 
3.4.4 Possible functions of CSA and CSB in different biological processes 
 
To find an explanation for the observed differences in γ-ray sensitivity between Csa- and 
Csb-deficient cells, we systematically list the possible functions of CSA and CSB in response 
to oxidative DNA damage. 
Transcriptional bypass  
It has been shown that oxidative DNA lesions (like 8-oxo-dG) can block RNA polymerase 
II, although far less efficiently than UV-induced lesions do (25). E. coli RNA polymerase can 
bypass 8-oxo-dG by putting either adenine or cytosine opposite the 8-oxo-dG (6, 57). For 
the yeast counterpart of CSB, Rad26, strong indications for a role in transcriptional bypass 
of MMS-induced DNA damage have been found (30). Recent reports show that also human 
RNA pol II is able to bypass oxidative DNA lesions in vitro (25, 49). Since, CSB has already 
been associated with transcription elongation (especially of damaged templates, pause sites 
and highly structured RNAs), these data suggest a possible role of CSB in transcriptional 
bypass of some oxidative DNA lesions. This function may probably require the reported 
chromatin remodeling activity of the CSB protein (8). Transcriptional bypass might be CSA-
independent, since for example CSA appears not to be involved in stimulation of 
transcription of genes for highly structured RNAs (59). This function of CSB may not be 
relevant to UV-induced damage as photolesions form strong RNA polymerase blocks and 
are therefore not subject to transcriptional bypass. 
Transcription-coupled repair  
Transcription-coupled repair of UV-induced lesions, as well as recovery of RNA synthesis 
after UV treatment, has been demonstrated to depend on both CSA and CSB (33, 54). 
Although bypass of 8-oxo-dG is possible, the absence of the mfd protein in E. coli (required 
for TCR) causes higher bypass rates, suggesting that TCR is acting on 8-oxo-dG (6). Also, 
several reports point to a function of mammalian CSB in TCR of oxidative DNA lesions 
((12) and references therein). The influence of CSA on TCR of oxidative DNA lesions is 
unknown. 
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Ubiquitination of RNA polymerase II 
Upon UV treatment, stalled RNA polymerase can be ubiquitinated in a CSA- and CSB-
dependent manner (7, 29, 40). This ubiquitination might be needed for TCR and/or the 
degradation of the stalled polymerase. The latter event would allow access of the repair 
machinery to the lesion and subsequent recovery of RNA synthesis (34). The potential link 
between CSA and ubiquitination of RNA polymerase II may lie in the fact that CSA is 
known to regulate the ubiquitin ligase activity of the complex containing DDB1, cullin 4A, 
Roc1 and the COP9 signalosome (17), and that this complex could, in some way, be 
involved in the ubiquitination of the polymerase. However, CSA and CSB proteins are not 
prerequisite for the break down of RNA polymerase II, as CSA and CSB deficient cells can 
still degrade the polymerase (32). Ubiquitination of RNA polymerase II has been shown to 
occur also after exposure of cells to oxidative DNA damage (22). However, the mechanism 
of ubiquitination differs from that provoked by UV-light and is not CSA- or CSB-
dependent (22). 
Other repair pathways 
Evidence for an indirect role of CSB in BER mediated global genome repair and 
mitochondrial DNA repair of oxidative DNA lesions has been reported (13, 38, 45, 46, 50).  
 
3.4.5 Explanation of Csa and Csb related differences in oxidative damage response 
 
Taking into account the possible functions of CSA and CSB, we discuss two scenarios that 
might explain our findings. 
1. Oxidative DNA damage does not have a major impact on the onset of Cockayne 
syndrome features. Although the effect of CSA on the response to oxidative DNA 
damage is poorly investigated, we do not favor this explanation, since this would argue 
against a large body of evidence supporting a function of CSB in repair of oxidative 
DNA damage and the general importance of oxygen radicals (12, 13, 26, 28, 38, 45, 46, 
50).   
2. The observed differences in oxidative stress sensitivity between Csb-/- and Csa-/- cells 
and animals are the consequence of the acute response of a heavily challenged system. 
The conditions used in cellular survival are not representative for the processes in a 
patient that cause the CS manifestations. Although in acute (high dose) experiments 
Csa- and Csb-deficient cells differ in sensitivity, under physiological conditions a 
deficiency for Csa or Csb may cause a similar effect upon exposition to constitutive low 
levels of oxidative DNA damage. The hyper-sensitivity of Csb-/- cells and mice could be 
due to other functions of CSB. For example Csb-/- cells could be unable to perform 
adequate transcription bypass, which might be CSA-independent. In the presence of 
high amounts of oxidative DNA damage, inefficient bypass in Csb-/- cells might lead to 
cell death. The absence of a significant RNA synthesis block after high γ-ray doses 
suggests that the majority of oxidative DNA lesions are bypassed. In contrast, since the 
major UV lesions are probably not bypassed during transcription, UV sensitivity of Csa- 
and Csb-deficient cell lines mainly reflects the inability of these cells to perform TCR 
and RNA synthesis recovery. These processes depend on both CSA and CSB for 
removal of the stalled RNA polymerase.  
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The second explanation suggests that the γ-ray sensitivity in Csb-/- cells could be partly 
attributed to other processes than a TCR-defect. Consequently, the lack of γ-ray sensitivity 
in Csa-/- cells does not per sé contradict a role of CSA in TCR of oxidative DNA damages. 
Moreover, the observed γ-ray sensitivity in Csa-/- ES cells suggests some function of CSA in 
response to oxidative DNA damage. Therefore a deficiency in TCR in specific cell types 
could still underlie CS symptoms. 
 
3.4.6 Concluding remarks 
 
Comparison of the response of isogenic cells of different tissues to ionizing radiation has 
demonstrated significant variation in sensitivity and in dependence on CS proteins. This 
finding suggests the use of different genome-caretaking strategies by different cell types and 
tissues. In addition, our study reveals that the absence of CSA or CSB has a different impact 
on the response to oxidative DNA damage, and consequently that both proteins are not 
functionally equivalent. However, this appears not to be reflected in the CS phenotype of 
patients and mice. The increased sensitivity for ionizing radiation due to Csb inactivation is 
consistent with a role of CSB protein in cellular resistance to oxidative damage. The notion 
that the TCR defect for UV lesions in both Csa and Csb mutants is the same suggests that 
the sensitivity to ionizing radiation of Csb deficient cells is due to some extra function of the 
CSB protein. However, this latter function does not significantly influence the clinical 
outcome. The above findings also highlight a hitherto unanticipated functional dissimilarity 
of the main TCR factors CSA and CSB.  
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Abstract 
 
Mutations in the CSA or CSB gene cause Cockayne syndrome (CS), a rare inherited 
disorder, characterized by UV sensitivity, severe neurodevelopmental and progeroid 
symptoms. CS proteins function in the transcription-coupled repair pathway of nucleotide 
excision repair (NER), responsible for the removal of UV-induced and other helix-
distorting lesions from the transcribed strand of active genes. Several lines of evidence 
support the notion that the CS-B transcription-coupled repair (TCR) defect extends to 
other non-NER type transcription-blocking lesions, like oxidative DNA damage. 
Surprisingly, a Csa defect does not inflict sensitivity for oxidative DNA damage in various 
mouse cell lines, indicating a difference in cellular response of Csa- and Csb-deficient cell 
lines. Whether Csa or Csb deficiency causes sensitivity for other types of non-classical-NER 
transcription blocking lesions, like DNA inter-strand cross-links is so far unknown. We 
used genetically defined CS mouse models to examine the relationship between the Csa or 
Csb defect and sensitivity to the cross-linking chemotherapeuticum MMC in different cell 
types and at the level of the intact organism. The main findings are: 
We observed that whereas Csb-/- and Xpa-/- MEFs are only slightly MMC sensitive, Csa-/- 
MEFs are hypersensitive to MMC. This sensitivity is not associated with a block in RNA 
synthesis; instead Csa-/- MEFs fail to recover DNA synthesis after MMC treatment. In 
addition, we show that ES cells are intrinsically hypersensitive to MMC, when compared to 
MEFs, and that a Csa, Csb or Xpa defect not further enhances the MMC sensitivity of ES 
cells. Finally, Csa-/- and Csb-/- mice, and to a lesser extent Xpa-/- mice are MMC sensitive. 
These findings establish a cell-specific sensitivity to MMC and suggest a cell- and organ 
specific contribution of inter-strand cross-links (generated by cellular metabolites) in the 
onset of the clinical phenotype of CS. 
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4.1 Introduction 
 
Cockayne syndrome (CS) is a rare inherited disorder, characterized by a plethora of physical 
and mental manifestations, including UV hypersensitivity, severe postnatal growth failure, 
chachectic dwarfism, progressive mental retardation, retinal degeneration, sensori-neural 
hearing loss, skeletal abnormalities and a bird-like face. Several of these symptoms classify 
CS in the category of premature aging disorders. Complementation studies revealed the 
involvement of two genes in the onset of CS, CSA and CSB (for review see (3, 24)). 
Mutations in these genes have been associated with a specific defect in the transcription-
coupled subpathway of nucleotide excision repair (TC-NER), which is responsible for 
removal of transcription-blocking lesions from the transcribed strand of active genes (30). 
The other subpathway, responsible for repair of helix-distorting nucleotide damage in the 
entire genome and referred to as global genome NER (GG-NER) is unaffected in CS. Both 
subpathways differ in the way damage is recognized, but subsequently use the same proteins 
for the actual excision of DNA lesions as a ±30 nt oligonucleotide, and resynthesis of the 
resulting single stranded DNA gap. Defects in genes involved in either the recognition of 
DNA damage in the GG-NER subpathway, or with a function in the core reaction of NER 
lead to another NER syndrome: xeroderma pigmentosum (XP). A total of seven genes have 
been associated with NER-deficient XP, referred to as XPA through XPG. Although XP 
resembles CS in pronounced UV sensitivity, major differences are observed. XP, in contrast 
to CS, is characterized by pigmentation abnormalities in sun-exposed skin and a more than 
1000-fold elevated skin cancer risk. Moreover, the pronounced premature aging features of 
CS are not observed in XP. Interestingly, a subset of mutations in XPB, XPD and XPG may 
give rise to a combined XP and CS phenotype (for review see (3, 12)).  
The notion that mutations in CSA or CSB cause a defect in one subpathway of NER is 
difficult to reconcile with the more severe symptoms observed in CS patients compared to 
XP patients, of which many carry mutations in both NER subpathways. Additional roles for 
CS proteins have been put forward. Specifically for CSB, an auxiliary role in transcription 
has been suggested (2, 8, 26). Moreover, CSB cells display an increased sensitivity for 
oxidative DNA damage (7, 20). A defect in transcription-coupled repair (TCR) of non 
classical NER lesions (e.g. oxidative DNA damage) has been for long a paradigm to explain 
CS features as well as a possible cause of aging (18-20). Whether TCR of oxidative DNA 
damage functions via NER or BER is unknown, therefore we refer to TCR when not per se 
TC-NER is meant. However, recent observations have shown that several Csa-deficient cell 
lines and also Csa-/- mice are not hypersensitive to oxidative DNA damage, suggesting that 
oxidative DNA damage is probably not the only cause for the observed CS features and 
aging (see chapter 3). 
Since, defective TC-NER is so far the only common molecular feature of CSA- and CSB-
deficient cell lines, we wondered whether other endogenously occurring transcription-
blocking DNA lesions could be implicated in the etiology of CS. Endogenous agents 
formed during lipid peroxidation, such as malondialdehyde, can lead to inter-strand cross-
links (4). By definition DNA inter-strand cross-links are a physical block for polymerases, 
since strand separation is prevented. In this study we used the chemotherapeuticum 
mitomycin C (MMC) as a model substrate causing inter-strand cross-links. We exploited 
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mouse models for CSA, CSB and XPA (6, 28, 29) to investigate whether CS cells and 
animals are hypersensitive to MMC. Usage of these mouse models in an isogenic genetic 
background (C57BL6/J) allows a unique comparison of defined genetic defects without the 
confounding effect of unknown differences in genetic make-up.  
 
4.2 Material and Methods 
 
4.2.1 Cell lines 
 
Isolation of primary Xpa-/- (C57Bl6J/129Ola) Csb-/- (FVB/129Ola) and Csa-/- 
(C57Bl6J/129Ola) MEFs and corresponding wild type cell lines has been described (6, 28, 
29). Cells were cultured in F10/DMEM (1:1) (Gibco) medium, supplemented with 10 % 
fetal calf serum and 50 µg/ml penicillin and streptomycin (Gibco). Spontaneously 
immortalized cell lines were obtained by continuous subculturing of primary MEFs.   
Isolation of Xpa-/-, Csb-/-, Csa-/- and wild type embryonic stem (ES) cell lines, in a C57Bl6 
background have been described (7)(see  also chapter 3). ES cells were maintained on 
gelatin-coated dishes in 50% buffalo rat liver cell conditioned DMEM / 50 % fresh DMEM 
supplemented with 15 % fetal calf serum, 0.1 mM non-essential amino acids (Gibco), 50 
µg/ml penicillin and streptomycin (Gibco), 1000 U/ml leukemia inhibitory factor 
(Chemicon) and 0.1 mM 2-mercaptoethanol (Sigma).  
 
4.2.2 Cellular sensitivity studies 
 
For determination of the MMC sensitivity of immortalized MEFs and ES cells, cells were 
plated in 6 cm dishes, at various dilutions. After 12-16 h, cells were treated for 1 hour with 
mitomycin C (0.2-8 µg/ml, Kyowa Hakko Kogyo Co., Ltd. Tokyo). Cells were grown for 5 
to 14 days, fixed, stained and counted to assess the colony-forming ability. All experiments 
were performed in triplicate.  
RNA synthesis recovery after UV or MMC treatment was performed as described (22), with 
several  modifications. Briefly, cell were seeded in 6 well plates and after 24 h labeled with 
[2-14C]-thymidine (50 µCi/ml, s.a. 50 mCi/mmole; Amersham) for 16 h. Cells were 
irradiated with 10 J/m2 UV (254nm, Philips TUV lamp) or treated for 1 h with 2 or 8 µg/ml 
MMC. Three and six hours after treatment with UV or MMC, RNA synthesis was 
determined by 1h labeling with [5,6-3H]-uridine (10 µCi/ml, s.a. 50 Ci/mmole; Amersham). 
3H and 14C ratios were measured by scintillation counting. The relative RNA synthesis was 
expressed as the quotient of these 3H-14C ratios of treated over untreated cells. 
DNA synthesis after MMC treatment was performed as described (11), with several 
modifications. Briefly, cells were seeded in 6 well plates and after 24 h labeled with [2-14C]-
thymidine (50 µCi/ml, s.a. 50 mCi/mmole; Amersham) for 16 h. Cells were treated for 1 h 
with 2 µg/ml MMC. DNA synthesis was determined by 1h labeling with [methyl-3H]-
thymidine (10 µCi/ml, s.a. 50 Ci/mmole; Amersham) after 7, 16, 24 and 48 hours post-
treatment. 3H and 14C ratios were measured by scintillation counting. The relative DNA 
synthesis was expressed as the quotient of these 3H-14C ratio of treated over untreated cells. 
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4.2.3 MMC treatment of mice 
 
Wild type, Csb-/-, Csa-/- and Xpa-/- mice (males; 2-4 months) in a C57Bl6 background were 
i.p. injected with increasing doses MMC; 1 mg MMC per kg bodyweight (wild type; 4, Csb-/-; 
7, Csa-/-;  6  and  Xpa-/-; 6 animals); 2.5 mg MMC/kg (wild type; 0, Csb-/-; 12, Csa-/-; 9 and 
Xpa-/-; 0 animals); 5 mg MMC/kg (wild type; 0, Csb-/-; 14, Csa-/-; 11 and Xpa-/-; 5 animals); 7.5 
mg MMC/kg (wild type; 12, Csb-/-; 5, Csa-/-; 4 and Xpa-/-; 10 animals); 10 mg MMC/kg (wild 
type; 15, Csb-/-; 10, Csa-/-; 2 and Xpa-/-; 4 animals). Animals were housed in isolators and 
followed for 15 days after the treatment. Animals were daily screened for discomfort. 
Differences in MMC sensitivity of wild type and mutant mice were assessed on the basis of 
the time interval between the last dose and death (latency period). For significance test 
Kaplan-Meier statistics with a log-rank testing was performed (wild type vs. Csb-/-, Csa-/- and 
Xpa-/- based on 7.5 and 10 mg MMC/kg; Xpa-/- versus Csb-/- and Csa-/- based on 5, 7.5 and 
10 mg MMC/kg; Csb-/- vs Csa-/- based on 1, 2.5, 5, 7.5 and 10 mg MMC/kg). Animal 
experiments were approved by the local animal ethical committee of the National Institute 
of Public Health and the Environment, Bilthoven, the Netherlands. 
 
4.3 Results 
 
4.3.1 Csa-/- mouse embryonic fibroblasts are hypersensitive to mitomycin C 
 
As part of a systematic characterization of 
the sensitivity spectrum of CS cells to 
different classes of genotoxic agents, we 
investigated whether Csa-deficient cell lines 
are hypersensitive to the cross-linking 
chemotherapeuticum mitomycin C (MMC). 
Clonogenic MMC survival assays on 
spontaneously transformed wild type and 
Csa-/- mouse embryonic fibroblasts (MEFs) 
revealed that Csa-/- MEFs are at least 4 
times more sensitive to MMC than their 
wild type counterparts (Figure 1, D37). 
Since MMC sensitivity can be influenced by 
differences in proliferation rate, we checked 
at least two independent cell lines with 
different proliferation rate per genotype. 
We did not mark any correlation between 
proliferation rate and sensitivity, arguing 
that indeed the observed MMC sensitivity 
in Csa-/- MEFs is due to the Csa-defect.  
Mitomycin C causes a spectrum of DNA 
lesions, including inter-strand cross-links, 
oxidative DNA damage and mono-adducts. 
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Figure 1 
MMC survival of Csb-/-, Csa-/-, Xpa-/- and wild 
type ES cells. 
Survival of spontaneously immortalized Csb-/-  
(diamonds), Csa-/- (triangles), Xpa-/- (circles) and wild 
type (squares) MEFs after exposure to increasing 
doses of mitomycin C, as determined by the colony 
assay. Shown is the average of at least three 
experiments, with for each genotype at least two 
independent cell-lines. Bars indicate the standard 
error of the mean.  
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A defect in transcription-coupled repair of these mono-adducts could cause the observed 
increase in MMC sensitivity in Csa-/- MEFs, compared to wt MEFs. This hypothesis predicts 
that also Csb-/- and Xpa-/- MEFs (that are both TC-NER deficient) would be hypersensitive 
for MMC. To test this model, we performed clonogenic MMC survival on Csb-/- and Xpa-/- 
MEFs, showing a marginal increase in MMC sensitivity compared to wild type MEFs 
(Figure 1). Therefore we conclude that the observed MMC sensitivity in Csa-/- MEFs is not 
associated with a TC-NER defect of mono-adducts. 
 
4.3.2 Severe MMC sensitivity in Csa-/- MEFs is not caused by a RNA synthesis block 
 
Given the fact that CSA is involved in transcription-coupled repair, we determined 
transcription activity in Csa-/-, Csb-/- and wild type MEFs after MMC treatment. We failed to 
show any block in RNA synthesis after MMC treatment at 2 or 8 µg/ml in wild type, Csa-/- 
or Csb-/- MEFs, while UV  treatment (10 J/m2) caused a clear block in RNA synthesis 
(Figure 2A, 2 µg MMC/ml not shown). It is therefore unlikely, that a stalled RNA 
polymerase causes the observed MMC sensitivity in Csa-/- MEFs. 
To further elucidate the mechanism causing the observed hypersensitivity to MMC in Csa-/- 
MEFs, we measured the induction of apoptosis after MMC treatment in wild type, Csb-/- and 
Csa-/- MEFs. Whereas we observed a clear induction of apoptosis 24 h after UV-treatment 
(10 J/m2), we fail to show any induction of apoptosis in wild type, Csa-/- and Csb-/- MEFs 
treated with 2 µg/ml MMC up to 72h after  treatment (subG1-assay; data not shown). Also, 
Figure 2 
RNA and DNA synthesis after MMC treatment in wild type, Csa-/- and Csb-/- MEFs after MMC 
treatment.  
Panel A: RNA synthesis of spontaneously immortalized wild type (squares), Csa-/- (triangles) and Csb-/- (diamonds) 
MEFs 3 and 6 hours after treatment with 8 µg/ml MMC (closed symbols) or 10 J/m2 UV (open symbols). 
Experiments were performed at least two times per cell-line, with at least 2 cell lines per genotype as determined by 
the [3H]-uridine incorporation assay. Shown are representative curves. Bars indicate the standard error of the mean. 
Panel B: DNA synthesis of spontaneously immortalized wild type (squares), Csa-/- (triangles) and Csb-/- (diamonds) 
MEFs 7, 16, 23 and 48 hours after treatment with 2 µg/ml MMC, as determined by [3H]-thymidine incorporation. 
Shown is the average of at least two experiments, with for each genotype at least two independent cell lines. Bars 
indicate the standard error of the mean. 
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 treatment of Csa-/- MEFs with 8 µg/ml MMC does not result in a strong apoptotic 
response at early time points (24h), but induces apoptosis at 72h in one of the two Csa-/- 
MEF lines tested (data not shown). In contrast, the other Csa-/- MEF line showed 
accumulation of cells in the G2 phase of the cell cycle (data not shown). Therefore we 
conclude that apoptosis observed in MMC-treated Csa-/- MEFs is probably a secondary 
effect, rather than the primary cause of MMC sensitivity of these cells. 
 
4.3.3 DNA synthesis block in MMC treated Csa-/- MEFs 
 
Besides a defect in recovering from a damage-induced RNA synthesis arrest, also a defect in 
recovery from a damage-induced block in DNA synthesis has been demonstrated for CSA 
and CSB fibroblasts (21, 27). To determine whether MMC treatment causes a DNA 
synthesis block in MEFs, and if so, whether Csa-/- MEFs are defective in recovering from 
such an arrest, we measured DNA synthesis after MMC treatment by the [3H]-thymidine 
incorporation assay. Upon treatment with 2 µg/ml MMC, we observe a clear drop in DNA 
synthesis in all genotypes tested. Moreover, after 24 and 48 h a significant recovery of the 
DNA synthesis arrest is observed in wild type and Csb-/- MEFs, while Csa-/- MEFs fail to 
recover DNA synthesis up to 48 h after treatment (Figure 2B). Similar results were obtained 
when cells were exposed to 4 and 8 µg/ml 
MMC (data not shown). This inability to 
restore DNA synthesis might significantly 
contribute to the observed MMC sensitivity 
of Csa-/- MEFs.  
 
4.3.4 Cell type-specific differences in 
MMC sensitivity, associated with the 
Csa-/- defect 
 
To determine whether  the sensitivity of 
Csa-/- MEFs to MMC is a general feature, 
we extended our study to another very 
different cell type. In contrast to data 
obtained in MEFs, clonogenic MMC 
survival experiments on wild type, Csa-/-, 
Csb-/- and Xpa-/- embryonic stem cells (ES 
cells) show similar MMC sensitivity for all 
genotypes tested (Figure 3). Strikingly, wild 
type ES cells are over 5 times more 
sensitive to MMC than wild type MEFs. 
This intrinsic hypersensitivity of ES cells is 
more pronounced for MMC-treatment, 
than for γ-ray- or UV-irradiation ((7), 
chapter 5).  
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Figure 3 
MMC survival of Csb-/-, Csa-/-, Xpa-/- and wild 
type ES cells. 
Survival  of  Csb-/-  (diamonds), Csa-/- (triangles), 
Xpa-/- (circles) and wild type (squares) ES cells after 
exposure to increasing doses of mitomycin C, as 
determined by the colony assay. Shown is the 
average of at least three experiments, with for each 
genotype at least two independent cell-lines. Bars 
indicate the standard error of the mean. For 
comparison, the survival of wild type MEFs 
following MMC trewatment is indicated by the 
dashed line. 
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Figure 4 
MMC survival of Csb-/-, Csa-/-, Xpa-/- and wild type mice.  
Surviving fraction of Csb-/- (diamonds), Csa-/- (triangles), Xpa-/- (circles) and wild type (squares) mice after different 
doses of MMC. Panel A: 2.5 mg MMC/kg bodyweight, Csb-/- (n=12), Csa-/- (n=9). Panel B: 5 mg MMC/kg 
bodyweight, Csb-/- (n=14), Csa-/- (n=11), Xpa-/- (n=5). Panel C: 7.5 mg MMC/kg bodyweight, Csb-/- (n=5), Csa-/- 
(n=4), Xpa-/- (n=10) wild type (n=12). Panel D: 10 mg MMC/kg bodyweight, Csb-/- (n=10), Csa-/- (n=2) Xpa-/- 
(n=4) wild type (n=15). 
 
4.3.5 MMC-toxicity in wild type, Csa-/-, Csb-/- and Xpa-/- mice 
 
The cell specific response to MMC observed above raises the clinical relevant question how 
the MMC response at the level of the whole animal is influenced by Csa, Csb or Xpa defects. 
To study the MMC response at the level of the whole animal, we injected mice 
intraperitoneally with a single dose of 1, 2.5, 5, 7.5 or 10 mg/kg MMC. Animals were 
housed in isolators throughout the experiment to minimize the risk of infections. Mice were 
scored as death either when found death, or when they had to be sacrificed, according to 
the local bio-ethical standards (criteria applied: severe weight loss (>20%), no food-intake, 
no movement, no response to external stimuli and hunchbacked appearance). Survival 
curves are shown in figure 4. Surprisingly, we observed a hypersensitive response to MMC 
treatment in both Csa-/- and Csb-/- mice, compared to wild type mice. Xpa-/- mice are also 
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Table 1: Kaplan-Maier statitistics on survival 
curves of MMC treated animals 
p = Xpa Csb Csa 
wt 0.0002 0.0000 0.0000 
Xpa  0.0218 0.0287 
Csb   0.4297
hypersensitive to MMC, although to a 
significant lesser extent than Csa-/- and 
Csb-/- animals (Table 1). Therefore, we 
conclude that mice defective in TCR 
only (Csa-/- and Csb-/-) are significantly 
more sensitive to MMC treatment 
than total NER deficient Xpa-/- mice, 
suggesting a NER-independent role of CSA and CSB in the response to MMC. Moreover, 
we show that MMC sensitivity in either MEFs or ES cells is not predictive for MMC 
sensitivity of the mouse.  
 
4.4 Discussion 
 
4.4.1 NER-independent sensitivity of Csa-/- MEFs to MMC 
 
We have exploited genetically defined mouse models for a detailed analysis of the effect of a 
Csa or Csb deficiency on MMC sensitivity at the level of cells and the whole organism. 
Mitomycin C produces a wide range of different DNA lesions. Besides mono-adducts and 
oxidative DNA damage, MMC causes a low percentage of DNA inter-strand cross-links. In 
general, these cross-links are regarded as the most cytotoxic lesions, being largely 
responsible for the extreme toxicity of MMC, particularly for proliferating cells (9). In line 
with previous observations in hamster cell lines (5, 13), we demonstrate that Xpa-/- and Csb-/- 
MEFs are slightly sensitive to MMC. This slight MMC sensitivity might be explained by a 
repair deficiency of mono-adducts and intra-stand cross-links. However, also a minor 
function of nucleotide excision repair in inter-strand cross-link repair has been suggested 
(23, 32-35). Surprisingly, Csa-/- MEFs appeared to be hypersensitive to MMC. This finding 
contrasts the observed induction of apoptosis in CSA, CSB, XPG and XPD human 
fibroblasts (all showing comparable induction) after continuous MMC treatment (1). 
However, clonogenic sensitivity studies do not per se reflect induction of apoptosis. 
The observed MMC sensitivity in Csa-/- MEFs is unlikely to be attributed to a TC-NER 
deficiency in these cell lines, since totally NER-deficient Xpa-/- MEFs are only slightly 
sensitive to MMC. Moreover, although cross-links might be repaired more efficient in 
transcribed areas (10, 14-17, 25, 31) and TCR might be involved in repair of a minor 
fraction of cross-links (35), also a deficiency in TCR does not seem to explain the MMC 
sensitivity in Csa-/- MEFs, since Csb-/- MEFs are less MMC sensitive than Csa-/- MEFs. 
Therefore, a deficiency in a CSB-independent TCR mechanism might explain the MMC 
sensitivity in Csa-/- MEFs.  However, no significant blockage of RNA synthesis after MMC 
treatment is observed. Finally, also defective cross-link repair by homologous 
recombination is an unlikely explanation, since no obvious deficiency in Rad51 foci 
formation after MMC treatment is observed in Csa-/- MEFs (data not shown). We conclude 
that Csa-/- MEFs are hypersensitive to MMC and that this hypersensitivity is not clearly 
associated with a deficiency in cross-link repair by NER, TCR or homologous 
recombination.  
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4.4.2 CSA is needed for restoration of DNA synthesis after MMC treatment 
 
Since MMC treatment did not cause a RNA synthesis block or a rapid induction of 
apoptosis, we wondered what could be the underlying cause of the observed MMC 
sensitivity in Csa-/- MEFs. DNA inter-strand cross-links by definition prevent strand 
separation and thereby block replication. We checked whether DNA synthesis is hampered 
in Csa-/- MEFs after MMC  treatment and  show that indeed MMC treated wild type and 
Csb-/- MEFs undergo a transient DNA synthesis block, but are able to recover, while Csa-/- 
MEFs fail to recover. This DNA synthesis block is probably not caused by the direct effect 
of a low number of DNA inter-strand cross-links that obstruct DNA polymerases, but 
might originate from an S-phase block caused by the inter-strand cross-links. Moreover, the 
function of CSA in the restoration of a DNA synthesis block remains to be elucidated. 
 
4.4.3 MMC sensitivity is cell type specific 
 
Interestingly, we observed a marked difference in MMC sensitivity between MEFs and ES 
cells. ES cells appear to be over 5 times more sensitive to MMC than MEFs. Since the 
majority of ES cells are in the S-phase of the cell cycle, it is tempting to speculate that this 
causes the hypersensitivity of ES cells. Although also lower thresholds for apoptosis 
induction or lower repair efficiency might contribute to this phenotype. Moreover, in ES 
cells a deficiency of CSA does not contribute to the MMC response. Whether the increased 
MMC sensitivity associated with a Csa deficiency is masked in ES cells by the intrinsic 
hypersensitivity of this cell type for this agent, or whether ES cells do not depend on the 
CSA protein in their response to MMC, is unclear.  
 
4.4.4 MMC effect on Csa-/-, Csb-/-, Xpa-/- and wild type mice 
 
Surprisingly, we show that Csa-/-, Csb-/- and Xpa-/- mice, in contrast to wild type animals, are 
hypersensitive to MMC treatment. Both Csa-/- and Csb-/- mice are significantly more MMC 
sensitive, than Xpa-/- mice.  This observation indicates that MMC sensitivity in Cockayne 
mice might be partly due to a NER defect. However, significant increased MMC sensitivity 
in Csa-/- and Csb-/- mice compared to Xpa-/- animals, indicates that besides NER also another 
mechanism contributes to the cellular MMC sensitivity. Whether this mechanism is 
transcription-coupled repair, still needs to be elucidated.  Strikingly, while γ-ray sensitivity of 
ES cells reflects the X-ray sensitivity of mice (7), the MMC sensitivity of mice is not 
reflected by MMC sensitivities in any cell system tested. The fact that cell lines do not have 
a predictive value for MMC sensitivity of the whole organism, asks for great care in MMC 
treatment of patients, especially of patients with an XP defect. 
Finally, although MMC sensitivity is cell type specific, it is tempting to speculate that cross-
links originating from endogenously produced agents in specific cell types, might contribute 
to the CS phenotype in the patient. 
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Abstract 
 
Pluripotent embryonic stem cells (ES cells) are the precursors of all different cell types 
comprising the organism. Since persistent DNA damage, which might lead to mutations, 
can cause huge malformations in the organism, genome caretaking is of prime importance 
to this cell type. We compared the sensitivity of mouse embryonic fibroblasts (MEFs) and 
ES cells for various genotoxic agents and show that ES cells are more sensitive to treatment 
with UV-light, γ-rays and mitomycin C.  
In this study, we further investigated the contribution of the transcription-coupled (TC-
NER) and global genome (GG-NER) sub-pathways of nucleotide excision repair (NER) in 
protection of ES cells. Therefore, we isolated wild type, Csb-/- (TC-NER-deficient), Xpc-/- 
(GG-NER-deficient) and Xpa-/- (TC- and GG-NER-deficient) ES cells and compared the 
UV response of these cells and MEFs. TC-NER deficient Csb-/- and Xpa-/- MEFs are 
hypersensitive to UV, whereas Xpc-/- MEFs attribute intermediate UV sensitivity. In 
contrast, the global genome repair deficient Xpa-/- and Xpc-/- ES are highly UV-sensitive, 
while a Csb deficiency only causes a mild increase in UV-sensitivity in ES cells. The 
observed hypersensitivity in Csb-/- and Xpa-/- MEFs correlates with increased apoptosis upon 
UV irradiation. Surprisingly, a hyperapoptotic response upon UV irradiation is mainly 
observed in Xpa-/- ES cells, suggesting a different mechanism of apoptosis induction in ES 
cells, mainly relying on damage in the global genome rather than in transcribed genes. 
Moreover, we show a pronounced S-phase delay in Xpa-/- and Xpc-/- ES cells. This 
mechanism might well function as a safeguard in heavily damaged cells in case apoptotic 
response fails. Our finding that although Xpa-/- and Xpc-/- ES are totally NER-defective or 
GG-NER-deficient respectively, the mutation induction upon UV is similar compared to 
wild type ES cells suggests indeed that the observed apoptotic and cell cycle response is 
sufficient to protect against progression of mutated cells. In conclusion, we show a double 
safeguard mechanism in ES cells against NER-type of damages, which mainly relies on 
damage detection in the global genome. 
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5.1 Introduction 
 
Preserving the genome is of prime importance for all living organisms since endogenous 
and exogenous agents (e.g. UV light, X-rays, oxidative stress and many chemicals) 
continuously induce a wide variety of DNA lesions. Replication of the damaged template 
may lead to mutations, potentially resulting in cancer. Alternatively, persistent DNA damage 
can hinder cellular key processes like transcription and replication, which may cause cell 
malfunctioning, ultimately leading to cell death. Evidence is accumulating that this overall 
functional decline of the genome may contribute to aging (reviewed in (31)). To counteract 
genotoxic stress, cells are equipped with an elaborate genome care-taking network, among 
which  different  DNA  repair  mechanisms  with  partly  overlapping substrate specificity: 
(i) Non-homologous end joining and homologous recombination, for repair of double 
strand breaks. (ii) A variety of base excision repair (BER) enzymes, coping with small base 
modifications, like methylation and oxidation. (iii) Nucleotide excision repair (NER), for 
removal of UV-induced and other helix-distorting lesions (for recent review see (13, 17)).  
The NER machinery consists of two sub-pathways, namely global genome NER (GG-
NER) and transcription-coupled NER (TC-NER). GG-NER removes DNA damage from 
the entire genome. TC-NER specifically and efficiently removes DNA damage from the 
transcribed strand of active genes, thereby releasing transcription arrest, caused by RNA 
polymerase II stalled at lesions. For some lesions that are repaired by the BER machinery, it 
has been shown that they can also be removed in a transcription-coupled manner (20, 21). 
Whether this process is performed by TC-NER or via transcription-coupled BER (TC-
BER) is disputed. In cases that it is unknown whether TC-NER or TC-BER is functional, 
we refer to transcription-coupled repair (TCR). Defects in TCR are associated with the rare 
inherited disorder Cockayne syndrome (CS), while GG-NER defects or total NER 
deficiencies are interrelated with xeroderma pigmentosum (XP) (for review see (4)). In 
addition to repair, transient cell cycle arrest provides the cell with a time window to fix 
damaged DNA before lesions are converted into permanent genetic changes (for review on 
DNA damage induced cell cycle regulation see (5)). When repair fails or takes too long, cells 
carrying too much genetic damage can be eliminated via apoptosis or become senescent 
(reviewed by (3, 19)).   
It has been suggested that, depending on cell type, differentiation-stage and age, cells may 
have a different need to withstand genotoxic stress and therefore might have different 
priorities in the use of the various genome-caretaking processes. For example, exposure of 
pregnant mice to very low doses of ionizing radiation causes severe apoptosis in the 
embryo, while apoptosis is not observed in extra-embryonic tissue (16). A similar 
observation has been made for the small intestine, where ionizing radiation-induced 
apoptosis is restricted to stem cells in the crypt and is absent in the more differentiated cells 
in the villi (35). An example of cell-type-specific usage of various repair pathways is the 
preference for error free repair of double strand breaks by homologous recombination in 
ES cells, while double strand break repair in more differentiated cells largely depend on the 
error prone non homologous end joining (12). It is even possible that certain repair 
mechanisms are only present in, and adapted to specific cell types. For example, neurons are 
postmitotic cells that do not divide and as a consequence will not use the gross of their 
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genome anymore. Therefore, it has been suggested that these cells do not need to keep their 
overall genome error-free, but instead only have to properly maintain their transcribed 
genes. Indeed, it has been shown that neurons have low levels of GG-NER, while TC-NER 
is normal (33). Since in the absence of GG-NER, damage could accumulate on the non-
transcribed strand of active genes (serving as a template for the TCR reaction) also the non-
transcribed strand of active genes should be kept lesion-free. A specific mechanism, 
differentiation associated repair (DAR), has been described to complement TC-NER by 
repair of damage in the non transcribed strand of active genes in neurons (32, 33).  
It is currently unknown whether, as in terminally differentiated cells, stem-cell-specific 
damage response pathways exist. Embryonic stem cells (ES cells) are the ultimate stem cells, 
and therefore can be considered at the far end of the spectrum ranging from 
undifferentiated to differentiated cells. Tolerance of DNA damage in pluripotent ES cells 
could have detrimental consequences. For example clonal expansion of mutated cells to 
considerable parts of the organism can lead to huge malformations. As part of the genome-
caretaking network, a hyperapoptotic response of ES cells to various genotoxic agents has 
been shown (1, 8, 38, 45). NER seems to contribute to some extent in protection against 
DNA damage (45). To get more insight in the contribution of TC-NER and GG-NER in 
the total genome care-taking machinery in pluripotent stem cells and in (partially) 
differentiated somatic cells, we established mouse ES cells and embryonic fibroblasts 
(MEFs) with defects in TC-NER (Csb-/-), GG-NER (Xpc-/-) or both pathways (Xpa-/-), as 
well as wild type cells. We show that, in comparison to MEFs, ES cells are hypersensitive to 
a wide variety of genotoxic agents. Interestingly, inactivation of specific repair genes has 
different effects on the damage response in ES cells and MEFs. Our data suggest that the 
contribution of damage in the global genome is the major determinant for the ES cell 
response to helix distorting lesions. Therefore, in contrast to the situation in MEFs, the 
main contributor to apoptosis induction in Xpa-/- ES cells is the deficiency for GG-NER, 
rather than the TC-NER-defect. Finally, our study provides evidence for a double safeguard 
mechanism against mutations in ES cells. 
 
5.2 Materials and Methods 
 
5.2.1 Cell lines 
  
Isolation of primary Csb-/- (FVB/129Ola), Xpa-/- (C57Bl6J/129Ola) MEFs and 
corresponding wild type cell lines has been described (10, 44). Xpc-/- (C57Bl6/129Ola) 
MEFs were isolated in a similar manner. Cells were cultured in F10/DMEM (1:1) (Gibco) 
medium, supplemented with 10 % fetal calf serum and 50 µg/ml penicillin and 
streptomycin (Gibco). Spontaneously immortalized cell lines were obtained by continuous 
subculturing of primary MEFs. Cellular sensitivity studies and RNA synthesis recovery 
experiments were performed on transformed MEFs. Cell cycle analysis and apoptosis 
induction was measured in primary MEFs. 
Wild type, Csb-/-, Xpc-/- and Xpa-/- embryonic stem (ES) cells were isolated from blastocysts 
(3.5 days post coitum) obtained from wild type, Csb-/-, Xpc-/- and Xpa-/- mice intercrosses 
respectively (all in a C57Bl6 genetic background) as described previously (11). ES cells were 
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maintained on gelatin-coated dishes or on lethally irradiated MEF feeder layers (20 Gy from 
a 137Cs source) in 50 % buffalo rat liver cell conditioned DMEM/50 % fresh DMEM 
supplemented with 15 % fetal calf serum, 0.1 mM non-essential amino acids (Gibco), 50 
µg/ml penicillin and streptomycin (Gibco), 1000 U/ml leukemia inhibitory factor 
(Chemicon) and 0.1 mM 2-mercaptoethanol (Sigma). 
 
5.2.2 Cellular sensitivity studies 
 
Determination of cellular survival of ES cells and MEFs was performed using a colony 
assay. UV survival of MEFs was established using a 3H-thymidine incorporation assay (41), 
however no difference in survival was observed for wild type MEFs using the two different 
assays (data not shown). 
Colony assays were performed using the following protocol. Cells were plated in 6 cm 
dishes, at various dilutions. After 12-16 h, cells were exposed to different doses of UV (254 
nm, Philips TUV lamp), irradiated with ionizing radiation, using a 137Cs source, treated for 
one hour with various concentrations of mitomycin C (Kyowa) diluted in growth medium, 
or exposed to increasing doses of Illudin S (isolated from O. illudins as described (2)) for 
72h diluted in growth medium. Cells were grown for 5 to 14 days, fixed, stained and 
counted to assess the colony-forming ability. All experiments were performed in triplicate.  
3H-thymidine incorporation assay was determined as described (41). Briefly, MEFs were 
exposed to different doses of UV (254 nm, Philips TUV lamp) and allowed to grow for 
another 3-5 days, before reaching confluency. The number of proliferating cells was 
estimated by scintillation counting of the radioactivity incorporated during a 3 hr pulse with 
3H-Thymidine (5µCi/ml, s.a. 40-60 Ci/mmole; Amersham). Cell survival was expressed as 
the ratio of 3H incorporation in treated and non-treated cells. 
 
5.2.3 RNA synthesis recovery 
 
RNA synthesis recovery after UV or MMC treatment was performed as described (29), with 
several  modifications. Briefly, cell were seeded in 6 well plates and after 24 h labeled with 
[2-14C]-thymidine (50 µCi/ml, s.a. 50 mCi/mmole; Amersham) for 16 h. Cells were 
irradiated with 10 J/m2 UV (254nm, Philips TUV lamp). Two and four hours after 
treatment with UV, RNA synthesis was determined by 1h labeling with [5,6-3H]-uridine (10 
µCi/ml, s.a. 50 Ci/mmole; Amersham). 3H and 14C ratios were measured by scintillation 
counting. The relative RNA synthesis was expressed as the quotient of these 3H-14C ratio of 
treated over untreated cells. 
 
5.2.4 Apoptosis analysis 
 
Determination of apoptosis by subG1 is performed as described (9). ES cells and MEFs are 
grown and UV irradiated (254 nm, Philips TUV lamp). After 24-48 h cells were washed and 
harvested by trypsinization. Growth medium, the washes and the harvested cells were 
pooled and fixed by ethanol fixation. From fixed cells small DNA fragments were extracted 
by a 0.2 M phosphate citrate buffer (pH 7.8). Subsequently cells were stained by PI and 
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DNA content was analyzed on a BD Facscan or a BD Facscalibur using Cellquest (pro) 
software. 
For measurement of apoptosis by the Annexin V assay, cells were grown and UV irradiated 
(254 nm, Philips TUV lamp). After 24-48 h cells were washed and harvested by 
trypsinization. Growth medium, the washes and the harvested cells were pooled. Harvested 
cells were collected by centrifugation, resuspended in 1 ml of culture-medium in an 
eppendorf-tube and allowed to recover for 30 minutes at 37°C. Cells were shortly 
centrifuged, resuspended in 95µl AnnexinV-solution (0.8 µl FITC-labeled Annexin V 
(Pharmingen) in PBS) and incubated for 15 minutes on ice. 300 µl PI-stain (3.3 µM PI in 
PBS) was added to the sample, incubated for 1 minute on ice and analyzed on a BD 
Facscan, using Cellquest software. AnnexinV-/PI- cells are viable, AnnexinV+/PI- are early 
apoptotic cells and AnnexinV+/PI+ are late apoptotic and necrotic cells. 
 
5.2.5 Cell cycle analysis 
 
Determination of cell cycle profile is performed as described (9). Shortly, ES cells are grown 
and UV irradiated (254 nm, Philips TUV lamp). After 4 -24 h cells were washed and 
harvested by trypsinization and fixed by ethanol fixation. Fixed cells were stained by PI 
staining and analyzed on a (BD Facscan or a BD Facscalibur) using Cellquest (pro) 
software. 
 
5.2.6 Mutation analysis 
 
Mutation analysis at the Hprt gene is performed as described (45). Briefly, ES cells are 
seeded on gelatin-coated plates and UV irradiated (254 nm, Philips TUV lamp). After UV 
irradiation, cells were trypsinized and seeded on MEF feeder layers. Cells were propagated 
for 6 days by passaging every 2 days. At least 9 x 106 cells were plated per dose after each 
passage. After the 6-day expression period 0.2-1 x 107 cells per dose were plated for 
selection with 2.5 µg/ml 6-thioguanine (Sigma, St Louis, MO) at a density of 2 x 105 cells 
per 100 mm dish. Additionally, the cloning efficiency was determined by seeding 750-2500 
cells per dish (five dishes per dose) in medium without 6-thioguanine. Colonies were fixed, 
stained and counted 6-7 days after seeding of the cells.  
6-Thioguanine-resistant clones were subcultered and frozen at -80°C. For RNA isolation, 
cell pellets were lysed in 100 µl of TRIzol (Life Technologies) and RNA was extracted, 
according to the manufacturer’s protocol. RNA was resuspended in 18 µl of annealing 
buffer (250 mM KCl, 10 mM Tris.HCl pH 8.3, 1 mM EDTA), mixed with 40 pmol of Hprt-
cDNA primer (GCAGCAACTGACATTTCTAAA ) and incubated at 65°C for 3 minutes 
to allow annealing of the primer to the Hprt mRNA strand. After this, the sample was split 
in two and cDNA synthesis was performed as described (47).  
3 µl of synthesized cDNA was used to amplify the coding region of the Hprt gene in a total 
volume of 100 µl containing 20 µl of a 5x PCR buffer (500 mM KCl, 100 mM Tris.HCl pH 
8.3, 15 mM MgCl2), 4 µl of a dNTP mix (2.5 mM), 1 unit of Amplitaq polymerase (Perkin-
Elmer) and 20 pmol of each of the PCR primers. For the first round of amplification the 
PCR primers were hprt-mus2 (AAAAAGCTTTACTAGGCAGATGG) and zee1-mus 
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(GGCTTCCTCC TCAGAC CGT). After an initial denaturation step for 5 min at 93°C, 35 
cycles of 1 min at 93°C, 1 min at 50°C, and 3 min at 72°C were performed followed by a 
final extension step of 8 min at 72°C. 1 µl of amplified DNA was used in a reamplification 
reaction of 25 cycles with an annealing temperature of 55°C using primers hprt-mus1 
(TTTTTGCCGCGAGCCGACC) and san2m13 (CGACGTTGTAAAACGACGGCCAGT 
GCAGATTCAACTTGCGCTC). 10 µl of amplified DNA was used for sequence analysis 
with  the Thermo  Sequenase  fluorescent  labelled  primer cycle sequencing kit containing 
7-deaza-dGTP (Amersham/Pharmacia/Biotech) on an automatic ALF sequencer 
(Amersham). 
 
5.3 Results 
 
5.3.1 ES cells are hypersensitive to a variety of genotoxic treatments 
 
To investigate whether ES cells are more sensitive to genotoxic stress than other cell types, 
we compared sensitivities of ES cells and spontaneously transformed mouse embryonic 
fibroblasts (MEFs) to various genotoxic agents. Although, we never observed effects of the 
genetic background in MEFs (C57Bl6/129Ola, FVB/129Ola and C57Bl6) on UV-
sensitivity, we isolated for this study ES cells in a pure C57Bl6 background to completely 
rule out the influence of differences in genetic background. As shown in figure 1A, ES cells 
attribute a modest increase in sensitivity to γ-ray irradiation, causing oxidative lesions and 
DNA breaks. Furthermore, we observe a strong hypersensitivity to the chemotherapeutic 
mitomycin C, which induces the very cytotoxic DNA inter-strand cross-links, besides a 
variety of other lesion, like oxidative DNA damage and mono-adducts. Finally, ES cells are 
more sensitive to UV-irradiation, than MEFs. Van Sloun et al reported that the same dose 
of UV causes half the amount of UV photoproduct in ES cells, compared to MEFs (45), 
indicating that the observed difference in UV sensitivity between ES-cells and MEFs is an 
underestimation. Taken together, we show that ES cells are more sensitive for a variety of 
different genotoxic agents than MEFs. 
 
5.3.2 Deficiency in global genome NER has more influence on survival, than 
deficiency in transcription-coupled repair 
 
Since the UV response is well-studied in human and mouse fibroblasts, but not in stem 
cells, we further focus on the UV response of ES cells. To investigate the contribution of 
GG-NER and TC-NER to cellular survival after UV treatment, we isolated wild type, Csb-/-, 
Xpc-/- and Xpa-/- ES cells in an isogenic C57Bl6 background. Prominent differences in 
growth characteristics or morphology between these cells are not observed (data not 
shown). We compared survival of UV-treated ES cells with MEFs, with the same genetic 
NER defect (Figure 1B). A total NER defect causes a comparable hypersensitivity to UV-
induced DNA damage in both Xpa-/- ES cells and Xpa-/- MEFs (when corrected for 
effective dose in ES cells). While TC-NER-deficient Csb-/-  MEFs show an almost similar 
UV survival as Xpa-/- MEFs, Csb-/- ES cells are just slightly more sensitivity to UV than wild 
type ES cells. In contrast, GG-NER-deficient Xpc-/- ES cells show a severe hypersensitivity 
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to UV, while Xpc-/- MEFs display an intermediate sensitivity. Taken together, we conclude 
that, as shown for human fibroblasts (7, 23, 24), UV sensitivity in MEFs is mainly 
associated with a TC-NER defect (hypersensitivity of Xpa-/- and Csb-/- MEFs). In ES cells, 
UV sensitivity correlates to a large extent with GG-NER capacity (hypersensitivity of Xpa-/- 
and Xpc-/- ES cells)  
 
5.3.3 Transcription-coupled repair is functional in ES cells 
 
The severe sensitivity of Xpc-/- ES cells, as well as the almost complete lack of UV sensitivity 
of Csb-/- ES cells, compared to wild type ES cells, can be explained by a lack of TC-NER in 
ES cells, or by an overruling response due to damage in the global genome. It should be 
noted that these two options are not mutually exclusive. To test whether TC-NER is 
functional  in ES cells, we measured RNA synthesis recovery after UV treatment, which is a 
Figure 1 
Survival of ES cells versus MEFs. 
Panel A: Survival of wild type ES cells (triangles) and spontaneously transformed MEFs (squares) after exposure to 
γ-rays, mitomycin C or UV-light. Except for the UV survival of MEFs, which is determined by thymidine 
incorporation assay, survival is determined by colony assay. Panel B: Survival of wild type (squares), Csb-/- 
(diamonds), Xpc-/- (triangles) and Xpa-/- (circles) ES cells and transformed MEFs after exposure to increasing doses 
of UV-light (254 nm), as determined by colony assay and thymidine incorporation assay respectively.  
Panel C: Survival of wild type (squares), Csb-/- (diamonds), Xpc-/- (triangles) and Xpa-/- (circles) ES cells after 
exposure to increasing doses of Illudin S for 72h, as determined by colony assay. For each cell-line, experiments 
were performed at least three times and for each genotype identical results were obtained with at least two 
independent cell-lines (data not shown). For all experiments, except UV survival of MEFs in panel B and Illudin S 
survival in panel C, the average of multiple experiments is shown. For the latter experiments representative 
examples are shown. Bars indicate the standard error of the mean. 
su
rv
iv
in
g 
fra
ct
io
n 
(%
)
UV (J/m2)
su
rv
iv
in
g 
fra
ct
io
n 
(%
)
γ-ray (Gy)
su
rv
iv
in
g 
fra
ct
io
n 
(%
)
MMC (µg/ml)
(A)
su
rv
iv
in
g 
fra
ct
io
n 
(%
)
su
rv
iv
in
g 
fra
ct
io
n 
(%
)
(B) (C)
su
rv
iv
in
g 
fra
ct
io
n 
(%
)
UV (J/m2) UV (J/m2) Illudin S (ng/ml/72h)
1
10
100
0 2 4 6 8
ES
MEF
1
10
100
0 2 4 6
ES
MEF
0.1
1
10
100
0 2 4 6
wt
csb
xpc
xpa
ES
0.01
0.1
1
10
100
0 2 4 6
wt
csb
xpc
xpa
MEF
0.01
0.1
1
10
100
0 0.1 0.2 0.3
wt
csb
xpc
xpa
1
10
100
0 2 4 6
ES
MEF
su
rv
iv
in
g 
fra
ct
io
n 
(%
)
su
rv
iv
in
g 
fra
ct
io
n 
(%
)
su
rv
iv
in
g 
fra
ct
io
n 
(%
)
su
rv
iv
in
g 
fra
ct
io
n 
(%
)
su
rv
iv
in
g 
fra
ct
io
n 
(%
)
su
rv
iv
in
g 
fra
ct
io
n 
(%
)
Chapter 5 108 
wide used indicator for TC-NER capacity. Remarkably, we could not detect any block of 
RNA synthesis in UV treated wild type or Csb-/- ES cells at early time points (2 and 4h after 
up to 10 J/m2 UV) (data not shown). In MEFs, a clear block in RNA synthesis has been 
reported at this dose and these timepoints. The lack of a rapid block in RNA synthesis in 
ES cells, together with the detachment of UV-treated ES cells as soon as 8 h after treatment 
from the surface, made it impossible to measure RNA synthesis recovery. To further test 
the relevance of TC-NER in ES cells, we treated wild type, Csb-/-, Xpc-/- and Xpa-/- ES cells 
with Illudin S, which induces DNA lesions that appear to be recognized and repaired by 
TC-NER, only. As reported for fibroblasts (18), Csb-/- and Xpa-/- ES cells are hypersensitive 
to Illudin S, while GG-NER-deficient Xpc-/- ES cells show the wild type sensitivity (Figure 
1C), suggesting that TC-NER is functional in ES cells. This finding makes it unlikely that 
the UV-hypersensitivity of wild type ES cells and the relative small difference between wild 
type and Csb-/- ES cells is due to a general lack of TC-NER in ES cells. 
 
Figure 2 
Apoptotic response of ES cells versus MEFs to exposure with UV light. 
Apoptotic response of wild type, Csb-/-, Xpc-/- and Xpa-/- ES cells and MEFs to exposure with UV-light (254nm) 
after 24 or 48 hours respectivicely. Apoptosis is shown by cell sorting of propidium iodide stained cells. Percentage 
of cells in apoptosis (subG1-fraction, marked in the figure with M1) is noted in the figure, after subtraction of 
background values (apoptosis in untreated sample). Cells marked with M2 are non-apoptotic cells, either in G1, S 
or G2 phase of the cell cycle. UV-dose is depicted above the columns; beside the rows genotypes are shown. Panel 
A: apoptotic response of MEFs. Panel B: apoptotic response of ES cells. For each cell-line, experiments were 
performed at least three times and for each genotype identical results were obtained with at least two independent 
cell-lines (data not shown). 
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5.3.4 Xpa-/-, but not Xpc-/- or Csb-/- ES cells are hyperapoptotic 
 
To test whether the observed UV sensitivity in ES cells is mainly caused by damage in the 
global genome, and to establish the mechanism underlying the observed hypersensitivity of 
(partly) NER-deficient ES cells, we examined the apoptotic reaction of these cells, using the 
subG1 assay. As reported for human fibroblasts (7), both Xpa-/- and (to a somewhat lesser 
extent) Csb-/- MEFs show a pronounced apoptotic response, judged from an increase in the 
subG1 population, measured 48h after exposure to 4J/m2 UV (Figure 2A). The induction 
of apoptosis in Csb-/- and Xpa-/- MEFs correlates well with the observed hypersensitivity of 
these cells to UV-light.  
Apoptosis induction in ES cells was determined after irradiation with 2 J/m2 UV, which 
causes a comparable percentage of surviving wild type ES cells, compared to wild type 
MEFs irradiated with 4J/m2 UV. While we show a strong increase in apoptosis in Xpa-/- ES 
cells 24h after UV-irradiation, only a marginal apoptosis-induction is observed in Csb-/- ES 
cells. Although Xpc-/- ES cell are almost as sensitive as Xpa-/- ES cells, we did not observe 
any induction of apoptosis in these cells (Figure 2B). Also, we do not observe any induction 
of apoptosis in Xpc-/- ES 48h after UV treatment (data not shown), suggesting that these 
cells lack UV induced apoptosis, rather than having a delayed apoptotic response. To 
exclude experimental artifacts, we confirmed these data by an AnnexinV assay (data not 
shown). In conclusion, we show that while Xpa-/- and Csb-/- MEFs are hyperapoptotic after 
UV, only Xpa-/- ES cells attribute higher apoptotic levels after UV treatment. Surprisingly, 
Xpc-/- ES cells fail to show a Xpa-like apoptotic response, although the UV-sensitivity of 
these two lines is comparable. 
 
5.3.5 S-phase delay in Xpa-/- and Xpc-/- ES cells upon UV exposure 
 
Close examination of the cell-cycle profiles of UV-treated Xpc-/- and Xpa-/- ES cells suggests 
an accumulation of cells in late S/G2 phase 24h after UV treatment (Figure 2B). To further 
investigate this phenomenon, we analyzed the cell cycle profile of ES cells upon UV 
irradiation (Figure 3). The cell cycle kinetics of wild type and Csb-/- ES cells are similar, 
showing a synchronized release of cells from G1- into S-phase and a recovery of the normal 
cell cycle profile 24h after treatment. Since cells propagate into the S-phase, it seems that ES 
cells do not have a G1-block upon UV-irradiation. Moreover, these profiles suggest a 
transient S/G2 block, circumventing mitosis and thereby replenishing of the G1 population. 
Xpa-/- and Xpc-/- ES cells show a slower progression through the S-phase than the wild type 
ES cells, with a considerable percentage of cells that are blocked in late S/G2 phase 24h 
after treatment. Because only attached cells are harvested (and floating, and thus apoptotic 
cells are discarded), in these experiments the subG1-population in UV-treated Xpa-/- ES 
cells is not observed. In conclusion, we show a correlation between the lack of GG-NER 
and a slower S-phase progression after UV treatment in ES cells. 
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Figure 3 
Cell cycle response of wild type, Csb-/-, Xpc-/- and Xpa-/- ES cells to exposure with UV-light (254nm). 
Various timepoints after UV exposure, cells were stained by propidium iodide. Cells in G1, S and G2 phase are 
marked in the figure. UV-dose and time are depicted beside the rows and genotypes are depicted under the 
columns. For each cell-line, experiments were performed at least three times and for each genotype identical results 
were obtained with at least two independent cell-lines (data not shown). 
 
5.3.6 Deficiency for TC-NER, but not for GG-NER, causes elevated UV-induced 
mutation rates in ES cells 
 
To investigate whether the lack of repair in NER-deficient ES cells and the observed 
differences in sensitivity, apoptotic and cell cycle response of these cells influence 
mutagenesis, we performed a UV-induced mutation induction analysis on the HPRT gene. 
Surprisingly, in wild type, Xpa-/- and Xpc-/- ES cells UV-induced mutability is comparable; 
only Csb-/- ES cells appear hypermutable (Figure 4). This is due to the genetic defect on the 
UV-response, since background mutation rates were comparable for the different mutant 
ES cells. The HPRT gene in surviving ES clones was sequenced for identification of 
mutations (Table 1). Xpa-/- ES lines show mainly mutations arising from CC or TC 
sequences in the transcribed strand. In contrast, in Xpc-/- ES cells, in which TC-NER is 
normal, mutations predominantly arise from DNA damage on the non-transcribed strand. 
Finally, a strong bias to mutations arisen from lesion on the transcribed strand is observed 
in Csb-/- ES cells, in which TC-NER is abolished. In conclusion, only a Csb deficiency causes 
higher mutation rates in UV treated ES cells, compared to wild type ES cells. 
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Table 1: Overview HPRT mutations 
    
pointmutations 
originate from 
Genotype
 
Transitions
 
Trans-
version 
Other
 
NTS 
 
TS 
 
wt 5 1 6 2 4 
CSB -/- 12 2 4 3 14 
XPC -/- 5 4 4 5 1 
XPA -/- 12  10 2 10 
 
Table 1 
Mutation induction of UV light in wild type, Csb-/-, Xpc-/- 
and Xpa-/- ES cells. 
Mutation induction on the Hprt-gene in wild type, Csb-/-, Xpc-/- and 
Xpa-/- ES cells after exposure to increasing doses of UV-light 
(254nm), as measured by 6-TG resistant clones. Mutation 
frequency is shown in figure 4. The amount of measured 
transitions, transversions and other mutations are shown. 
Moreover, the amount of point mutations, originating from 
photoproducts in the transcribed or the non-transcribed strand of 
the HPRT gene, is noted. 
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Figure 4 
Mutation induction of UV light in wild 
type, Csb-/-, Xpc-/- and Xpa-/- ES cells. 
Mutation induction on the Hprt-gene in 
wild type, Csb-/-, Xpc-/- and Xpa-/- ES cells 
after exposure to increasing doses of UV-
light (254nm), as measured by 6-TG 
resistant clones. Mutation frequency is 
shown on the y-axis after subtraction of 
spontaneous mutation frequency in un-
irradiated ES cells.  
 
5.4 Discussion 
 
5.4.1 A hypersensitive response of ES cells to a wide variety of genotoxic treatments 
 
In this study, we show that pluripotent undifferentiated ES cells respond differently to 
genotoxic stress when compared to more differentiated mouse embryonic fibroblasts. ES 
cells are more sensitive to UV (causing helix-distorting photoproducts), gamma rays 
(inducing double strand breaks and oxidative lesions) and mitomycin C (evoking mono-
adducts, oxidative lesions, intra- and inter-strand cross-links), than MEFs. It is unlikely that 
the transformation process that MEFs underwent is the main cause of the relative resistance 
of these cells to a variety of genotoxic treatments, since UV sensitivity of primary MEFs is 
comparable to transformed MEFs (data not shown). Hypersensitivity could be caused by 
reduced repair capacity. However, in line with other reports we have shown that a 
deficiency for certain DNA repair factors in ES cells can cause hypersensitivity to various 
genotoxic agents, indicating that these repair pathways are active in ES cells (12, 43, 45). 
Moreover, using the repair replication assay it has been shown that NER kinetics at low 
doses (5 J/m2) are comparable between ES cells and MEFs, although repair capacity seems 
to saturate already at 10 J/m2 (45). In conclusion, these studies show that DNA repair is 
functional in ES cells, although the efficiency might be lower at more extreme doses. 
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5.4.2 Difference in contribution of TCR and GGR on cellular survival of MEFs and 
ES cells 
 
UV sensitivity of MEFs and human fibroblasts correlates with the ability of these cells to 
perform TCR, as attributed by a severe UV-sensitivity in Xpa- and Csb-deficient fibroblasts 
(this study and (7, 23, 24). In contrast to MEFs, in ES cells, global genome repair-capacity is 
the major determinant of UV sensitivity, as shown by the marked UV sensitivity of Xpa-/- 
and Xpc-/- ES cells. This observation can be explained by either a lack of TC-NER in ES 
cells and/or an overruling response from damage that is normally repaired by GG-NER.  
Non-functionality of TC-NER in ES cells does not seem to be likely, since we show that 
Csb-/- and Xpa-/- ES cells are hypersensitive for Illudin S, a DNA damaging agent that is 
specifically repaired by TC-NER. The extent of this hypersensitivity compares well with that 
observed in human fibroblasts (18). Therefore, TC-NER seems to be functional in ES cells, 
although the process might be overruled by damage responses originating from damage in 
the entire genome. In line with these observations, we previously showed that a TCR defect, 
associated with CSB deficiency, inflicts a more pronounced influence on sensitivity for 
oxidative lesions in MEFs than in ES cells (11).  
The  observed  UV  hypersensitivity  of Xpc-/- and Xpa-/- ES cells suggests that a lack of 
GG-NER inflicts greater deleterious effects on ES cells than a lack of TC-NER, as 
discussed above. Since Xpc-/- ES cells are deficient for GG-NER, and Xpa-/- ES cells lack 
both TC-NER and GG-NER, it is tempting to speculate that the extra deficiency in TC-
NER makes up the difference between Xpa-/- and Xpc-/- ES cells. Judging only from the 
slightly increased UV-sensitivity of Xpa-/- compared to Xpc-/- ES cells, this could be a valid 
explanation. However, the fact that we only observe a strong apoptotic response in Xpa-/- 
ES cells and not in Xpc-/- or Csb-/- ES cells indicates that the response of Xpa-/- and Xpc-/- ES 
cell lines differs fundamentally. Not only lack of GG-NER, but as well lack of either XPA- 
or XPC-protein determines the UV response of ES cells. This suggests that XPA and/or 
XPC proteins, beside their repair function, might have an additive role in apoptosis and/or 
cell cycle regulation.  
 
5.4.3 XPC might be involved in apoptotic signaling in ES cells 
 
In contrast to Xpa-/- ES cells, Csb-/- ES cells do not display a strong apoptotic response after 
UV treatment, arguing that the trigger for DNA damage-induced apoptosis in ES cells 
mainly arises from damage in the entire genome and not specifically from damage in the 
transcribed  strand,  as has been shown in fibroblasts (this study and (7)). The fact that 
XPC-/- ES cells are not triggered for apoptosis, but instead show a cell cycle block, suggests 
that in ES cells the XPC protein itself might be involved in sensing DNA damage and 
executing the apoptotic response. Contrarily, one could argue that XPA is needed to 
execute the cell cycle block and that a lack of this protein causes the switch-on of a 
safeguard mechanism by committing apoptosis. A strong argument against this second 
hypothesis is the fact that the low number of Xpa-/- ES cells that do not undergo apoptosis, 
show an identical cell cycle behavior as the Xpc-/- ES cell after UV treatment. Therefore, we 
hypothesize that the primary UV response is induction of apoptosis via a XPC mediated 
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pathway. The function of XPC in this pathway is unclear. A possibility could be that a partly 
assembled NER complex is a trigger for apoptosis. Since Xpc-/- ES cells miss the first step of 
damage recognition (42, 46), the complex is not formed and apoptosis is not induced. In 
this regard, analysis of ES cell lines lacking both XPA and XPC would be of great interest. 
Moreover, since it is disputed whether p53 plays any function in the protection of ES cells 
against genotoxic insults (1, 8) it is interesting to investigate whether this main apoptotic 
pathway in ES cells is p53 dependent. 
 
5.4.4 Xpc-/- ES cells are hypersensitive to UV in an apoptotic independent fashion 
 
Upon UV-irradiation, Xpc-/- ES cells as well as the fraction of Xpa-/- ES cells that did not 
undergo apoptosis, display a slower S-phase progression and probably arrest at late S/G2 
phase. The fate of these arresting ES cells is unclear. They might die later (although 
induction of apoptosis could not be observed up to 48h after UV-exposure) or stay in a 
senescent state. Analysis of these remaining cells is complicated by possible overgrowth of 
surviving cells. Also in hamster cells, it has been shown that DNA damage can cause S-
phase delay (34). It would be interesting to see whether p53 is needed for this response, 
since in fibroblasts it has been shown that both p53-/- and wild type mouse fibroblasts 
attribute a DNA replication arrest in response to UV (15). In conclusion, we suggest that in 
ES cells a sensitive apoptosis checkpoint as well as a cell cycle block, originating from un-
repaired UV damage in the entire genome, protect against genotoxic assaults. 
 
5.4.5 A double safeguard mechanism in ES cells protects against mutation 
accumulation  
 
We failed to show a difference in the UV induced HPRT mutation rate between wild type, 
Xpa-/- and Xpc-/- ES cells. This observation is in strong contrast with the previously observed 
UV-hypermutability of Xpa-/- and Xpc-/- fibroblasts (22, 27, 28). This indicates that the 
strong apoptotic response in Xpa-/- ES cells is likely to counteract mutation accumulation by 
eliminating premutagenic cells and thereby compensates for the mutagenic consequences of 
a total NER defect. Moreover, the observed S-phase delay in combination with a potential 
cell cycle block, as observed in Xpa-/- and Xpc-/- ES cells, is so effective that a deficiency in 
apoptosis induction is efficiently compensated. The observed safeguard mechanism in ES 
cells might be absent in other cell types. This might partly explain why Xpc-/- animals show 
an elevated mutation rate (30, 48, 49).  
However, CSB deficient ES cells are hypermutable, which might be due to the fact that 
although GG-NER is proficient, these cells keep a higher damage load in the transcribed 
strand, due to a deficiency in TC-NER. Escape from the cell cycle and apoptosis is probably 
relying on damage in the transcribed strand via a mechanism comparable to that observed in 
differentiated cell types (7, 23, 24). As known for these cell types, this mechanism is not able 
to completely protect cells from mutation induction (22). Moreover, ES cells lack a 
proficient G1 block (this study, (1, 36)), which is probably associated with a much simpler 
G1-S transition in ES cells. For example cyclinD/cdk4 and hypophosphorylated Rb are 
hardly detectable in ES cells (39, 40). Strikingly, a bias to mutations arisen from the 
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transcribed strand in Csb-/- and from the non-transcribed strand in Xpc-/- reflects the specific 
repair deficiencies in these cell lines. In Xpa-/- ES cells, mutations are mainly found in the 
transcribed strand, as was shown previously for human fibroblasts and Chinese hamster 
cells. 
In conclusion, progression of pre-mutagenic ES cells is strongly counteracted by apoptosis 
and cell cycle arrest, both relying on sensing DNA damage in the entire genome.  
 
5.4.6 ES cells: a model cell type for stem cells in the adult organism? 
 
The observed balance between the different genome caretaking mechanisms in ES cells is 
probably the extreme example of how an undifferentiated, pluripotent cell reacts to 
genotoxic stress (as summarized in Figure 5). On the right side of this figure, the classical 
view is depicted, showing how a more differentiated, proliferating cell type like a fibroblast 
copes with DNA damage. First, it attempts to repair the DNA lesions. To provide enough 
time for DNA repair, the cell can temporally arrests the cell cycle. Ultimately, when the 
repair capacity is exhausted, the cell might undergo apoptosis or a permanent cell cycle 
arrest. The left side of the figure presents a possible mechanism used by ES cells. These 
cells mainly rely on apoptosis and cell cycle delay, induced by damage in the global genome, 
to counteract the mutagenic effects of DNA damage. It is likely that in most cell types, a 
combination of these extremes can be observed. 
The optimal balance between the different genome caretaking processes is dependent on 
the specific requirements of that particular cell-type. For example, in postmitotic cells, 
which only have to maintain the genomic integrity of transcribed genes, global genome 
repair is not observed and only repair of transcribed areas is detected (32, 33). In contrast, 
reliance on only TC-NER in ES cells would be detrimental, since non-transcribed genes in 
an ES cell will accumulate damage and mutations, which might underlie severe 
malformation of the organism. Therefore, damage responses in ES cells are mainly focused 
on the damage in the global genome. Evidently, the strategy used by one cell type does not 
have to be beneficial for another cell type. 
As a consequence of stringent  genome caretaking processes ES cells show a lower 
mutation frequency, compared to MEFs (6). The drawback of this strategy is the high 
incidence of apoptosis. It is reasonable to assume that MEFs cannot use the same strategy, 
since it might cause an exhaustion of repopulation capacity and therefore MEFs should 
tolerate more mutations. Moreover a permanent G1 block, leading to senescence might be a 
valuable strategy for terminally differentiated cells, which do not have to divide per sé. The 
balance towards apoptosis and cell cycle block in ES cells, might as well explain the 
hypersensitivity of ES cell derived teratocarcinomas to chemotherapeutic cancer treatments 
(25, 26). Moreover, a similar strategy of high apoptotic levels is probably used by other 
stem-cell like cells with high proliferative rates, including cells from early developmental 
embryos (14, 16, 37) and stem cells in the intestine (35). It would be interesting to 
investigate whether indeed also in these cells apoptosis induction mainly relies on damage in 
the entire genome.  
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Figure 5 
Hypothetic model for a cell-type specific response on NER lesions.  
DNA damage can be repaired either by global genome repair or transcription-coupled repair. Persisting DNA 
damage in the transcribed strand blocks RNA polymerase II, which in turn can trigger apoptosis and/or a G1 
block. This response is probably the major pathway on which differentiated proliferating cells rely to guard their 
genome. Contrarily, damage in non transcribed areas might as well fire apoptosis and/or arrest the cell cycle. This 
pathway is the main pathway in ES cells and might as well be in other stem cells. As shown in the model a balance 
between these different pathways to repair DNA damage or to quit the cell cycle will finally account for the 
specific response of a certain cell type. 
5.4.7 Concluding remarks 
In this study, we put forward alternative ways which an undifferentiated pluripotent ES cell 
uses to cope with genotoxic stress, safeguarding the entire organism for huge malformations 
and mutations. Knowledge on how this cell type, and presumable comparable cell types, 
handle DNA damage may shed light on processes as cancer and aging. 
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Since the integrity of the genome is continuously challenged by a wide variety of different 
genotoxic insults, cells are equipped with an extensive set of genome caretaking processes. 
These include (i) various DNA repair pathways to remove DNA lesions, (ii) cell cycle 
regulation mechanisms that provide the cell with the possibility to extent the time window 
for repair of DNA damage, and (iii) pathways (e.g. apoptosis, senescence and mitotic death) 
that remove cells with excessively damaged genomes. As mentioned in the introduction, a 
specific balance between these mechanisms might exist in different cell types, in order to 
allow a cell type specific response to DNA damage. Hereby, the particular needs of the cell 
and the organism can be met. For example, persistent DNA damage in proliferating cells 
(e.g. skin or intestinal epithelium) can lead to mutations and thereby cause cancer. To 
counteract this process, a cell is able to commit apoptosis and thereby prevent accumulation 
of pre-mutagenic cells. However, loss of cells due to a high level of apoptosis can result in 
the loss of tissue homeostasis. This is extremely evident for non-regenerative tissues such as 
the brain, where neuronal loss is not compensated by tissue renewal. But even in the case 
tissue regeneration can take place, like in the liver, excessive apoptosis in principle can 
exhaust the regenerative capacity as a result of stem cell depletion by senescence or 
apoptosis. This depletion of regenerative potential may underlie the aging process. In short, 
it seems that genome caretaking is a continuous balance between cancer and aging.  
 
6.1 A cell type specific DNA damage response 
 
The work presented in this thesis has uncovered a marked difference between different cell 
types in their response to genotoxic treatments. Pluripotent embryonic stem cells (ES cells) 
were shown to be more sensitive than more differentiated cell types like mouse embryonic 
fibroblasts (MEFs) for treatment with UV-light, ionizing radiation or mitomycin C (chapter 
5). In contrast, keratinocytes are more resistant to UV-light and ionizing radiation than 
MEFs (chapter 3). Also, deficiencies for repair genes may have a different effect on cellular 
sensitivity in different cell types. We showed that whereas a deficiency for Csb causes γ-ray 
sensitivity  in  MEFs,  keratinocytes and ES cells (chapter 2 and 3), a Csa deficiency causes 
γ-ray sensitivity in ES cells, but not in MEFs and keratinocytes (chapter 3). Moreover while 
Xpa-/- MEFs are not sensitive for ionizing radiation, Xpa-/- ES cells and mice are (chapter 2). 
Similarly, while Csa-/- MEFs are sensitive for mitomycin C, Csa-/- ES cells attribute a similar 
sensitivity as wt ES cells. Moreover, Csa- and Csb-deficient mice attribute a similar 
mitomycin C sensitivity, while in MEFs only a Csa-deficiency causes mitomycin C sensitivity 
(chapter 4). Finally, we showed that in ES cells regulation of apoptosis and cell cycle after 
UV-irradiation mainly depends on damage in the entire genome, whereas in MEFs, lesions 
that hinder transcription are a strong trigger for apoptosis and cell cycle regulation (chapter 
5). This is reflected by the fact that the severest UV-sensitivity is found in GG-NER 
deficient ES lines and in TC-NER deficient MEFs. Moreover, although Xpa- and Xpc-
deficient ES cell lines are both UV-sensitive, only Xpa-/- ES cells show a marked induction 
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in UV-induced apoptosis. Therefore we suggested in chapter 5 that probably XPC protein 
might play a role in apoptosis induction in ES cells. 
In conclusion, we clearly showed a marked heterogeneity in stress response between 
different cell types. This is reflected both by the intrinsic sensitivity as well as by the effect 
of mutations in DNA repair genes on this sensitivity. Taken in account this heterogeneity it 
is difficult to extrapolate sensitivities from one cell type to another. Moreover, this can 
severely hinder extrapolation of data found in cell lines to the level of the whole organism. 
Studying only one cell type could therefore severely bias the conclusions. As a consequence, 
when studying the cause of certain diseases, the use of different cell types (ideally those cell 
types with relevance for the disease-etiology) is recommended. 
 
6.2 Phenotypical differences between CSA and CSB? 
 
Cockayne syndrome (CS), a rare inherited disorder characterized by UV sensitivity, severe 
neurodevelopmental and progeroid symptoms, is caused by mutations in the CSA or CSB 
gene. The loss of functional CSA or CSB proteins leads to a deficiency in the transcription-
coupled repair pathway of NER. In contrast, mutations that cause a complete inactivation 
of the whole NER reaction (as in XPA) lead to the disease xeroderma pigmentosum. 
Although this disease is characterized by severe photosensitivity and increased 
carcinogenesis, XP does not share with CS the severe neurodevelopmental and progeroid 
symptoms, and can therefore be regarded as milder. These data suggest that the function of 
CS-proteins may not be restricted to TC-NER. Indeed, functions of CSB in transcription as 
well as in (transcription-coupled) repair of non-NER lesions have been put forward. 
In line with these findings, we have provided evidence that Csb-deficient MEFs, 
keratinocytes, and ES cell are sensitive for oxidative DNA damage, which is not considered 
to be a classical NER-lesion (chapter 2 and 3). Moreover, Csb-/- mice are sensitive for 
oxidative DNA damage (chapter 2 and 3). Strikingly, completely NER-deficient Xpa-/- 
MEFs are not hypersensitive to γ-rays, whereas Xpa-/- ES cells and mice appear to be 
sensitive to oxidative DNA damage. This suggests that, at least in some cell types, repair of 
oxidative DNA damage requires classical TC-NER, while in other cell types a distinct non-
NER related function of the CSB protein is needed. 
Systematic differences in the symptoms between patients belonging to complementation 
group A or B have not been found. Similarly, Csa- and Csb-deficient mice attribute a 
comparable phenotype in all parameters studied thus far. Therefore, it has often been 
assumed that CSA and CSB function in the same pathway(s), and that mutations (or 
deletions) in the CSA or CSB genes cause the same phenotype. Interestingly, the work 
presented in this thesis for the first time uncovers a difference between CSA and CSB cells. 
We show that cells lacking Csa, in contrast to Csb-deficient MEFs and keratinocytes, are not 
sensitive for oxidative DNA damage. Similarly, Csa-/- mice appear not sensitive to the higher 
levels of 8-oxo-dG originating from a DEHP containing diet, whereas DEHP-evoked 
cytotoxic effects (detected as loss of body weight) are readily observed in Csb-/- mice 
(chapter 3). These findings seriously question the paradigm that CS is mainly caused by a 
defect in repair of oxidative DNA damage.  
Concluding remarks and future directions 125 
Differences in DNA damage sensitivity between CSA and CSB cells appear not restricted to 
oxidative DNA damage. We observed that Csa-/- MEFs attribute hypersensitivity to 
mitomycin C treatment, whereas the sensitivity of Csb-/- MEFs for this compound is within 
the wild type range (chapter 4). Therefore, we propose that the CSA and CSB proteins may 
function in different, not completely overlapping pathways. This hitherto unanticipated 
finding of mitomycin C sensitivity in Csa-/- MEFs, suggests a role of CSA in the cellular 
response to cross-links. Another NER-factor, ERCC1, has also been associated with cross-
link repair, as indicated by the severe cross-link sensitivity in Ercc1-deficient cells. However, 
whereas Csa-/- mice posses a mild phenotype, Ercc1 deficient mice are severely affected and 
die before weaning. Thus it appears that there is a different need for CSA and ERCC1 in 
cross-link repair. Therefore, it would be interesting to test the functionality of factors 
known to be involved in cross-link repair in a Csa-deficient background.  
 
6.3 Future directions 
 
The next paragraph lists a few issues that so far remained unsolved and that are interesting 
to be tackled.  
 
The studies presented in this thesis have shown the existence of different balances between 
genome caretaking mechanisms in different cell types. These studies were all performed on 
in vitro cultured, and thus proliferating cells. Since proliferation could have a major impact 
on cellular sensitivity as well as on which genome caretaking processes are needed, it would 
be interesting to extend these studies to non-dividing cells, or to cells that only divide after 
specific triggers. Furthermore, the mechanisms that cause these differences between the 
various cell types are still fairly unknown. Closer examination of the cytotoxic and genotoxic 
effects of DNA damaging agents on the various cell types studied thus far, and extension of 
these assays to other (non-dividing) cell types or organotypic cultures, will further help to 
unravel these mechanisms. To our opinion, these studies should use a combination of 
different techniques. Classical genetics and cell biology should be combined with powerful 
new techniques such as transcriptomics and proteomics. 
For example, to shed more light on the function of XPC in the UV response, a genetic 
approach can be taken. Here fore, ES lines defective for both Xpa and Xpc can be isolated. 
Classical experiments like survival, apoptosis and cell-cycle assays can already disclose part 
of the picture. However we strongly belief that for example expression profiling of the 
cellular response to stress at the RNA, as well as at the protein level can provide us with an 
more integrated picture. To our opinion such an integrated approach is not only 
recommended for this particular example, but can also easily be applied to more general 
questions like what causes the difference in stress responses in various cell types. To this 
end, we recently started to explore in our laboratory the transcriptional response of mouse 
dermal fibroblasts and embryonic stem cells to exposure to UV light in a dose and time 
dependent manner. These studies will probably be extrapolated to other cell types as well as 
expanded by proteomic studies.  
Our findings that CSB is involved in the cellular response to oxidative DNA damage, and 
that in contrast CSA is involved in cellular resistance against mitomycin C, suggest an 
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additional role of these proteins in different pathways. So far, it is not exactly known how 
the CSA and CSB proteins function in the cellular response to oxidative DNA damage and 
interstrand cross-links, respectively. To unravel these questions, an integrated approach is 
needed. On the one hand, we need to establish how mutations in the Csa or Csb gene 
influence the cellular stress response to various genotoxic agents. To achieve this goal, the 
“–omics” approaches as well as classical cell biological and genetic tools can be used. On 
the other hand, detailed knowledge on the function of these proteins in the cell upon DNA 
damage should be gathered. To answer these questions, classical biochemistry as well as live 
cell imaging are powerful techniques. To this latter end, specific proteins can be tagged with 
fluorescent markers. A promising recent development in this field is the use of cells (and 
tissues) derived from knock-in mouse models that express fluorescent protein tagged repair 
proteins at physiological levels from the endogenous locus, rather than (over)expressing the 
tagged proteins by cDNA-transfection. In addition, the combined use of a fluorescent 
protein tag with an HA or his-tag will permit rapid isolation of the tagged protein (or 
protein complex) of interest from a variety of cells in a defined genetic background. 
Moreover, proteomic approaches could unravel complexes wherein these proteins are 
constituents and thereby provide knowledge on their possible roles. Integration of data 
obtained in these different experimental systems will eventually lead to a better 
understanding of the function(s) of these proteins and thereby also shed light on the 
underlying cause of the associated disease.     
Last but not least, a major challenge for (molecular) biologists, geneticists and 
bioinformaticists will lie in the development of high-quality bioinformatics tools that 
integrate the wealth of heterogeneous data sets produced by the (semi) high throughput 
approaches as depicted above in order to provide a systemic picture of the biological 
processes that make up life. 
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Samenvatting 
 
 
7.1 Inleiding 
 
Het menselijke lichaam is opgebouwd uit vele honderden miljarden cellen, die afhankelijk 
van hun functie, kunnen worden onderverdeeld in ongeveer 200 verschillende celtypen 
(bijvoorbeeld huid-, spier-, bloed-, en zenuwcellen). Een groep van verschillende soorten 
cellen samen vormt een orgaan, dat een bepaalde functie in het lichaam vervult. De 
informatie die nodig is voor het functioneren van de cel en het bouwplan van de organen 
(en uiteindelijk het gehele organisme) is opgeslagen in de genen in het DNA, de drager van 
het erfelijke materiaal. Met de overdracht van één set DNA in de bevruchte eicel is alle 
erfelijke informatie aanwezig die nodig is om uit te groeien tot een compleet organisme. 
Elke cel bevat hetzelfde DNA, maar door het wel of niet actief zijn van verschillende genen 
kunnen cellen verschillende functies hebben. Met actief zijn van genen wordt bedoeld dat 
deze afgelezen (dat wil zeggen gekopieerd) worden (dit proces wordt transcriptie genoemd). 
Deze gekopieerde informatie, het RNA, wordt vervolgens door de cel vertaald in de 
functionele onderdelen (eiwitten) van de cel (dit proces heet translatie). 
Het is van groot belang is dat het DNA intact blijft, echter de integriteit van het DNA 
wordt continu bedreigd. DNA schade ontstaat door exogene bronnen, zoals zonlicht, 
Röntgenstraling, chemotherapeutica en polycyclische koolwaterstoffen (onder andere 
aanwezig in sigarettenrook en uitlaatgassen), maar ook door endogene bronnen, zoals 
zuurstof radicalen die tijdens het normale cel metabolisme gevormd worden. Het kopiëren 
van beschadigd DNA tijdens de celdeling kan leiden tot permanente veranderingen in het 
DNA (mutaties). Mutaties kunnen ongeremde celgroei veroorzaken, waardoor een cel zich 
kan ontwikkelen tot een kwaadaardige tumor. Een ander nadelig effect van DNA schade is 
dat de schade ervoor kan zorgen dat de informatie in het DNA, zoals opgeslagen in de 
genen, niet goed afgelezen wordt en dat daardoor de cel zijn functie niet meer kan vervullen 
en sterft. Celsterfte als gevolg van DNA schade, en daarmee de teloorgang van de cellulaire 
opbouw van weefsels en organen, wordt gezien als een mogelijke oorzaak van het 
verouderingsproces.  
Om het DNA intact te houden is de cel uitgerust met verschillende DNA herstel 
mechanismen. Elk mechanisme verwijdert een bepaalde klasse van DNA beschadigingen, al 
is er wel overlap tussen de verschillende herstel mechanismen (zie figuur 1 van de 
introductie). Om de cel voldoende tijd voor herstel te geven kan de celcyclus tijdelijk 
gestopt worden, waardoor de cel niet meer deelt en er dus ook geen mutaties kunnen 
ontstaan. Als echter de hoeveelheid DNA beschadigingen te groot is, kan de cel zelfmoord 
(apoptosis) plegen, waarmee voorkomen wordt dat er eventueel een tumor ontstaat. 
Een van de herstel mechanismen, ‘Nucleotide Excision Repair’ (NER), herstelt schades 
veroorzaakt door zonlicht en door bijvoorbeeld polycyclisch koolwaterstoffen (onder 
andere aanwezig in sigarettenrook en uitlaatgassen). Voor het opsporen van DNA 
beschadigingen gebruikt NER twee subroutes van het NER systeem. In het ene geval zoekt 
het NER systeem het gehele genoom af naar beschadigingen, in het andere geval loopt de 
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transcriptiemachinerie vast op beschadigingen en draagt daarmee zorg voor de schade 
herkenning. Mutaties in genen betrokken bij NER veroorzaken een aantal erfelijke 
aandoeningen. Het bekendste voorbeeld is xeroderma pigmentosum (XP). Deze ziekte 
wordt gekenmerkt door een zon- en UV-licht gevoelige huid, met zeer veel moedervlekken 
op de blootgestelde delen van de huid en een verhoogde kans op zonlicht geïnduceerde 
huidkanker. Een andere ziekte die geassocieerd wordt met een defect in NER is Cockayne 
syndroom. Deze ziekte veroorzaakt net als XP zonlichtgevoeligheid, maar wordt vooral 
gekenmerkt door een scala van lichamelijke en geestelijke afwijkingen. De 
levensverwachting van een CS patiënt is gemiddeld slechts 12 jaar. 
 
7.2 Dit proefschrift 
 
7.2.1 Hoe wordt CS veroorzaakt? 
 
XP kan veroorzaakt worden door mutaties in verschillende genen. Zowel defecten in het 
centrale mechanisme van NER als in de herkenning van beschadigingen in het gehele 
genoom kunnen leiden tot XP. CS wordt veroorzaakt door mutaties in het CSA of het CSB 
gen die leiden tot defecten in schadeherkenning via de vastlopende transcriptiemachinerie.  
Het is vreemd dat het uitschakelen van één herkenningsmechanisme tot een ernstigere 
ziekte leidt dan het uitschakelen van de totale herstelcapaciteit. Daarom is er gesuggereerd 
dat CSA en CSB eiwitten ook betrokken zijn bij andere processen dan NER. Het is 
aangetoond dat cellen van een patiënt met een defect in het CSB gen gevoelig zijn voor 
ioniserende straling. Ioniserende straling veroorzaakt onder andere oxidatieve DNA 
beschadigingen, die ook door het normale metabolisme ontstaan. Deze schade wordt niet 
door NER maar door een ander herstel mechanisme gerepareerd. Het zou dus goed kunnen 
dat het CSB eiwit betrokken is bij schadeherstel van oxidatieve DNA beschadigingen en dat 
endogeen ontstane oxidatieve DNA beschadigingen bijdragen aan het ontstaan van de 
symptomen van CS. 
In ons onderzoek hebben we vastgesteld dat verschillende soorten cellen, geïsoleerd uit 
muizen met een vergelijkbaar Csb defect als gevonden in een patiënt, gevoelig zijn voor 
oxidatieve DNA schade. Echter een Csa defect veroorzaakt geen gevoeligheid voor dit type 
schade. Deze vinding zet vraagtekens bij de veronderstelling dat CS veroorzaakt wordt door 
oxidatieve DNA schade.  
Verder hebben we onderzocht of cellen met een defect in de Csa of Csb genen gevoelig zijn 
voor andere typen schade. Het bleek dat Csa deficiënte cellen gevoelig zijn voor het 
chemotherapeuticum mitomycin C. Op cel niveau leidt een defect voor Csb echter niet tot 
een verhoogde gevoeligheid voor mitomycin C, terwijl muizen met een defect in Csa of Csb 
beiden gevoelig zijn. Dus ook voor deze andere schade is er geen consistent beeld. Dit alles 
wijst erop dat CSA en CSB eiwitten blijkbaar in verschillende mechanismen kunnen 
functioneren. 
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7.2.2 Verschillen tussen cellen in de DNA schade respons 
 
De vele verschillende celtypes in het lichaam kunnen ieder op hun eigen manier op DNA 
schade reageren. Een cel kan enerzijds proberen de schade te herstellen, waarbij de cel 
weliswaar in leven blijft maar wel de kans loopt op permanente veranderingen in het DNA, 
maar kan anderzijds ook besluiten over te gaan tot apoptosis, zodat potentiële kankercellen 
worden afgevoerd. In dit onderzoek hebben we gekeken naar de verschillen tussen cellen in 
hun repons op DNA schade. Hiertoe hebben we verschillende celtypes geïsoleerd. Naast de 
veelgebruikte fibroblasten (bindweefselcellen) hebben we ook gekeken naar keratinocyten 
(huidcellen) en embryonale stamcellen (ES cellen). ES cellen zijn de vroegste, nog totaal 
ongedifferentieerde cellen die het embryo vormen. Vanuit deze cellen ontstaan tijdens de 
groei en differentiatie van een embryo alle andere soorten cellen. Wij zagen dat ES cellen, 
vergeleken met de andere cel typen, extreem gevoelig waren voor verschillende soorten 
DNA schade. Vervolgens hebben we gekeken naar de functie van NER in deze cellen. Het 
bleek dat inactivatie van NER genen deze cellen nog gevoeliger maakt voor schadelijke 
gevolgen van UV licht. Ook in fibroblasten leidt het uitschakelen van NER tot een 
verhoogde UV gevoeligheid. Echter in fibroblasten veroorzaakt vooral het uitschakelen van 
de schadeherkenning door de vastlopende transcriptiemachinerie een verhoogde UV 
gevoeligheid, terwijl in ES cellen juist het uitschakelen van de algemene schadeherkenning 
er voor zorgt dat de cel erg gevoelig wordt voor UV. Het lijkt erop dat het voor een ES cel 
veel belangrijker is om het DNA intact te houden dan voor een fibroblast. Dit kan ermee te 
maken hebben dat een ES cel zijn DNA doorgeeft aan heel veel dochtercellen, terwijl 
fibroblasten het DNA alleen nog gebruiken om RNA af te schrijven en daarmee hun 
specifieke functie te vervullen. Het effect van deze verhoogde gevoeligheid is weliswaar 
meer celdood, maar de hersteldeficiënte ES cellen hebben een zelfde mutatiefrequentie als 
ES cellen zonder herstel defect. 
  
List of abbreviations 135 
List of abbreviations 
 
 
ATM  ataxia telangiectasia mutated (gene) 
BER  base excision repair 
CPD  cyclobutane pyrimidine dimer 
CS  Cockayne syndrome 
CSA/CSB Cockayne syndrome A/B (protein) 
DAR  differentiation associated repair 
DDB  DNA damage binding protein 
DEHP  di(2-ethylhexyl)phthalate 
ss/dsDNA single/double stranded DNA 
DNA  deoxyribonucleic acid 
DSB  double strand break 
ERCC  human excision repair cross complementing (gene) 
ES  embryonic stem (cell) 
FA  Fanconi anemia 
GG-NER global genome NER 
HNPCC  hereditary non-polyposis colorectal cancer 
hHR23B  human homolog of S.cerevisiae repair protein RAD23B 
HPLC  high performance liquid chromatography 
HR  homologous recombination 
kDa  kilodalton 
MEF  mouse embryonic fibroblast 
Mfd  mutation frequency decline 
MMC  mitomycin C 
MMR  mismatch repair 
NER  nucleotide excision repair 
NHEJ  non homologous end-joining 
nt  nucleotide 
8-oxodG  8-oxo-2’-deoxyguanosine 
PCNA  proliferating cell nuclear factor 
(6-4)PP  (6-4) pyrimidine-pyrimidone photoproduct 
RFC  replication factor C 
RNA  ribonucleic acid 
ROS  reactive oxygen species 
RPA  replication factor A 
TC-NER  transcription-coupled NER 
TCR  transcription-coupled repair 
TFIIH  transcription factor IIH 
TLS  translesion synthesis 
TTD  trichothiodystrophy 
UV  ultraviolet (light) 
wt  wild type 
XP  xeroderma pigmentosum 
XPA-G,V xeroderma pigmentsosum group A-G,V (protein) 
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